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Summary

An

investigation

of

the

two

major

stress

pathways,

the

sympathomedullary system, and the hypothalamic-pituitary-adrenal (HPA)
axis and their role in the mediation of the physiological response to acute
stress was undertaken in the sheep. Particular emphasis was given to the
metabolic regulation initiated by these two stress pathways. In addition, the
specific role of each pathway was assessed. This was achieved by using
tw o different approaches. Firstly, by the active immunisation against ACTH
1-24,

which

acts to

immunoneutralise the

glucocorticoid

response.

Secondly, a pharmacological approach using non-selective adrenergic
receptor antagonists. Propranolol HCI, a /^-adrenergic antagonist and
phentolamine methane-sulfonate, a or-adrenergic antagonist were used. To
determine the contribution of the sympathetic nervous system

tyramine

HCI, a potent sympathomimeteic agonist compound was infused into
sheep.

The stress response to dynamic exercise (2.5 km/h and 5 km/h) was
examined in both ACTH-immune and non-immune sheep

(a? =

3 per group).

During the experiments the adrenergic antagonists were infused into both
groups of animals.

in the non-immune sheep, exercise activated both stress pathways and
the degree of stimulation was proportional to the exercise intensity. In the
ACTH-immune sheep, only the sympathomedullary system was activated.
Exercise stimulated the level of plasma glucose and lactate in both groups,
while maintaining plasma insulin concentrations at or near basal levels. In
addition, there was little difference in the cardiovascular response in either
group.

The importance of the hypothalamic-pituitary-adrenal axis during exercise
particularly in relation to energy substrate metabolism was highlighted by
v

the failure of the ACTH-immune group to mobilise plasma free fatty acids
(FFA's). The increase in FFA's was shown to be mediated by the /?adrenergic receptor. Inhibition of insulin section and the stimulation of
glucose release was shown to be mediated by the a-adrenergic receptor.

The contribution of the sympathetic nervous system to an acute stress
response was examined by infusion of tyramine HCL into non-immune
sheep. In addition, the receptor type responsible for the mediation of
metabolic and haemodynamic changes was also assessed. Tyramine HCI
infusion

into

non-immune

sheep

(/? = 4)

stimulated

the

release

of

endogenous noradrenaline. Neither plasma adrenaline or cortisol levels
increased. Tyramine HCI infusion increased plasma FFA's, plasma glucose
and plasma insulin levels as well as increasing arterial blood pressure.
Plasma

insulin

levels

were

unaffected

by

the

increased

plasma

noradrenaline levels, suggesting that the inhibition of insulin secretion in the
sheep is mediated by adrenaline and not noradrenaline.

Surgical procedures under general anaesthesia and anaesthesia alone were
used as "unnatural" acute stressors to assess the stress response in both
ACTH-immune and non-immune sheep (/? = 3 per group). The carotid artery
from both the ACTH-immune and non-immune groups was catheterised
under general anaesthesia. Only the non-immune sheep were subjected to
the anaesthesia only treatment. The stress responses were quite distinct
with anaesthesia exerting less influence on the endocrine function than the
combined stress of surgery and anaesthesia. The sympathomedullary
pathway was suppressed in both groups in response to anaesthesia only or
surgery. Activation of the HPA axis during surgery in the non-immune group
was associated with

increased plasma glucose, FFA's and reduced

circulating insulin levels. In contrast, the ACTH-immune sheep were unable
to modulate these metabolic and endocrine changes.

It is concluded, that the nature of the stressor itself dictates the response
vi

from the two stress pathways. The sympathomedullary pathway appears to
be the most important axis during exercise and the hypothalamic pituitary
adrenal pathway to be the dominant axis during surgery. Exercise as a
stress stimulates catecholamine release which in turn mobilises stored
energy substrates while inhibiting peripheral insulin. The HPA-axis plays an
important role during exercise in energy substrate mobilisation especially
the lipolytic response. Suppression of the sympathomedullary pathway
results in a more dynamic role for the HPA-axis whereby it initiates
catecholamine-like

effects;

mobilising

suppressing insulin secretion.
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Chapter 1

Introduction

"Stress Is a dangerous and useless word. It may seem useful because it is a
unifying word, but it unifies our ignorance rather than our knowledge"

(Zanchetti 1972).

This notion was further elaborated by Harvey and co-workers (1984) and
they characterised stress as being "an ill-defined concept, that attempts to
describe the interaction

of an organism with

environmental stimuli

perceived as imposing a threat, real, or anticipated, on its survival or
wellbeing".

Exposure to a variety of environmental events can evoke a wide range of
physiological changes. Historically, these physiological adaptations were
divided into two distinct phases "the emergency reaction" and the "general
adaptation syndrome". The "emergency reaction" as described by Cannon
(1935) involves actions which are mediated via the stimulation of the
sympathetic nervous system and the release of hormones from the adrenal
medulla. Cannon delineated this reaction as an acute response and involved
the

release of humoral factors

(catecholamines) that mobilised the

organisms physiological resources for "flight or fight".

Hans Seyle (1936) described the overall physiological response to "diverse
noxious agents", which encompassed both an acute as well as a chronic
phase. This latter phase Seyle termed the "general adaptation syndrome" in
which the organism adapts to a given stressor over time with a standard
physiological response irrespective of the nature of the stressor. This long
term reaction is characterised by the activation of the hypothalamicpituitary-adrenal (HPA) axis. It involves the release of adrenocorticotropic
hormone (ACTH) from the pituitary gland, which in turn stimulates the
1

synthesis and the secretion of corticosteroids from the adrenal cortex.
These

corticosteroids

then

modulate

the

non-specific

physiological

adaptation of peripheral tissues.

The activation of the sympathomedullary system and the HPA axis in
response to various potential hostile stressors and the animals responses to
their release enables the cells of an organism to be maintained within
closely defined physiological limits. Thus the maintenance of a constant
interior milieu, recognised by the 19th century physiologist Claude Bernard

(1878) can be maintained by physiological and behavioural homeostatic
adaptations.

Judge and co-workers (1966) claimed that farm animals were prone to the
unfavourable consequences of stress because their genetic selection results
in metabolic processes which are anabolic in nature, whereas mechanisms
aimed at survival are, on the whole, catabolic in nature. This reduced
homeostatic capacity of farm animals to respond to stress is manifested by
ongoing farm practices in which animals are helped to cope with stress by
the farmer. For example domestic animals are provided with a variety of
anti-stress drugs, to repress their reactions to environmental stressors;
antibiotics to control microbial growth and hormones and vitamins to
compensate for a deficiencies in their physiological defence mechanisms
(Dantzer and Mormede, 1979).

Most of the past research into the effects of stress on farm animals has
focused on chronic stress conditions whereby animals are exposed to the
same stressors or to repeated stressors for a long period of time, rather
than acute stress. This may be an important consideration in animal
practice as chronic stressors are not uncommon in animal husbandry.
However, acute stressors undoubtedly have wide ramifications for the well
being of farm animals and therefore animal product quality especially when
stressors are novel.
2

In this thesis, I explore the physiological responses of sheep following
exposure to acute stress. Particular emphasis was given to processes
involving metabolic regulation. These studies were aimed at achieving a
better understanding of the interaction between the two major stress
pathways, the adrenomedullary system and the HPA axis when sheep are
subjected to acute stress.

3

Chapter 2

Literature Review

The Sympathetic Nervous System and the Hypothalamic-Pituitary-Adrenal
Axis

2.1. Introduction

The catecholamines and adrenocorticosteroids are both

important

physiological responses to stress. They are also, in themselves important
endocrine regulators which act to maintain homeostasis in many species,
including the sheep. Adrenaline and noradrenaline play a major role in the
short term regulation of energy substrate availability and have significant
effects on the metabolism of carbohydrate, fat, and protein (McDowell and
Annison, 1991). These two catecholamines, along with dopamine, are the
active neurotransmitters of the adrenal medulla and sympathetic nervous
system. This sympathomedullary system is basically the alarm system for
"fight or flight".

The hypothalamic-pituitary-adrenal axis also plays a major role in
facilitating other physiological systems to maintain homeostasis during
exposure to stress. Stimulation of this axis by acute stressors has profound
metabolic effects. These involve the promotion of carbohydrate metabolism
and lipolysis, with the subsequent release of free fatty acids (Odio and
Brodish, 1988; Widmaier, 1992). However, it is in their role as co
ordinators of the long term adaptations to chronic stress that the
glucocorticoids exert their most important effects.

4

2 .2 Catecholamines

2.2.1 Biosynthesis of Catecholamines

The principal catecholamines are noradrenaline, adrenaline and dopamine.
Both adrenaline and noradrenaline occur in high concentrations in the
adrenal medulla, with dopamine present in only small amounts. The
catecholamines are stored in the chromaffin granules which are analogous
to the secretory granules found in many other endocrine tissues (Blaschko
and Welch, 1953). Chromaffin granules also contain ATP, chromogranin,
lipids, and RNA (Hillarp eta/. ,1955; Philippu and Schümann, 1963).

Catecholamines are formed by the hydroxylation and decarboxylation of
precursor amino acids, phenylalanine and tyrosine. Some important steps in
the pathway are the formation of DOPA (Imaizumi, 1938), and conversion
of DOPA to dopamine by DOPA decarboxylase (Holtz, 1939). From these
and other studies the following biosynthetic pathway was derived, tyrosine
-> DOPA

dopamine

noradrenaline -* adrenaline.

The presence of dopamine in the adrenal gland was first reported by
Goodall (1950). In vivo experiments using dopamine-C14 demonstrated that
it was converted to adrenaline within the adrenal medulla deeper and
Udenfriend, 1956) and similar experiments by Masuoka et a/. (1956)
demonstrated that noradrenaline-C14 was also converted to adrenaline. The
presence of these products within the adrenal gland has lent support to the
existence of a catecholamine biosynthetic pathway within the adrenal gland
which had been postulated by Blaschko (1939). The same pathway for
catecholamine synthesis has also been confirmed in organs other than the
adrenal gland, including the brain (Carlsson et aL, 1958) and the splenic
nerve (Schümann, 1956).

Dietary tyrosine is the normal precursor of catecholamine biosynthesis but
5

dietary phenylalanine can be converted to tyrosine by phenylalanine
hydroxylase in the liver, and the tyrosine formed in this way can also act as
the precursor. Tyrosine is transported to the adrenal medulla, adrenergic
nerve endings, brain, and sympathetically innervated tissues where it is
converted to dopa and then to catecholamines. The conversion occurs in
the cytoplasm and is activated by tyrosine hydroxylase which

can be

inhibited by the subsequent products, dopamine and noradrenaline. The
conversion of tyrosine to DOPA is the rate limiting step in the biosynthetic
pathway. Phenylanaline hydroxylase is exclusively localised in the liver and
this contrasts to tyrosine hydroxylase which is localised within the
catecholamine containing organs. Upon formation, dopamine enters the
granulated vesicles of the adrenal medulla and the neuronal cells where
conversion to (and the storage of) catecholamines occurs. Noradrenaline is
synthesised within the adrenergic nerve endings; however, some of the
noradrenaline is also manufactured elsewhere and is taken up from the
blood stream. Circulating adrenaline is also taken up in small amounts by
the noradrenergic nerve endings. Catecholamines cannot pass through the
blood brain barrier (Jesova et at., 1990). Therefore, brain catecholamines
are synthesised de novo from precursor amino acids which are taken up
from the circulation across the blood brain barrier.

Dopamine represents only a small percentage of the total adrenal
catecholamines; most of the adrenal dopamine is beta-hydroxylated to
noradrenaline and then to adrenaline (Carlsson et at., 1973). While its
synthesis in the adrenal medulla and the adrenergic nerve endings is similar,
some

of

the

medullary

cells

contain

the

cytoplasmic

enzyme

phenylethanolamine-N-methyltransferase (PNMT). This enzyme catalyses
the conversion of noradrenaline to adrenaline and is found in high
concentrations only in the adrenal medulla. For this reason it is only the
adrenal medulla that produces substantial quantities of adrenaline.

6

2 .2 .2 . Metabolism of Catecholamines

As with all neurotransmitters and hormones, the released agent must be
rapidly dissipated when the response it induced is no longer necessary
(Mersmann, 1989). Catecholamines, when released, may re-enter the nerve
endings

via

specific

uptake

transport

mechanisms

(Iverson,

1974;

Trendelenburg, 1979) or dissipate from the effector site. This latter action is
the major source of circulating noradrenaline and dopamine (Mersmann,
1989). The catecholamines are converted to biologically inactive products
under

the

influence

of

catechol-o-methyltransferase,

(COMT),

and

monoamine oxidase, (MAO). Catechol-o-methyltransferase promotes the
methylation of the hydroxyl group at position 3 on the aromatic ring to
produce the inactive metabolites methoxytyramine, normetanephrine, and
metanephrine from dopamine, noradrenaline, and adrenaline, respectively
(Goldberg and Marsden, 1975). Monoamine oxidase acts to

remove the

amine group from the side chain of the catecholamines (Mersmann, 1989).
As most noradrenaline is released directly into individual tissues from the
sympathetic nerve endings, considerable metabolism may occur before it
reaches the circulation. Degradation of adrenaline in the circulation is via omethylation by COMT in the liver.

2.3. The Autonomic Nervous System

The autonomic nervous system is also termed the visceral, vegetative, or
involuntary nervous system. It's peripheral representation consists of
nerves, ganglia and plexuses that provide the innervation to the heart,
blood vessels, glands, viscera and smooth muscles. In general, this system
regulates the activities of structures that are not under voluntary control.
Respiration, circulation, digestion, thermoregulation, metabolism, and the
secretions of certain endocrine glands are regulated, in part or whole by the
autonomic nervous system. This system is divided into two subdivisions,
these

are

the

parasympathetic

(or
7

craniosacral

outflow)

and

the

sympathetic (or thoracolumbar outflow) nervous systems.

The sympathetic system is distributed to effectors throughout the body,
whereas the parasympathetic distribution is more limited. The sympathetic
nerve fibres form branches which may traverse a considerable distance
along the sympathetic chain passing through several ganglia before it finally
synapses with a post ganglionic neuron. The parasympathetic system has
its terminal ganglia near to the innervated organs and therefore is more
discrete and limited in its discharge of impulses. The sympathetic and
parasympathetic systems are considered to be physiological antagonists; if
one system inhibits a certain function, the other often augments that
function. The sympathetic system and the parasympathetic system are
normally active at all times, with the level of activity varying from moment
to moment and organ to organ. This enables fine adjustments to a
constantly

changing

environment.

The

sympathomedullary

system,

consisting of the sympathetic nervous system and the adrenal medulla,
together act as a single unit, especially during rage and fright when all
sympathetically innervated structures are affected simultaneously. This
prepares the organism for "fight or flight". The parasympathetic system is
organised mainly for discrete and localised discharge and not for mass
responses. It is concerned primarily with the functions of conservation and
restoration of energy reserves rather than with the expenditure of energy
(Grollman, 1978).

Transmission of impulses through the synapses of the autonomic nervous
system

is

mediated

by

two

neurotransmitters,

acetylcholine

and

noradrenaline. In the parasympathetic system, transmission at the synapses
of both the ganglion and the neuroeffector junctions is mediated by the
production of acetylcholine; this is termed cholinergic transmission. The
sympathetic system is considered to be adrenergic as transmission through
the synapses involves both acetylcholine and noradrenaline, the former at
the presynaptic, the latter at the neuroeffector junction although, in some
8

animals acetylcholine is released at post-synaptic sites (Koelle, 1975).
2.4. Adrenergic Transmission

Von Euler (1954) found a sympathomimetic like substance in highly
purified extracts of sympathetic nerves and effector organs, and determined
that the substance bore a strong resemblance to noradrenaline. He
proposed that the sympathetic transmitter was noradrenaline and that
during sympathetic nerve stimulation small quantities of adrenaline may
also be liberated. Other workers (see review by Hillarp et a!., 1966),
confirmed

that

noradrenaline

is

the

predominant

sympathomimetic

substance in postganglionic sympathetic nerves and is the adrenergic
mediator liberated after their stimulation.

The adrenal medulla is considered to be part of the sympathetic nervous
system; however, physiologically the adrenal medullary cells differ from
sympathetic neurones. The adrenal medulla secretes a mixture of both
adrenaline and noradrenaline, whereas the sympathetic neurones secrete
mainly noradrenaline. The medulla releases these hormones into the
peripheral circulation and its physiological action is at distant sites. In
contrast,

the

sympathetic

neurones secrete

noradrenaline from

the

terminals of their axons in intimate association with the tissue to be
influenced.

2.5. Catecholaminergic Receptors

Adrenaline and noradrenaline regulate physiological processes through
their

interaction

with

specific

cell

surface

receptors.

These

catecholaminegic receptors were initially classified as a- and /?-adrenergic
based on their relative pharmacological properties (Alquist, 1948). The
classification is based on the relative abilities of adrenaline, noradrenaline
and isopropylnoradrenaline to produce a particular response from these
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receptors.

Noradrenaline

stimulates

principally

t he

a-receptors;

isopropylnoradrenaline stimulates principally /7-receptors and adrenaline
stimulates both, (Himms-Hagen, 1967). Later studies by Lands et a!.,
(1967) described two classes of ^-adrenergic receptors, termed /?1 and /?2
and tw o classes of or-adrenergic receptors, termed o1 and a2. Ariens et a!.
(1979) suggested that the /?1 -receptors are stimulated by noradrenaline
released from the sympathetic nerves and that the /72-receptors are
stimulated by adrenaline released from the adrenal medulla. Evidence of
three /7-receptor types was suggested to account for the non-/?1- and non/?2-adrenergic responses of rat brown and white adipose tissue. The
characterisation of a gene coding for a third /?-adrenergic receptor was
reported in humans (Emorine et a!., 1989) and

rodents (Nahmias et a!.,

1991). Recent studies have confirmed the existence of three distinct /?adrenergic receptors (Caron and Lefkowitz, 1993).

Separate intracellular events characterise ar1- and the a2-receptor
stimulation as they are linked to different intracellular second messenger
pathways (Fain and Garcia-Sainz, 1983). The a1-adrenergic receptor affects
involve the turnover of phosphatidylinositol and the elevation of cytosol
Ca2+ while the a2-adrenergic receptor affects involve the inhibition of
adenylate cyclase (Wikberg, 1979). Stimulation of the a1- receptors is by
noradrenaline released from the sympathetic nerve endings and stimulation
of the o2- receptors is by adrenaline released from the adrenal gland.
Recent studies have found three distinct a1- and three distinct a2adrenergic receptors (Caron and Lefkowitz, 1993). These receptors are all
encoded by different genes and are all pharmacologically distinguishable.

Both

a-

and

^-adrenergic

receptors

bind

ligands

with

different

pharmacological profiles and are coupled to different signal transduction
mechanisms (i.e. stimulation or inhibition of adenyl cyclase or stimulation of
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phosphatidylinositol hydrolysis (Caron and Lefkowitz, 1993).

Adrenergic

receptors mediate a series of complex transmembrane signalling events or
intracellular processes that often lead to gene activation. This signalling
system is composed of three functional components, the receptor with its
seven

hydrophobic

transmembrane

segments,

a guanine

nucleotide

regulatory protein, (G protein), that mediates the interactions of the
receptor, and an effector component that can be either adenyl cyclase or an
ion channel, (K+ or Ca2+) (Lefkowitz and Caron, 1988; Casey and Gillman,
1988). Activation of the receptor leads to the subsequent interaction of the
receptor with it's appropriate G protein which in turn promotes nucleotide
exchange and activation of the G protein. This results in the modulation of
the activity of an effector system. Activation of the adrenergic receptor,
which increases cyclic AMP levels due to activation of adenyl cyclase,
results in phosphorylation of protein kinase A (Alberts et al., 1989).
2.6. Catecholamine Release in Response to Stress
Stimuli from the internal and external environment are transformed into
neural information and integrated within the central nervous system where
they may be perceived as being stressful (Ramade and Bayle, 1982).
Stressors known to activate the sympathetic nervous system in the intact
animal include exposure to cold or heat, emotional stress, trauma, tilting,
hypotension, exercise, birth, hypoxia, hypercapnia, arousal from hibernation
and surgery (Graham, 1975).
Stress results in the stimulation of the sympathetic nervous system and
the rapid release of the catecholamines from the adrenal chromaffin cells
and the sympathetic nerve terminals into the peripheral circulation. The
catecholamines

may

be

released

in

proportion

to

their

adrenal

concentration, however, adrenaline can be preferentially released following
methylation of noradrenaline by phenylethanolamine-N-methyltransferase
(PNMT) (Harvey et a!., 1984). The release of catecholamines during stress
11
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can

therefore

deplete

adrenal

catecholamine

stores,

especially

the

noradrenaline content (Rees et a/., 1984). The maintenance of elevated
plasma adrenaline concentrations during stress or the replenishment of
adrenaline stores is ensured by increased levels of adrenal PNMT activity
(Jurani et aL, 1978).

2.7. Metabolic Effects of Adrenaline and Noradrenaline

2.7.1. Carbohydrate Metabolism

Both noradrenaline and adrenaline promote hyperglycaemia. Associated
with this are increased glycogenolysis, increased gluconeogenesis and
decreased peripheral glucose utilisation. In this regard adrenaline is far more
effective than noradrenaline. For example in the sheep it has been reported
that noradrenaline is only 20% as effective as adrenaline with respect to
the

glycaemic

rise

(Bassett,

1970).

Both

hepatic

and

muscular

glycogenolysis rates are increased via activation of the /?2-adrenergic
receptors (McDowell and Annison, 1991). Infusion of adrenaline into sheep
(Bassett, 1970) increased muscle glycogenolysis as evidenced by the
increased circulating lactate levels. When catecholamines bind to the ßadrenergic receptors on the plasma membrane of hepatocytes, this
activates adenylate cyclase which, in turn, catalyses the formation cyclic
AMP (cAMP). This cAMP activates a protein kinase which phosphorylâtes
both phosphorylase kinase and glycogen synthetase.

Phosphorylated

phosphorylase kinase enhances glycogen breakdown while phosphorylation
of glycogen synthetase inhibits its action.
Adrenaline stimulates gluconeogenesis in the liver by increasing the
availability of the gluconeogenic substrates, lactate and glycerol which are
generated

during

lipolysis.

Increases in gluconeogenesis

have

been

demonstrated in the dog following administration of adrenaline (Stevenson
et aL, 1991). This increase was suggested to result from firstly, the
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stimulation of precursor release from peripheral stores which initiated
substrate movement into the hepatocytes and, secondly, by increased
intrahepatic gluconeogenic efficiency. In his studies on sheep, Bassett
(1970) demonstrated that the infusion of noradrenaline had no stimulatory
effect on either blood glucose or lactate levels. Infusion of catecholamines
is also associated with a decrease in the metabolic clearance rates of
glucose (Himms-Hagen, 1967). This effect could be due to an increase in
muscle cell glucose-6-phosphate levels formed during glycogenolysis. This
intermediary in glucose metabolism is a potent inhibitor of glucose uptake
(Brockman and Laarveld, 1986).

Glucagon, which is secreted by the pancreatic a-cells, plays an important
role in stimulation of hepatic glycogenolysis and hepatic gluconeogenesis.
In both cases increases in cyclic AMP have been shown to coincide with
increases in glucose output after glucagon stimulation (Sutherland et a!.,
1968). Both adrenaline and noradrenaline have been shown to stimulate
glucagon levels, (Steffens and Strubbe, 1983).

The catecholamines have indirect actions on carbohydrate metabolism by
affecting insulin secretion in sheep (Bassett, 1970) and man (Clutter et a!.,
1988). Inhibition of insulin secretion is mediated via the a2-adrenergic
receptors of the /?- pancreatic cells (Clutter et aL, 1980). This or2-adrenergic
action

inhibits insulin secretion independently of the blood glucose

concentration. Activation of /?2-adrenergic receptors stimulates insulin
release (Remie et a!., 1989). When the sympathetic nerves to the islets of
Langerhans are activated, noradrenaline is released as well as the peptide
galanin which is present,

colocalised with noradrenaline (Dunning et a!.,

1990). Suppression of insulin secretion and the increase in both plasma
adrenaline and noradrenaline through activation of the sympathetic nervous
system is highly coordinated. This occurs firstly by the release of both
noradrenaline and galanin and secondly, by the

stimulation of the ¡32-

adrenergic receptor by adrenaline resulting in the release of noradrenaline
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and galanin from the sympathetic nerve endings (Scheurink et aL, 1992).

Because catecholamines have effects on both insulin and glucagon, the
molar ratio between these two pancreatic hormones can be altered. A
decrease in the insulin to glucagon ratio results in the mobilisation of
metabolic fuels such as glucose and free fatty acids (FFA's) into
extracellular fluids. Increased glucagon levels decrease glucose uptake by
cells and also decrease the capacity of the liver to synthesise glycogen. A
fall in the insulin : glucagon ratio was observed by Boettger et aL, (1972)
when dogs were exercised on a treadmill to the point of collapse. This is
related to the animals requirement for increased glucose utilisation, rather
than to a state of hypoglycaemia, which was not evident in this study.
2 .7 .2 . Lipid Metabolism

The sympathetic nervous system is the main regulator of lipolysis in man
(Webber and Macdonald, 1993) and sheep (Bassett, 1970). In ruminants,
catecholamines are more potent stimulators of lipolysis than glucagon
(Vernon,

1980).

Adipocytes

possess

both

stimulatory

^-adrenergic

receptors and inhibitory a2-adrenergic receptors with /7-receptors being the
more abundant. Both /?1- and /?2-adrenergic receptors have been identified
in human subcutaneous adipose tissue and more recently the /?3-adrenergic
receptor has been shown to be active in adipose tissue although less active
in superficial tissues (Emorine et aL, 1994). Catecholaminergic stimulation
of the ^-adrenergic receptor causes dissociation and activation of the GTPbinding protein (Gs, stimulatory), which interacts with and activates
adenylate cyclase. Adenylate cyclase catalyses the formation of cyclic AMP
which activates protein kinase-A which in turn acts to phosphorylate
hormone-sensitive lipase. The end result is the release of fatty acids and
glycerol into the peripheral circulation. The rate-limiting step in lipolysis is
the initial hydrolysis of stored triglycerides by hormone-sensitive lipase.
There are other hormones which will also activate the /7-adrenergic
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receptor, including growth hormone and the glucocorticoids. It has been
suggested that growth hormone may enhance the transduction of the /?adrenergic signal by increasing the number of /?-adrenergic receptors
(Vernon, 1992). Other studies have failed to reveal an effect of growth
hormone on the a2-adrenergic receptor (Vernon, 1992). Glucocorticoids will
increase the ^-adrenergic receptor number in rats, (Giudicelli et aL, 1989),
however, associated with this is a decrease in maximum adenylate cyclase
activity.

In ruminants, catecholamines inhibit lipogenesis (Vernon, 1980) and this is
associated with a decrease in the activity of acetyl CoA carboxylase, an
enzyme essential for lipogenesis. Changes in the phosphorylation state
have been shown to play a major role in the acute control of acetyl CoA
carboxylase

(Vernon,

1992),

but

the

mechanism

by

which

the

catecholamines induce these changes remains to be determined.

Mobilisation of lipid stores requires a close interaction between adrenergic
actions on adipose tissue blood flow and those on lipolysis. The
sympathetic innervation of white adipose tissue is mainly of the vasculature
rather than the adipocytes (Fredholm, 1985). Stimulation of a-adrenergic
receptors

results

in vasoconstriction

and activation

of ^-adrenergic

receptors results in vasodilation. It is considered that catecholamines act
mainly on the adipocytes while neuronal effects on lipolysis are indirect and
due to changes in blood flow to adipose tissue (Webber and Macdonald,
1993). Lands et aL, (1967), reported that lipolysis was mediated by
stimulation of the £1 -adrenergic receptor and that vasodilation was
mediated by stimulation of the /?2-adrenergic receptors. They also reported
that noradrenaline preferentially activates the /?1 -adrenergic receptor while
adrenaline is a potent agonist for the /?2-adrenergic receptor. This suggests
that direct effects on lipolysis are largely due to noradrenaline and effects
on vasodilation are largely due to adrenaline.
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2.7.3. Protein Metabolism

Catecholamine effects on protein metabolism are not as well documented
as those on carbohydrate and lipid metabolism. Infusion of adrenaline into
humans decreased plasma amino acid levels, and this was especially so for
the branch chained amino acids (Shamoon et a!., 1980). The response to
adrenaline was thought to be mediated via the ^-adrenergic receptor
because the decrease in amino acid levels was prevented by the
administration of propranolol, a nonselective ^-antagonist. The effect on
protein metabolism was

similar to that of insulin. This was observed by

Miles et al. (1984), who demonstrated a decreased rate of proteolysis
during adrenaline infusion in humans which is similar to the response
induced by insulin. However, unlike insulin there was no stimulation of
protein synthesis (Castellino

et a!.,

1990; Mathews et a!.,

1990).

Adrenaline acts to increase the splanchnic uptake of gluconeogenic amino
acids and also to increase the production of alanine from muscle. Branched
chain amino acid levels within the muscle decreased after adrenaline
treatment, indicating reduced protein synthesis (Del Prato et a!., 1990).

Adrenaline infusion for 8 days has been reported to have anabolic effects
in

rats (Racotta et al., 1986). In this experiment, growth rate was

suppressed for 8 days during the infusion and then anabolic processes
returned to normal once the infusion was stopped. The infusion of
noradrenaline also depressed growth rate in these rats but returned to
normal after the end of the infusion.

Little is known of the effects of catecholamines on growth in ruminants.
Oddy et al. (1987) showed no change in proteolysis in the hindlimb muscle
of lambs during the infusion of adrenaline, but the rate of protein synthesis
was reduced.
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2.8. Activation of the Sympathetic Nervous System and Adrenergic
Antagonists

Adrenergic blocking agents, have been used in many studies to determine
the metabolic responses mediated by the activation of the sympathetic
nervous system. These molecules bind to the receptors without eliciting a
response and prevent binding of the endogenous ligand. Early studies were
chiefly

concerned

with

the

metabolic

action

of

adrenaline

and

noradrenaline. The aim of these studies was to determine the metabolic
responses elicited by activation of the a-adrenergic receptors and those
elicited by activation of the ^-adrenergic receptors.

2 .8 .1 . Catecholamine Infusions

A classical study by Bassett (1970) in sheep demonstrated increased
plasma levels of glucose, lactate, and free fatty acids (FFA) after a 30
minute

intravenous

adrenaline

infusion.

Intravenous

infusion

of

noradrenaline for 60 min increased plasma FFA levels only, but had only a
small effect on plasma glucose and lactic acid concentrations. Similar
effects on plasma glucose, lactate, and free fatty acid levels have been
reported in sheep after a 3 hour intravenous infusion of adrenaline
(Halmagyi et a!., 1967). These workers also observed increases in pyruvic
acid, systemic arterial pressure, cardiac output and oxygen consumption. In
sheep, an intravenous adrenaline infusion for 3 hours increased heart rate,
and progressively lowered arterial blood pressure during the infusion period
(Wood et a\., 1979).

These physiological and endocrine changes have also been reported in
other species. Both adrenaline and noradrenaline infusions increased plasma
FFA's and glycerol levels in fed and fasted cattle (Blum et al., 1982).
Adrenaline infusion also increased glucose and lactic acid concentrations in
both groups. A lower energy balance in the fasted group altered the
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metabolic response to the adrenaline infusion; FFA levels were more
pronounced in the starved group compared to the control, while the rise in
both glucose and lactic acid were blunted. In a more recent study,
adrenaline infusion increased FFA levels and glucose concentrations in
steers (Frohli and Blum, 1988). Noradrenaline infused into steers increased
glucose levels but not FFA concentrations and this was in conflict with the
observation made by Bassett (1970) in sheep. Similar to the studies in
sheep and cattle, adrenaline increased plasma glucose, free fatty acids and
glucagon in the rabbit (Knudtzon, 1984). In humans, adrenaline infusion
resulted in increased systolic and diastolic blood pressure and heart rate
(Hjemdahl et a!., 1983). In the same study, noradrenaline infusion increased
systolic and diastolic blood pressure, but decreased heart rate. Infusions of
both catecholamines blunted the insulin response to increased energy
availability in sheep (Bassett, 1970) and steers (Frohli and Blum, 1988). In
sheep

there

was

catecholamine

no change

infusion

(Bassett,

in

insulin
1970),

concentrations
while

during

the

insulin concentrations

decreased in steers during the infusion (Frohli and Blum, 1988). A decrease
in circulating insulin levels has also been reported for rabbits following
adrenaline infusion (Knudtzon, 1984).

2.8.2. cr-Adrenergic Receptor Antagonism During Catecholamine Infusion

Propranolol HCI, a non-selective /^-adrenergic receptor antagonist, and
phentolamine methane-sulfonate, a non-selective a-adrenergic receptor
antagonist, have been used to investigate the metabolic changes associated
with adrenergic receptor blockade (Bassett, 1970; Frohli and Blum, 1988;
and Blum et a!., 1982).

Phentolamine infusion followed by either adrenaline infusion (Bassett,
1970; Frohli and Blum, 1988) or noradrenaline infusion, (Frohli and Blum,
1988) increased

plasma insulin levels. As a result, there was no rise in

plasma glucose levels following either the adrenaline or noradrenaline
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infusion. Bassett (1970), reported a decrease in plasma FFA levels
following phentolamine infusion whereas levels increased in the studies of
Blum et al. (1982) and Frohli and Blum, (1988). An increase in FFA levels
following adrenaline stimulation in animals having only the a-adrenergic
receptors blocked, has also been reported for the rabbit (Knudtzon, 1984).
Pre-treatment of rabbits with either prazosin, an a1-receptor antagonist or
yohimbine, an a2-receptor antagonist, failed to prevent an increase in either
FFA or insulin following adrenaline infusion (Knudtzon, 1984). However,
blockade of either the a1- or a2-receptors prevented the adrenaline induced
rise in plasma glucose and glucagon. The a-adrenergic receptors of sheep
can be blocked with the non specific a-antagonist phenoxybenzamine. In
sheep, adrenaline infusion increased plasma glucose, oxygen consumption,
and cardiac output and these effects were not prevented by pre-infusion
with phenoxybenzamine, however, the increase in the systemic blood
pressure following adrenaline infusion was prevented (Halmagyi et aL,
1967).

A

decrease

in arterial

pressure following

pre-infusion

with

phenoxybenzamine has also been reported in the sheep by Wood et al.
(1979), although in their study, arterial pressure was more marked after the
start of the adrenaline infusion.

2.8.3. /?-Adrenergic Receptor Antagonism During Catecholamine Infusion

Pre-infusion with the non-selective ^-receptor antagonist propranolol HCI
prevented the adrenaline induced rise in plasma lactic acid and FFA's but
failed to prevent the rise in plasma glucose in sheep (Bassett, 1970) and
steers (Blum et a!., 1982; Frohli and Blum, 1988). When phentolamine and
propranolol were infused into steers followed by adrenaline (Frohli and
Blum, 1988) plasma glucose levels decreased and FFA levels remained
constant. A combined infusion of phenoxybenzamine or yohimbine (aantagonists) and propranolol, followed by adrenaline, prevented the rise in
plasma FFA's, and plasma glucose in the sheep (Halmagyi et a!., 1967) and
rabbit, Knudtzon (1984). In the study of Halmagyi et al. (1967) the pre
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infusion of the same antagonists also prevented the adrenaline induced
increase in cardiac output, systemic blood pressure, oxygen consumption,
plasma lactic acid and plasma pyruvic acid. In these studies selective or
non selective ^-adrenergic blockade failed to affect the insulin response to
adrenaline infusion. In humans, the

-selective antagonist metoprolol has

been shown to partially block the adrenaline-induced rise in blood pressure
and heart rate, while propranolol, the non-selective ^-antagonist has been
shown to reduce both blood pressure and heart rate (Hjemdahl, et a!.,
1983).

2.8.4. Summary of Sections 2.8.1 to 2.8.3

Intravenous infusion with catecholamines has pronounced physiological
effects on energy substrate mobilisation, cardiovascular function and
haemodynamics. The infusion of adrenaline results in increased circulating
levels of glucose, lactate, FFA's glycerol and glucagon, while increasing
blood pressure, heart rate, cardiac output and oxygen consumption.
Infusion of noradrenaline results in increased circulating levels of glucose,
FFA's and glycerol while increasing blood pressure but decreasing heart
rate. When both catecholamines are infused the insulin response is blunted
in respect to an increase in energy availability. The a-adrenergic receptor
mediates glucose and glycogen release while inhibiting insulin secretion. In
addition the a-adrenergic receptor inhibits systolic blood pressure. The /?adrenergic receptors mediate FFA and lactic acid release as well as
modulating blood pressure and cardiac output

2.8.5. Problems Associated with Exogenous Catecholamine Infusion

Webber and Macdonald (1993), have made reference to one of the major
problems involved with intravenous infusions of catecholamines; that is the
failure to mimic the normal route of delivery. This is especially so for
noradrenaline which mainly functions as a neurotransmitter within the
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sympathetic nervous system and whose effects are at the local tissue level.
This is important when interpreting data from infusion studies, especially in
relation to metabolism.

Himms-Hagen (1967) in his extensive review on sympathetic regulation of
metabolism in various species has also cast doubt upon the interpretation
of some aspects of infusion studies using catecholamines. He states, "that
different effects from the intravenous infusion of catecholamines may be
produced by large and small doses of adrenaline and noradrenaline, the
same dose given by different routes, or the same dose in animals of
different species, different ages, or different environmental experience".

Other difficulties which he proposed from his review were the use of
adrenergic antagonists. These agents block the actions of exogenous
noradrenaline but they may not always block the actions of endogenous
noradrenaline liberated from the nerve endings.

2.8.6. Stimulation of the Sympathetic Nervous System by the
Sympathomimetic amine Tyramine Hydrochloride

Tyramine hydrochloride (HCI) can indirectly act as a sympathomimetic
amine because it results in displacement of noradrenaline from it's storage
vesicles, (Poch and Kopin, 1966). Tyramine is actively transported into the
sympathetic

nerve endings and acts as a competitive

inhibitor of

noradrenaline uptake, (Burgen and Iverson, 1965). Active uptake of
tyramine HCI into the noradrenaline storage vesicles displaces noradrenaline
into the cytosol. Noradrenaline accumulates in the presence of tyramine
HCI, and because it is not degraded by monoamine oxidase, it remains
physiologically active, and in turn, it stimulates the noradrenergic receptors,
(Usdin and Snyder, 1973). Thus tyramine HCI is therefore used in
experimental studies to stimulate the sympathetic nervous system by
increasing endogenous release of noradrenaline from the neurones.
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Tyramine HCI and l-tyramine infused into humans resulted in decreased
heart rate and increased systolic blood pressure (Scriven et aL, 1983). The
physiological responses to both treatments were similar but plasma
noradrenaline concentrations were significantly lower in the tyramine
infused subjects. Interestingly, the lower peripheral noradrenaline levels,
and the associated increase in blood pressure in the tyramine HCI infused
subjects were similar to both the endogenous noradrenaline levels and the
increase in blood pressure stimulated by cigarette smoking (Cryer et a!.,
1976). Tyramine HCI infusion or injection will increase blood pressure in
foetal sheep (Walker and Schuijers, 1989) and newborn lambs (Lumbers et
a!., 1980). When tyramine HCI was perfused into the isolated rat pancreas

the insulin secretion rate declined and the glucagon secretion rate increased
(Hirose et aL, 1994), The secretion rates of both hormones were similar to
that when noradrenaline was used to perfuse the pancreas.

2.8.7. Sympathomedullary Response To Exercise
Plasma catecholamine concentrations have been reported to increase in
response to physical exercise in man (Christensen and Galbo, 1983; Kjaer
et aL, 1987), calves (Blum and Eichinger, 1988), sheep (Palmer et aL,

1984), and rats (Scheurink et aL, 1989a). This increase is the result of an
increased rate of release of the hormones rather than a reduced uptake rate
into the tissue, (Christensen and Galbo, 1983). The concentration of
catecholamines released is dependent upon both the intensity and duration
of the exercise, (Christensen and Galbo, 1983; Kjaer et a!., 1987; Palmer et
aL, 1984). Both static (isometric) and dynamic exercise stimulate the

release of noradrenaline and adrenaline, (Kjaer et aL, 1987). The quantity
of adrenaline released during static exercise is greater than the quantity of
noradrenaline released while the reverse is true during dynamic exercise,
(Kjaer et aL, 1987).

In man, intensive exercise results in increased sympathetic nervous
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activity which increases blood flow and oxygen supply to the working
muscles and away from areas of less need, such as resting skeletal
muscles, kidneys, and the splanchnic bed (Christensen and Galbo, 1983).
In the sheep, the blood flow away from the splanchnic tissues is not as
great as in man and it has been suggested that this is an adaptation by the
sheep to maintain gut function, thereby allowing normal rates of nutrient
absorption (Pethick eta !., 1991).

During intensive exercise, activation of the sympathetic nerves supplying
the islets of Langerhans inhibits insulin release from the pancreas (man;
Christensen and Galbo, 1983, cattle; Blum and Eichinger, 1988, rats;
Scheurink et a/.,

1989 (b), sheep Brockman and Halvorson, 1981). Such

declines in plasma insulin can be prevented if phentolamine is infused prior
to

a

period

of exercise

(Brockman

and

Halvorson,

1981).

These

observations suggest, that in sheep, the exercise-induced decline in plasma
insulin is mediated via a-adrenergic activity. The decline in plasma insulin
concentrations in man following the initiation of intensive exercise,
promotes the mobilisation of energy stores and this results in the
subsequent release of glucose and FFA's, (Christensen and Galbo, 1983).
Increases in both glucose levels and FFA's during exercise have also been
shown for the rat, (Scheurink et al., 1989b), cattle, (Blum and Eichinger,
1988), dogs, (Issekutz, 1978) and sheep, (Brockman and Halvorson, 1981,
and Palmer et a!., 1984).

2.8.8. a-Adrenergic Receptor Antagonism During Exercise

Blockade of the a-adrenergic receptors increases the rate of insulin release
from the pancreas, (man: Kjaer, et aL, 1987;

sheep: Brockman and

Halvorson, 1981). In a study by Scheurink et aL, (1989b), a single dose of
yohimbine, (an a2-adrenergic receptor selective antagonist), given before
exercise elevated plasma insulin in the rat. In the same study, the exercise
induced rise in plasma glucose was inhibited using yohimbine, but there
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was no effect on plasma FFA's, as the levels remained elevated in response
to exercise. Phentolamine infused into sheep throughout an exercise period
reduced

both

plasma

glucose and glycogen

levels

(Brockman

and

Halvorson, 1981).

2.8.9. /^-Adrenergic Receptor Antagonism During Exercise

Exercise-induced increases in energy availability following the release of
catecholamines can be blocked or inhibited

by adrenergic receptor

antagonists. In man, blocking ^-adrenergic receptors will prevent the
increase in fat catabolism, turnover rate of plasma FFA's and the increases
in plasma FFA's and glycerol concentrations, (Christensen and Galbo,
1983). In the rat, the /?2-antagonist, ICI 118551 given as a single dose
before the onset of an exercise period reduces the rise in both plasma
glucose and FFA's (Scheurink et a/., 1989b). Similar effects were reported
for the sheep by Brockman and Halvorson (1981). In their study propranolol
HCI infused prior to an exercise period prevented the rise in plasma glucose
and plasma glucagon. Propranolol HCI similarly administered to dogs
prevented the rises in FFA's, glucose and lactate (Issekutz, 1978). In all
these studies /7-adrenergic receptor blockade prevented any rise in plasma
insulin. Insulin levels remained either constant or declined during the period
of exercise.

2.8.10. Summary of Sections 2.8.7. to 2.8.9.

Exercise stimulates the release of adrenaline and noradrenaline which,
inturn stimulates plasma glucose and FFA release. In addition, exercise
increases blood flow and oxygen supply to the working muscle. During
exercise the cr-adrenergic receptor mediates glucose and glycogen release
and inhibits insulin secretion. Whereas the /^-adrenergic receptor mediates
FFA and glycerol release as well as stimulating plasma glucose, glucagon
and lactate levels.
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2.8.11. Sympathomedullary Response to Surgery

Stimulation of noradrenaline and adrenaline release during and following
surgery and anaesthesia has been demonstrated conclusively by a number
of investigators (humans: Felländer et aL, 1994; Bickel et al., 1991;
Tonnesen et a!., 1984; Halter and Pflug 1980; and Halter et a!., 1977; rat:
(Roizen et aL,

1974). For the rat, the total plasma catecholamine

concentration decreases as the quantity of anaesthetic agent administered
increases (Roizen et al., 1974). In their study, plasma adrenaline levels
decreased at the time of anaesthesia induction and then rose towards the
end of anaesthesia and surgery, and remained elevated during the recovery
period following surgery. In similar studies plasma noradrenaline either
declined (Bickel et a!., 1991; Roizen et a!., 1974) or remained constant
after the induction of anaesthesia (Tonnesen et al., 1984; Halter and Pflug,
1980; and Halter et a!., 1977) and then increased during the surgical
procedure and into the recovery period. In contrast, Felländer et al., (1994)
found that plasma levels of noradrenaline and adrenaline increased
throughout the surgical procedure but did not decline following induction of
general anaesthesia. This difference is likely due to the anaesthetic agent
used. Fellander et al., (1994) maintained patients under general anaesthesia
with nitrous oxide in oxygen whereas in the other studies, the general
anaesthetic agent used was halothane.

Hormone and metabolic responses to anaesthesia and surgery have also
been extensively studied in man, (Felländer et a!., 1994; Bickel et a!., 1991;
Hagen et a!., 1980; Halter and Pflug, 1980, and Clarke, 1970) and the
horse (Robertson et a!., 1990). Regardless of which anaesthetic agent was
used to induce anaesthesia, plasma glucose concentrations increased. The
rise in glucose is related to the severity of the surgical procedure. Clarke
(1970) reported higher glucose levels during intra-abdominal surgery when
compared to body surface surgery while anaesthesia alone produced no
significant change in glucose concentrations. In humans, insulin levels have
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been reported to be either suppressed by anaesthesia followed by a slow
increase during surgery (Halter and Pflug, 1980) or to remain constant
throughout anaesthesia and surgery (Felländer et a/., 1994). A significant
rise in plasma insulin 10 minutes after induction of anaesthesia followed by
a decline was reported by Robertson et al., (1990) for the horse.

Lipolytic activity has been shown to increase continuously from the start
of anaesthetic induction until the end of surgery in humans (Felländer et a!.,
1994). In contrast, plasma FFA levels in the horse declined during surgery
and remained suppressed until the recovery period (Robertson et a!., 1990).
Prolactin levels increased before skin incision (Bickel et a!., 1991), or after
induction with general anaesthesia (Hagen et al., 1980). In both these
studies prolactin levels remained high until the recovery period. Growth
hormone has been reported to increase during surgery and recovery in
humans (Hagen et a!., 1980, Noel et a!., 1972 and Ichikawa et a!., 1971).
Noel et al. (1972) reported that the rise in growth hormone during surgery
occurred later than did the rise in prolactin and these findings are in
agreement with those of Ichikawa and co-workers (1971) who found that
the peak in growth hormone concentration occurred 30 minutes after skin
incision. Human studies have shown that vasopressin levels and diastolic
blood pressure increase during surgery but systolic blood pressure and
heart rate remain unchanged (Bickel et a!., 1991). In the study of Halter et
al. (1977), arterial pressure increased as catecholamine concentrations

increased. There was a positive relationship between catecholamine levels
and blood pressure during surgery (Halter et al.f 1977A

Epidural analgesia administered to humans with or without general
anaesthesia alters the neuroendocrine, endocrine and metabolic responses
to surgery when compared to general anaesthesia alone (Tonnesen et al.,
1984; Halter and Pflug, 1980; and Hagen et a!., 1980). Plasma adrenaline
and

noradrenaline

concentrations

remained

at

pre-operative

levels

throughout the surgery and the period immediately post-surgery (Tonnesen
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et al. 1984; Halter and Pflug 1980). Halter and Pflug (1980) observed no

changes in glucose and insulin concentrations during surgery. Under general
anaesthesia Hagen et al. (1980) reported no increase in plasma prolactin
concentrations

but,

when

patients were administered

both

epidural

analgesia and general anaesthetic (Tonnesen et a!., 1984), prolactin levels
increased during both anaesthesia induction and surgery. Growth hormone
concentrations were significantly lower during surgery in the patients given
epidural anaesthesia Hagen et al. (1980), however, during the post
operative period growth hormone levels increased.

2 .8 .1 2 . Summary of Section 2.8.11.

General anaesthesia and surgery stimulates the release of adrenaline and
noradrenaline as well as increasing plasma glucose and FFA levels and
blood pressure. In addition, general anaesthesia and surgery stimulate the
release of

prolactin, growth hormone, and vasopressin while either

stimulating or inhibiting insulin secretion. In contrast epidural blockade
prevents the rise in adrenaline and noradrenaline as well as preventing the
rise in plasma glucose and circulating growth hormone levels.

2.9. The Hypothalamic-Pituitary-Adrenal Axis

The components of this axis are the hypothalamus, the pituitary gland and
the adrenal gland and together they function as a hierarchically-integrated
feedback system (Seeman and Robbins, 1994). Stimulation of the axis
results in the rapid release of the glucocorticoids from the adrenal cortex
into the peripheral circulation (Munk et a!.f 1984). Glucocorticoids, as their
name implies, affect carbohydrate metabolism and many other physiological
functions; these include stimulation of hepatic gluconeogenesis, inhibition
of glucose uptake by peripheral tissues, suppression of inflammation,
enhanced secretion of a water load, as well as inhibition of the release of
some hormones and neuropeptides (Munk et at.,
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1984). The major

glucocorticoid for some mammal species including the sheep is cortisol, but
cortisone and corticosterone are also present (Baxter and Rousseau, 1979)
while corticosterone is the major glucocorticoid in rodents and birds
(Buttemer et a!., 1991).

2.9.1. Biosynthesis of Adrenocortical Hormones

The adrenal cortex is the site of cortisol synthesis. Aldosterone is also
synthesised in the adrenal cortex and is referred to as a mineralocorticoid
because it affects mainly salt and water metabolism (Seyle, 1946). The
adrenal cortex is anatomically divided into three zones; the glomerulosa
(outer zone), the fasciculata (central zone) and the reticularis (inner zone).
The glucocorticoids are synthesised in the zona fasciculata and the
mineralocorticoids in the zona glomerulosa (Dallman et a!., 1987). These
hormones are structurally related to each other and are derived from
cholesterol. They have a steroid nucleus consisting of three cyclohexane
rings designated A, B and C and a cyclopentane ring designated as D. A
system of nomenculture that numbers the positions on the rings identifying
modifications at specific positions is widely used. Two structural types of
steroids are formed in the cortex, these are termed C21 or C19 steroids
depending upon the total number of carbon atoms in the molecule. C21
steroids have a 2-carbon side chain attached at position 17 of the D ring
while C19 steroids have a keto- or hydroxyl group at position 17. The C21
steroids which also have a hydroxyl group at position 17, in addition to the
side chain, are called 17-hydroxycorticoids or 17-hydroxycorticosteroids.
Both the mineralocorticoids and the glucocorticoids are C21 steroids.
Acetate is the major precursor for the synthesis of cholesterol. Preformed
cholesterol is converted to pregnenolone which is the precursor from which
other steroid

hormones are synthesised.

Progesterone formed

pregnenolone

is

adrenocorticoids.

the

precursor

for

the

from

Different

biosynthetic pathways lead to the formation of both glucocorticoids and
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mineralocorticoids and while there are similarities in the pathways there are
also different steps (Baxter and Rousseau, 1979). The rate limiting step in
the synthesis of the glucocorticoids is the conversion of cholesterol to
pregnenolone (Baxter and Rousseau, 1979).

Adrenocorticotropic
stimulates both the

hormone

(ACTH)

released

from

the

pituitary

synthesis and secretion of adrenocorticoids by

catalysing a step in the conversion of cholesterol to pregnenolone (Ganong,
1971). Continued exposure to high levels of ACTH levels enhances the
secretion of the glucocorticoids, but depresses the secretion of the
mineralocorticoids. While ACTH may be the only secretagogue that drives
the fasciulata cells, there are other substances which synergise with ACTH
to potentiate the rate of steroidogenesis (Dallman et al., 1987).
2.9.2. Glucocorticoid Metabolism

Ninety percent of the circulating cortisol is normally bound to a specific
plasma alpha globulin called corticosteroid-binding globulin (CBG) or
transcortin and binds to a lesser degree to serum albumin. Binding to CBG
does not appear to be necessary for glucocorticoid action as low
concentrations of hormone dissolve in plasma and are physiologically
effective (Baxter and Rousseau, 1979). Hormone bound to CBG is
essentially inactivated. While CBG does not appear to be necessary for
glucocorticoid action, it probably influences the plasma kinetics of the
glucocorticoid response or steroid metabolism (Baxter and Rousseau,
1979). During "non activated" periods

most of the plasma cortisol is

bound to the CBG. When secretion of cortisol is increased, the rise in
plasma cortisol is due to an increase in the amount of unbound cortisol
(Ganong, 1971).

Free cortisol is rapidly removed from the circulation (Cope, 1972).
Estimates of the biological half life vary from four hours (Grodsky, 1983) to
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one hour (Cope, 1972). Cope (1972) reported that cortisol is extensively
metabolised in a number of tissues. Estimates of the amount secreted into
urine range from 2% (Cope, 1972) to 70% (Grodsky, 1983). The variation
could be due to the amount of cortisol bound to CBG during different
physiological states as protein binding reduces the amount of free cortisol
in urine (Ganong, 1971).

The liver is the principal site of glucocorticoid catabolism (Cope, 1972;
Ganong, 1971). Degradation of cortisol takes place by ring reduction of the
3-ketone group by NADPH-requiring hydrogenases (Grodsky, 1983). Some
cortisol is converted to cortisone in the liver. Little of this cortisone enters
the circulation as it is reduced and then conjugated (Ganong, 1971). These
conjugates enters the circulation and are then excreted in the urine.
Cortisone, however, is not secreted by the adrenal cortex.
2.10. Glucocorticoid Receptors

The glucocorticoid hormone receptors are ubiquitous throughout the body
i.e. they are found in every mammalian tissue (Ballard et aL, 1974). The
glucocorticoid receptors are a member of the superfamily of steroid/thyroid
hormone nuclear receptors which control differential gene expression by
acting as an enhancer of specific gene transcription (Evans, 1988; Beato,
1989). The steroid is thought to cross the plasma membrane and to
penetrate the cell by simple diffusion but this is not considered to be rate
limiting (Baxter and Rousseau, 1979). The steroid binds reversibly with high
affinity to complementary intracellular receptor proteins. The steroid
receptor is a polypeptide chain and is folded into 3 distinct domains: the
carboxyl-terminal domain which binds the hormone, the middle domain
which binds to DNA and an amino terminal domain which activates gene
transcription. Receptor binding initiates a conformational change of the
receptor and this process is dependent on both temperature and ionic
strength (Baxter and Rousseau, 1979). These conformational changes
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following steroid binding to the receptor increase the affinity of the complex
for deoxyribonucleic acid (DNA), result in binding to specific genes and
regulates their transcription. A small number of genes are activated or
occasionally suppressed by the glucocorticoids and other steroids. Most of
the activated steroid receptors bind to sites which do not initiate
transcription. In a study using cultured rat hepatic cells which were
exposed to cortisol the rate of synthesis of only 6 out of 1000
distinguishable proteins increased, while the rate of synthesis of one protein
decreased (Alberts et aL, 1989). Selectivity of gene expression is achieved
by restricting the expression of the different receptors in specific cells and
tissues. The chromatin structure of each cell type is uniquely organised and
different sets of genes in different cells will be accessible to the hormone
receptor complex (Evans, 1988). Steroid hormone receptors can bind to an
inhibitor protein, heat-shock protein hsp90. Binding of hsp90 blocks the
DNA binding domain of the receptor. When the hormone binds to the
receptor the inhibitor protein dissociates and this leads to receptor
activation.

Modulation of gene expression results in transcription of specific mRNAs
(Sarker et al.f

1976). The proteins that these mRNAs encode are

responsible for eliciting the cellular effects attributed to the glucocorticoids.
The glucocorticoid regulated proteins are frequently enzymes that catalyse
reactions responsible for the observed metabolic changes. Because the
hormone-initiated events involve transcription and translation, there can be
a lag-time before physiological effects are detected (Christy,

1971).

Therefore, some glucocorticoid actions may persist for long periods of time.
The rate of degradation of the components in the process following
receptor stimulation can vary substantially, and this can in turn influence
the

duration

of the

glucocorticoid

effects.

Thus

the

physiological

consequences can continue for some time after the steroid stimulus is
removed (Baxter and Rousseau, 1979).
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2.11. Metabolic Effects of the Glucocorticoids

Ingle (1952) recognised the involvement of the glucocorticoids in a wide
variety of metabolic processes. From these observations he postulated that
the glucocorticoids act as hormones which permit key metabolic processes
to achieve maximal rates but by themselves have little effect. Some of the
metabolic processes in which the glucocorticoids have a "permissive" role
include glycogenolysis, gluconeogenesis, lipolysis and glycogenesis.

The effects of glucocorticoids on intermediary metabolism have been
demonstrated for

a number of tissues including the liver, muscle, skin,

adipose and lymphoid tissues. Effects on glucose and protein metabolism
result in hyperglycaemia and nitrogen wasting, respectively (Baxter and
Rousseau, 1979).

2.11.1. Effects on Carbohydrate Metabolism

The glucocorticoids act permissively to influence the actions of glucagon
and

adrenaline

in

inducing

gluconeogenic

enzymes

in

the

liver.

Glucocorticoids act to increase the availability of amino acid substrates for
liver gluconeogenesis (Baxter and Rousseau, 1979). This was demonstrated
in rats by Long et a/. (1940) who found that the glucocorticoids influence
gluconeogenesis by stimulating the release of amino acids from peripheral
tissues. This was confirmed in the study of Caldwell et al. (1977) when
they reported that adrenalectomy reduced the amount of glucogenic and
branched chain amino acids released from skeletal muscle and that
glucocorticoids could reverse this effect. The increase in the rate of
gluconeogenesis observed after administration of cortisol to sheep (Reilly
and Black, 1973) was associated with an increase in utilisation of amino
acids.
Hormones such as adrenaline which act to influence lipolysis and
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glycogenolysis and act via cyclic AMP have a reduced effectiveness in
adrenalectomised

rats

(Exton,

et

aL,

1972).

This

decrease

in

responsiveness is a result of a decreased responsiveness to cyclic AMP
rather than a reduction in cyclic AMP production (Exton et aL, 1972).

In

adrenalectomised rats which are adequately fed, the basal rate of
gluconeogenesis is not impaired but the response to both glucagon and
catecholamines is diminished (Exton et al.f 1972). However, in fasted
adrenalectomised rats there is a significant reduction in the basal rate of
hepatic gluconeogenesis but the administration of glucocorticoids will
reverse this effect (Exton et aL, 1973). Cortisol will accentuate the state of
hyperglycaemia produced by both glucagon and adrenaline (dogs; Eigler et
aL, 1979; sheep Brockman and Laarveld, 1986). The glucocorticoids have

been shown to increase glucose concentrations in both fed (Reilly and Ford,
1971) and fasted (Bassett, 1968) sheep, and this is associated with a
reduction in glucose production and peripheral tissue glucose utilisation.

Changes in the gluconeogenic flux which occur following steroid depletion
and replenishment in the rat have been shown to involve two enzymes,
these being phosphoenolpyruvate carboxylase (Exton et aL, 1973) and
glucose-6-phosphatase (Ashmore and Weber, 1959). Glucocorticoids affect
the rate of synthesis of phosphoenolpyruvate carboxylase (which is
involved in the formation of glucose from pyruvate) at the level of
transcription (Wicks and McKibbin, 1972).

The rate of gluconeogenesis can also be modulated by the glucocorticoids
acting to decrease the sensitivity of peripheral tissues to insulin. Barseghian
and Levine (1980) reported that corticosterone inhibited the secretion of
insulin in the rat following both glucose and alanine administration and
enhanced the secretion of glucagon. In the same study phentolamine, a
non-selective a-adrenergic receptor antagonist, diminished the ability of
corticosterone to inhibit insulin secretion. These observations led the
authors to suggest that the inhibition of insulin secretion was related to
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activation of the a-adrenergic receptors. Cortisol administration will also
reduce the insulin response in sheep (Bassett and Wallace, 1967) and man
(Simmons e ta !., 1984).

Some glucocorticoids have been reported to influence liver glycogen
deposition in both fed and fasted rats (Long et al.f 1940). Hornbrook et al.,
(1966) reported that for rats, cortisol increased the conversion of glycogen
synthetase from it's inactive form to its catalytically active form. When rats
and mice were exposed to stress that increased plasma corticosterone the
rate of glycogen accumulation in the liver increased as did the conversion
of hepatic glycogen synthase from it's inactive to it's active state (Oyama
and Platt, 1964; Oyama et al., 1966; and Oyama and Daligcon, 1967).
Hornbrook et al. (1966) reported a lower level of hepatic glycogen synthase
in it's active form and a reduced capacity for hepatic glycogen storage in
the adrenalectomised fed rat compared to normal rats.

2.1 1 .2 . Effects on Lipid Metabolism

The glucocorticoids stimulate lipolysis and promote the lipolytic action of
adrenaline in adipose tissue (Baxter and Rousseau, 1979). However, the
role of the glucocorticoids in lipid metabolism appears to be ambiguous. In
patients with Cushings syndrome the hypersecretion of glucocorticoids
results in obesity but the adipose deposition sites are selective (e.g. Buffalo
hump on neck)

(Cushing,

1932).

Humans given large amounts of

glucocorticoids have increased fat deposition (Ingle, 1943). In contrast, the
studies of Dreiling et al. (1962) and Nayak et al. (1962) show increased
FFA release 1-2 hours after glucocorticoid administration to humans.
In vivo and in vitro studies in the rat have shown modulation of lipolysis

by the glucocorticoids (Leboeuf et al., 1962). In the studies of Fain (1962),
starvation induced FFA release which was impaired by adrenalectomy and
restored

by

treatment

with

glucocorticoids.
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In

the

same

study,

adrenalectomy

also

diminished

the

lipolytic

action

of

both

the

catecholamines and growth hormone as FFA release was reduced and
glucose utilisation increased in the adipose tissue of the adrenalectomised
rats (Fain, 1962). Significant increases in FFA release were also reported
when growth hormone and dexamethasone, a synthetic glucocorticoid,
were administered together to cultures of adipose tissue from control rats
compared to treatment with growth hormone alone. in vivo dexamethasone
treatment of sheep adipose tissue increased the response and sensitivity to
isoproterenol, a synthetic adrenergic agonist (Finley et aL, 1990).

As with the effects on glycogenolysis, lipolytic glucocorticoid potentiation
may not be mediated through changes in cAMP accumulation (Fain, 1979).
Glucocorticoids increase the ^-adrenergic receptor numbers in rat adipose
tissue but decrease adenylate cyclase activity (Giudicelli et al.r 1989; Ross
et aL, 1989). A decrease in adenylate cyclase activity in adipose tissue

following dexamethasone administration and followed by isoproterenol
treatment has also been reported for the sheep (Finley et aL, 1990).

Munk et aL (1984), suggested that the prime metabolic role of the
glucocorticoids is the antagonistic action on insulin secretion. As previously
discussed, the glucocorticoids have been shown to reduce insulin secretion
in the rat (Barseghian and Levine, 1980), sheep (Bassett and Wallace,
1967) and man (Simmons et aL, 1984). Dexamethasone will inhibit
lipogenesis in the presence of low concentrations of insulin, however, at
high concentrations of insulin, dexamethasone synergises with insulin and
thereby increases the rate of lipogenesis (Walton et aL,

1986). In

ruminants, insulin influences lipid metabolism altering the release of FFA's
(Brockman and Laarveld, 1986). A reduced rate of lipolysis decreases the
amount of FFA's available to the liver for oxidation to ketone bodies. In
vivo studies in sheep (West and Passey, 1967) demonstrated the anti

lipolytic nature of insulin. Adipose tissue of ruminants has been shown to
be well supplied with insulin receptors and they have similar properties to
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those of other species (Vernon and Sasaki, 1991).
2.11.3. Protein Metabolism

The most profound effect that the glucocorticoids have on protein
metabolism is the influence they exert on nitrogen wasting (Baxter and
Rousseau, 1979). They induce muscle wasting and this process acts as a
major source of plasma amino acids (Goldberg, 1969; Odera and Millward,
1982). Glucocorticoids also act to break down nucleic acids as well as
decreasing protein synthesis within muscle tissue (Baxter and Rousseau,
1979). Amino acid catabolism is one of the few metabolic process which
are sensitive to levels of glucocorticoids within the normal physiological
range

(Reeds

and

Davis,

1992).

In

vivo

studies

with

rats

have

demonstrated a reduced rate of protein synthesis after dexamethasone and
corticosterone treatment (Garlick et at., 1987; Southern et al., 1990). A
reduced rate of protein synthesis also occurs when muscle tissue from rats
or rabbits is incubated with either glucocorticoids or dexamethasone
(McGrath

and

Goldspink,

1982;

Reeds

and

Palmer,

1984).

In

adrenalectomised rats there is no change in either protein synthesis or RNA
synthesis, however, when they are treated with corticosterone, both
protein synthesis and RNA synthesis are significantly depressed (Odera et
al., 1982). These effects are attributed to an inhibition of translational

efficiency (Reeds and Davis, 1992). The mechanism which produces the
above effects remains to be determined, however, Reeds and Davis (1992)
have suggested that the glucocorticoid effects on protein metabolism are
mediated through the cytoplasmic receptor binding to a specific promoter
sequence on DNA which in turn influences the transcription of mRNA.
Prolonged treatment periods with glucocorticoids have been shown to be
associated with a reduction in the RNA/protein ratio (Kelly and Goldspink,
1982; Odera ef a/.,1983).
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2.12. Activation of the Hypothalamic-Pituitary-Adrenal Axis

Stimulation of this axis involves a cascade of events
release

of

corticotropin-releasing

factor(s)

(CRF's)

initiated by the
by

hypothalamic

neurosecretory neurones. When released into the hypophyseal-portal blood
these factors stimulate the secretion of pituitary adrenocorticotrophic
hormone (ACTH) which is released into the systemic circulation. The ACTH
initiates the release of the glucocorticoids from the adrenal cortex (Baxter
and Rousseau, 1979).

Corticotropin-releasing hormone (CRH) also referred to as corticotropin
releasing factor (CRF) has been reported to be the only physiological
regulator of ACTH release from the anterior pituitary, in man, rats, goats,
and cattle (Rivier and Plotsky, 1986). Vale et a!. (1981) identified and
characterised in vitro a 41-amino acid sequence of CRH from ovine
hypothalami

which

Corticotropin-releasing

stimulated
hormone

ACTH

release

is synthesised

from
by

the

the

pituitary.

parvocellular

neurosecretory neurones which are localised within the paraventricular
nucleus of the hypothalamus. It is released into the portal circulation from
nerve endings found in the external zone of the median eminence (Antoni,
1986). The synthesis and secretion of CRH is influenced by a number of
stimulatory and inhibitory factors and these include the catecholamines,
serotonin, acetylcholine, angiotensin II, interleukins, y-aminobutyric acid
(GABA) and the glucocorticoids (Assenmacher et ai., 1987, Tsagarakis et
ai., 1989). Activation of the pituitary corticotrophs (ACTH releasing cells)

by CRH is through an interaction with specific plasma membrane receptors
(Abou-Samra et ai., 1987), and these undergo marked regulatory changes
during stimulation of the HPA axis (Aguilera et ai., 1987).

Oxytocin and vasopressin play an important role in the pituitary-adrenal
response to stress. Both peptides have been reported to interact with CRH
to promote ACTH secretion (Plotsky, 1985). in vivo studies have shown
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vasopressin to be more potent than CRH in stimulating ACTH release in the
sheep (Smith and Funder, 1989). However, in a recent study by Liu (1994)
there was a greater release of ACTH in ovine anterior pituitary cells
incubated with CRH

than those incubated with vasopressin. Studies in

ewes have demonstrated the release of both CRH and vasopressin in
response to an audiovisual stimulus

(a barking dog) and hypoglycaemia

(Engler et al., 1988). Vasopressin and oxytocin are secreted from the
magnocellular

neurosecretory

system

located

within

both

the

paraventricular nucleus and in the supraoptic nucleus of the hypothalamus
(Sawchenko et al., 1992).

2.12.1. Processing of the Pro-opiomelanocortin Precursor Molecule

Pro-opiomelanocortin (POMC) the precursor for ACTH is derived from the
cells of the anterior and intermediate lobes of the pituitary gland. Both /?lipotrophin and ^-endorphin are also proteolytically processed from the
POMC molecule in the anterior lobe (rats: Eipper and Mains, 1981; sheep:
Smith and Funder, 1988; man: Grossman, 1988). In the intermediate lobe,
a-melanocyte-stimulating hormone formation occurs from the additional
processing of ACTH.

This lobe also secretes the corticotropin-like

intermediate peptide (CLIP).
The POMC molecule is also translated and transcribed in extra-pituitary
tissues. The mRNA for POMC has been identified in the placenta, ovary,
testis, pancreas, gastrointestinal tract, immune cells (Smith and Funder,
1988) and the skin (Slominski et a!., 1992). The physiological roles of the
peptides derived from the POMC molecule are well established; they are
both

disparate

and

numerous.

While

ACTH

controls

adrenocortical

regulation it also stimulates muscle cell glucose uptake (Levin et a!., 1990)
and has been reported to act as a specific mitogen for mammalian
myogenic cells (Cossu et al., 1989). Beta-endorphin acts as an analgesic
and has a major role in the regulation of eating, drinking, cardiovascular
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responses, respiration and a range of behavioural responses (Olson et a/.,
1991). Alpha-melanocyte-stimulating hormone has a major role in skin
pigmentation.
2.12.2. Circadian Rhythms within the Adrenocortical System

ACTH production has a circadian pattern which follows the sleep cycle.
Levels are highest during the night in diurnally active animals with a peak in
the early morning whereas in nocturnal animals, the peak in ACTH occurs
late in the afternoon. A circadian rhythm for the POMC peptides and
corticosteroids have been reported for many species, (man and rats:
Fischman eta/., 1988; deer: Newman eta/., 1991; sheep: Jones, 1990).
This pattern is thought to be controlled by direct inputs from the
suprachiasmatic nuclei within the hypothalamus to the paraventricular
nucleus (Fischman et a/., 1988) because the rhythm is abolished when the
suprachiasmatic nuclei is no longer functional (Krieger et a/., 1979).
There is a negative feedback control of the HPA axis where hormones
secreted from the adrenals in response to ACTH act to inhibit further
activation of components higher in the axis, (the pituitary, hypothalamus
and other higher brain centres). In adrenalectomised rats, hypersecretion of
ACTH and an increase in POMC mRNA in the anterior pituitary have been
reported

(Jingami,

et

a/.,

1985).

Plotsky

and

Sawchenko

(1987)

demonstrated increased CRH and vasopressin release into the hypophysial
portal blood following pharmacological adrenalectomy of rats. Other studies
have also demonstrated increased levels of mRNA for CRH (Jingami, et a/.,
1985)
nucleus

and
after

vasopressin (Wolfson, et a/., 1985) in the paraventricular
adrenalectomy.

These effects

were

reversed

by the

administration of exogenous steroids. When dexamethasone was implanted
into the brain of adrenalectomised rats, CRH mRNA decreased (Kovacs and
Mezey, 1987). Circulating CRH and vasopressin levels were also reported
to be lower in adrenalectomised rats when dexamethasone implants were
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placed directly over the paraventricular nucleus (Sawchenko, 1987; Kovacs
and Mezey, 1987). The dexamethasone implants placed into other areas of
the brain had no effect on CRH or vasopressin levels (Sawchenko, 1987;
Kovacs and Mezey, 1987).

2.12.3. Hypothalamic-Pituitary-Adrenal Axis Response To Exercise

Physical exercise will activate the hypothalamic-pituitary-adrenal axis in
man, (Petrides et aL, 1994; Grossman et aL, 1984)

rats, (Chin and

Evonuk, 1971) and sheep, (Apple et a!., 1994). Stimulation of this axis has
been shown to elicit both neuroendocrine and metabolic responses
proportional to the relative intensity and duration of the exercise (Deuster et
aL, 1989).

Increases in plasma ACTH and plasma cortisol, which is the major
glucocorticoid in man and sheep, were reported from the onset of exercise,
in man (Petrides et aL, 1994; Grossman et aL, 1984) and in sheep (Apple
et aL, 1994). Increased circulating cortisol levels act to mobilise fuel stores

with a consequent increase in blood glucose and FFA levels (Deuster et aL,
1989). Increased levels of circulating lactate and glucose have also been
reported from the onset of exercise, in man (Petrides et aL, 1994;
Grossman et aL, 1984) and sheep (Apple et aL, 1994). This is a response
which allows metabolic homeostasis to be maintained during physical
exercise (Galbo, 1983). In contrast, plasma corticosterone (the major
glucocorticoid in the rat) levels decreased in rats in response to exercise
(Chin and Evonuk, 1971). This difference in glucocorticoid responses to
those conducted in sheep and man may be the result of different
experimental procedures employed. Chin and Evonuk (1971) subjected rats
to chronic exercise over a six week period whereas in the other studies
(Petrides et aL, 1994, Grossman et aL, 1984 and Apple et aL, 1994) acute
exercise was applied for only minutes.
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Of interest are the recent studies by Wittert et al. (1994) and Inder et al.
(1994) who report elevated basal ACTH levels in highly trained male
ultramarathon athletes compared to non-sedentary control subjects. The
early morning surge in plasma cortisol levels, associated with the diurnal
rhythm, occurred earlier in trained athletes compared to control subjects
(Wittert eta/., 1994).

2.12.4. Summary of Section 2.12.3.

Exercise stimulates ACTH and cortisol release, in addition to plasma
glucose, lactate, and FFA levels.

2.12.5. Hypothalamic-Pituitary-Adrenal Axis Response To Surgery
Stimulation of the HPA axis in response to surgical procedures is
supported by the increased levels of circulating ACTH and cortisol observed
during surgery, (man: Felländer et a!.,

1994;

Bickel et al.,

1991;

Lacoumenta et a!., 1987; Tonnesen et a!., 1984; Madsen et al., 1976;
Gordon et al., 1973; and Clarke et a!., 1970; sheep; Jones, 1990; Shutt et
a!., 1987; horse: Robertson et a!., 1990). Blood cortisol levels increase

immediately following the time of incision and continue to increase
throughout the period of surgery and into the recovery period, (man;
Lacoumenta et a!., 1987; Clarke et a!., 1970; Madsen et a!., 1976; and
Tonnesen et a!., 1984; sheep: Jones, 1990). However, in the studies of
Felländer et a!., (1994), cortisol levels did not begin to increase until 10 min
to 15 min after the time of incision. This delayed response in cortisol levels
may be a function of the anaesthetic agent used. In the study of Felländer
et al. (1994) nitrous oxide in 0 2 plus fentanyl and pancuronium were used

for the maintenance of anaesthesia as opposed to the other studies where
halothane and oxygen were used.

The cortisol response in man depends upon the severity of the surgical
41

operation, with higher levels occurring with the more invasive procedures
(Clarke et aL, 1970; Madsen et a!., 1976). The increase in cortisol has been
shown to coincide with an increase in glucose levels (Clarke et aL, 1970;
Madsen et aL, 1976). This association between glucose production and
cortisol levels was also reported by Lacoumenta et aL, (1987). In their
study, either cortisol or saline was infused into women during surgery. The
cortisol infusion resulted in a greater increase in glucose levels during the
operation compared to the women receiving saline alone. Epidural blockade
in women undergoing surgery will either prevent (Hagen et al.f 1980) or
suppress the rise in circulating cortisol (Gordon et aL, 1973) when
compared to patients under general anaesthesia alone.

In the sheep, increased levels of the POMC peptides, ACTH, jff-endorphin
and a-melanocyte-stimulating hormone, were observed during surgery
(Jones, 1990). Levels increased at the time of skin incision and remained
elevated throughout the period of the operation and then declined at the
cessation of the surgical procedure. Shutt et at. (1987) reported increased
levels of cortisol and ^-endorphin following routine surgical procedures in
lambs without administration of anaesthetic. In the horse, /?-endorphin
levels have also been reported to increase during surgery (Robertson et aL,
1990). However, in the study of Jones (1990), the initial increase in
endorphin levels in response to surgery was followed by a period (30 min)
in which levels declined prior to cessation of the operation.
2.12.6. Summary of Section 2.12.5

General anaesthesia and surgery stimulate circulating levels of ACTH,
cortisol, ^-endorphin, and ar-melanocyte-stimulating hormone as well as
Increasing plasma glucose levels. In contrast, epidural blockade prevents
the rise in circulating cortisol levels.
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2.13. Modulation of the Secretion of Corticotropin Releasing Factor and
Adrenocorticotropin Hormone by the Catecholamines

Any stimulus which perturbs an animal's homeostasis involves activation
of both the HPA and the sympathomedullary system (Smelik, 1981; Levine,
1985). Long (1952) and Axelrod and Reisine (1984) both hypothesised that
the activation of the HPA is evoked by sympathomedullary activation. This
hypothesis was based on the close interrelationship between these two
axes.

Both medullary noradrenergic and adrenergic inputs have been shown to
innervate the parvicellular and the magnocellular systems localised within
the parventricular nucleus of the hypothalamus (review: Plotsky et a!.,
1989). In addition, noradrenergic inputs innervate the supraoptic nucleus of
the hypothalamus (review: Plotsky et a!., 1989). Both dendrites and somata
of paraviceilular and magnocellular neurosecretory cells have been shown
to receive noradrenergic input (Silverman et a!.,

1985). Adrenergic

synapses have also been described on dendrites and somata of parvicellular
neurosecretory cells in the paraventricular nucleus as well as CRH
containing cells (Liposits et al. , 1988).

An intra-paraventricular infusion of adrenaline leads to CRH release in rats
and this is followed by a prolonged period of ACTH hypersecretion
(Barbanel et a/. 1991). In a more recent study, Itoi et a/. (1994) reported
increased levels of POMC and CRH mRNA, and increased plasma ACTH
levels following microinjection of noradrenaline into the paraventricular
nucleus. These components increased in a dose dependent manner
following noradrenaline microinjection.

Ganong (1984) suggested that the catecholaminergic innervation of the
hypothalamus had a predominately inhibitory role on the corticotropic
response to stressors. More recent studies suggest that the major
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catecholaminergic pathways innervating the paraventricular nucleus convey
the most potent stimulatory signals to the CRH neurones (Assenmacher et
a!., 1992). Studies conducted with rats involving the destruction of the

major catecholaminergic pathways to the paraventricular nucleus have
shown a significant decrease in plasma concentrations of CRH which in
turn caused a significant fall in plasma ACTH, (Guillaume et a!., 1987) and
prevention of the ACTH surge following ether stress, (Szafarczyk et al.,
1985).

These effects

infusions

of

were subsequently

noradrenaline or adrenaline

reversed

by hypothalamic

(Szafarczyk et a!.,

1985).

Pharmacological studies show that the main catecholaminergic pathways to
CRH neurones act as a stimulator of the CRH-ACTH axis across
postsynaptic ar1, a l, and ft adrenergic receptors (Assenmacher et aL,
1992). These adrenergic receptors located

within the paraventricular

nucleus and the median eminence of the hypothalamus are unevenly
distributed with the relative density of these binding sites being present in
the paraventricular nucleus in the order of a l, a*\ and /?1 and 01, the latter
two being present at the lowest but equal concentrations (Plotsky et al.,
1989). The adrenergic receptor subtypes can be differentially regulated by a
variety

of factors,

including,

photoperiod,

nutritional

state

(glucose

availability), afferent tone, and glucocorticoid hormone levels (Plotsky et al.,
1989). The a l adrenergic receptor number has been shown to be the most
responsive to these factors while the 0 receptor number is the least
sensitive (Plotsky et al., 1989). In their review, Plotsky et a!., (1989)
suggest from the pharmacological and physiological studies reported that
the catecholaminergic regulation of CRH is mediated via adrenergic
subtypes. This group have proposed that:
1: the stimulation of CRH release is mediated via the a1 adrenergic
receptors.
2: unlike noradrenaline, adrenaline can facilitate CRH release through a
mixed population of both a1 and 0 adrenergic receptors.
3: the a l adrenergic receptor subtype may inhibit activity of the HPA axis.
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2 .1 4 Aims of this Thesis

The main aim of this thesis was to further understand what physiological
actions the sympathomedullary axis and the HPA axis initiate in response to
an acute stress. Stimulation of both pathways and the subsequent effects
on an animals physiology in preparation for the "flight fight" response has
been extensively reported in the literature. Review of the literature shows
that little is known of the role each pathway plays in altering homeostasis
and also whether the physiological response initiated by either pathway is a
function of a close interrelationship between the two axes or an
independent one.

A means of isolating the effects of one axis from the other is necessary in
determining the contribution each axis has to the maintenance of
homeostasis. Active immunisation against ACTH has been shown to
significantly reduce cortisol levels in the sheep (Wynn et al. 1994). Using
this immunological approach the physiological action of cortisol on energy
substrate mobilisation can be negated. In addition, the use of non-selective
adrenergic receptor antagonists enables the identification of the receptor
type responsible for eliciting the response for each parameter measured. To
determine the contribution of the sympathetic nervous system to the
alteration

in

the

physiological

response,

tyramine

HCI,

a

potent

sympathomimetic agonist compound was used.
Dynamic exercise, a "natural" stressor

and surgery an "unnatural"

stressor have been shown to stimulate both the sympathomedullary axis
and the HPA axis. These two stressors were chosen for studies in this
thesis because they have been shown to have pronounced effects on
homeostasis as a consequence of the activation of the two stress axes
under study.
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2 .1 4 .1 . Objective 1

The experiment reported in chapter 4 describes the cardiovascular and
metabolic effects of aerobic and anaerobic exercise for ewes in which:
1) the HPA axis has been modified by ACTH immunisation.
2) the sympathomedullary axis has been modified by adrenergic receptor
blockade.

2.14.2. Objective 2

The

experiment

in

chapter

5 was

designed

to

determine

the

haemodynamic and metabolic responses associated:
1) with the stimulation of endogenous noradrenaline release using tyramine
HCI infusion.
2) the blockade of a- and ^-adrenergic receptors using non-selective
adrenergic receptor antagonists.
2.14.3. Objective 3

The experiment reported in chapter 6 describes the metabolic response to
anaesthetic and surgical stress in ewes when the HPA axis is modified by
ACTH immunisation.
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Chapter 3

Materials and Methods

3 .1 . Protein Assays

Reagents

All chemicals used in buffer preparations were of analytical grade and
were dissolved in reverse osmosis water unless specified otherwise.
3 .1 .1 . Stripped Ovine Plasma

Hormone free plasma was used in the preparation of standards for all
hormone assays. It was prepared by adding Norit A charcoal (AJAX
Chemicals, Auburn Australia) to pooled ovine plasma at a concentration of
10mg/ml. The mixture was incubated at room temperature and stirred
constantly for 5 h This procedure was repeated 3 times. The solution was
then centrifuged (Beckman USA Model J2-21M) at 5,000 g, 4°C for 15
min, the plasma was then removed and stored frozen until required.
3 .1 .2 . Normal Rabbit Serum (NRS)

Normal rabbit serum was obtained from the ear vein of mature New
Zealand White rabbits by withdrawing 5ml of whole blood using a 25g
needle (0.50x19mm, Terumo Pty Ltd, Melbourne Australia). Blood was
allowed to clot at room temperature then held at 4°C for 10 hrs. The serum
was collected and then centrifuged (Beckman USA Model J2-21M) at
5,000 g, 4°C for 30 min. The supernatant was removed and stored frozen
until required.

3 .1 .3 . Normal Guinea Pig Serum (NGPS)

Normal guinea pig serum was obtained from mature guinea pigs by
withdrawing 5 ml of whole blood from the heart using a 21 g needle 0.8x38
47

mm. Prior to heart puncture animals were anaesthetised with Anaesthetic
Ether (Hoechst Limited Victoria Australia). The whole blood was processed
and stored in a similar manner to that for the NRS.

3.1.4. Donkey Anti-Rabbit Serum (DARS) or Donkey Anti-Guinea Pig Serum
(DAG PS)

To obtain the DARS or DAGPS a primary immunisation of 1 mg of rabbit
gamma globulin or guinea pig gamma globulin was dissolved in 2.5 ml
saline and this emulsified with 2.5 ml Freunds Complete Adjuvant (Sigma
Chemical Co. USA).

At 4 weeks post primary the donkeys were given a

booster immunisation using a similar regime, however, the Freunds
Complete Adjuvant was replaced with Freunds Incomplete Adjuvant. One
week after this boost blood was withdrawn from the jugular vein of the
treated donkeys using a 13G needle (Solila Pty Ltd. Melbourne, Australia).
Blood was allowed to clot at room temperature and then kept at 4°C
overnight before serum was harvested. Serum was centrifuged (Beckman
USA Model J2-21M) at 5000 g, 4°C for 30 min and the supernatant
collected and stored at 4°C until required.
3.2. Protein lodination

Buffers

3.2.1. Stock: 0.5 M P04
This buffer was made up by dissolving 78 g of NaH2P042H20 and 16 g of
NaOH into 1 litre of distilled water. The pH of the buffer was adjusted to
7.4 by using 4M NaOH.
3.2.2. Buffer A
A 0.25M P04 buffer was prepared by taking 100 ml of the stock buffer
and diluting it with distilled water to give a final volume of 200 ml.
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3.2.3. Buffer B
A 0.05M P04 buffer was prepared by taking 10 ml of the stock buffer
and diluting it with distilled water to give a final volume of 100 ml.
3.2.4. Buffer C
A 0.05M P04 buffer was prepared by taking 100 ml of the stock buffer
and diluting it with distilled water to give a final volume of 1 litre. To this
solution BSA# Fraction V (Sigma Chemical Co. USA) was added to give a
concentration of 0.25% weight/volume.
3.2.5. Preparation of Sephadex Column for Protein and Free Label
Separation

Five g of Sephadex (Amrad Pharmacia, Melbourne, Aust. ) was rehydrated
in 100 ml of distilled water. The Sephadex solution was heated in a boiling
water bath for 6 h and then allowed to cool to room temperature. The
Sephadex solution was de-gassed before loading onto a glass column, (1.5
cm x30 cm) and then was left to stand for 2 days to allow column to "bed
down". The column was equilibrated by gravity flow with 0.05M P04,
(Buffer C) before use. A column containing Sephadex G 50 was used to
separate labelled growth hormone from free radioactive iodine and
Sephadex G 100 was used to separate

labelled insulin from free

radioactive iodine.
3.2.6. Reagent Preparation
Protein for iodination was dissolved in Buffer A to give a concentration of
'\pg/p\. Chloramine T was used as an oxidising agent at a concentration of

1mg/ml of Buffer B. Sodium Metabisulphide was used to stop the reaction
and was used at a concentration of 0.2 mg/ml of Buffer B. Potassium
Iodide was used as the eluent at a concentration of 1mg/ml of Buffer C.
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3.2.7. Reaction Procedure
The lodination procedure was based on that reported by Greenwood et aL
(1963) and was carried out in accordance with the CSIRO Division of
Animal Production's health and safety guidelines.
To a glass reaction vial, containing 5 //g of protein was added 5//I I125
containing approximately 18 MBq. To this was added 5 //I of Chloramine T
and then allowed to react for 30-45 sec's. To stop the reaction, 10 //I of
Sodium Metabisulphide solution was added and this was followed by the
addition of 0.2ml Potassium Iodide solution. The mixture was then
transferred onto the separation column and then eluted with Buffer C. The
eluent was collected as fractions the sizes of which were determined by
following the separation of labelled protein on a radiometric pen recorder.
The desired fractions were then stoppered and kept frozen at -2 0 ° C until
required.
3.3.

Insulin RIA

Plasma concentrations of insulin were determined in duplicate using the
double-antibody RIA method of Downing et ai. (1995). The sensitivity of
the assay was 0.1 ng/ml and the inter and intra assay variation were 6.1%
and 13.7% respectively.
Assay Reagents

Buffers

3.3.1. Stock :2M P04
This buffer was made up by dissolving 15.6 g of NaH2P042H20 and 3.2 g
NaOH in 200 ml of distilled water.
3.3.2. Buffer 1
A 0.04M P04 buffer was prepared by taking 20 ml of stock buffer and
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diluting it to 1 litre with distilled water. To this solution was added 8.77 g
of NaCI and 0.1% weight/volume of BSA, Fraction V. (Sigma Chemical Co.,
St. Louis, USA).

3 .3 .3 . Buffer 2

A 0.04M P04 buffer was prepared as for Buffer 1. To this buffer 18.6 g
EDTA was added and the pH adjusted to 7.4 using a 4M NaOH solution.
3 .3 .4 . Primary Antibody:

The insulin antibody used in this assay was raised in guinea pigs at the
CSIRO Division of Animal Production, Prospect, NSW Australia. A primary
immunisation of 1 mg crystalline bovine insulin (Burroughs Wellcome, Batch
No 2189) was dissolved in 1 ml sterile saline and emulsified with 1 ml of
Freund's Complete Adjuvant. Guinea pigs were injected subcutaneously at
multiple sites using a 21 g needle. Six weeks later the guinea pigs were
boosted with bovine insulin, emulsified in Freund's Incomplete Adjuvant
and injected as for the primary vaccination. The guinea pigs were given 4
subsequent boosts at 3 weekly intervals before blood collection. Blood was
withdrawn from the guinea pigs as described previously (section 3.1.3.).
The antiserum was divided into 0.1 ml aliquots and stored frozen at
—20°C. The primary antibody used for assays described in this thesis was
GP2 collected on 21/7/87. The antiserum was found to have the following
cross-reactivities.

Peptide

Percentage Cross-reactivity
(%)

Ovine insulin

100

Bovine insulin

100

Equine insulin

63

Porcine insulin

56

Pro-insulin

32

Somatostatin

0
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Ovine GH

0

Bovine C-peptide

0

Bovine glucagon

0

Prolactin

0

3 .3 .5 . Insulin Standard

The insulin standards were prepared from purified porcine insulin (Elli Lilly
Pty Ltd). Initially this was made up to a concentration of 100ng/ml in Buffer
1 and stored in aliquots at -2 0 °C . When needed, sufficient of the stock
was serially diluted in buffer 1 down to a concentration of 0.078 ng/ml
using Buffer 1.

3 .3 .6 . Assay Procedure

All samples were assayed in 10 mm x 75 mm, P4 (John Morris Ltd.,
Sydney, NSW) plastic tubes. The samples and the quality controls were
assayed in duplicate and the insulin standards were assayed in triplicate.

On day 1, 100//I of sample was diluted with 500//I of Buffer 1. The
standard curve was prepared by adding 100//I of the insulin standard, 100//I
of the hormone stripped plasma and then diluting this with 400//I of Buffer
1. The insulin antisera was made up to a working dilution of 1:100,000 in
Buffer 1 which contained NGPS (1:500). A 100//I volume of antisera
solution was added to each assay tube and then the tubes were vortexed
and left to incubate at 4°C for 24 h. On the third day the insulin tracer was
diluted in Buffer 2 and 100//I containing 14,000 cpm was added to each
tube before being vortexed. The assay tubes were then incubated at 4°C
for 48 hr. On the fifth day DAGPS was diluted to a working dilution of 1:4
with Buffer 1. A volume of 100//I of this mixture was added to each tube
before being vortexed and then left 4°C for 18 h. On the following day the
assay tubes were centrifuged (Sorvall RC3C, Sorvall Instruments DuPont,
USA) at 1,500 g for 45 min. The supernatant from each tube was removed
and the pellet was then counted on a gamma counter (Gammamaster, LKB
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Wallac, Turku, Finland). The insulin concentration was determined using a
specific RiaCalc (Wallac Oy, Pharmacia, Finland) computer program.
To determine the inter- and intra-assay variation, quality controls, plasma
containing a known low, medium and high insulin concentration were
repeatedly spaced throughout each assay.
3.4. Growth Hormone RIA

Plasma concentrations of growth hormone (GH) were determined by the
double-antibody RIA assay method of Downing et ai.

(1995). The

sensitivity of the assay was 0.45 ng/ml and the inter- and intra-assay
coefficients of variation were 8.1% and 8.4% respectively.
Assay Reagents
3.4.1. Primary Antibody
The antisera was obtained as a gift from NIADDK (OGH2). For the assay
the antisera was diluted in Buffer 1 to give a working dilution of 1:20,000.

3.4.2. GH Standard
The standard was obtained as a gift from NIADDK, (oGH-1-4 code no
AFP8758C). The GH standards were made up in Buffer 1 to give a range
from 0.50 ng/ml to 80.03 ng/ml.
3.4.3. Assay Procedure
The GH RIA protocol was essentially the same as for that of the Insulin
RIA, with some differences in the reagents used. Normal rabbit serum was
used in place of NGPS and DARS was used in place of DAGPS.
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3.5. ^-Endorphin RIA

The /?-Endorphin assay was kindly performed by A. Shaneh, University of
Sydney,

Camden

NSW.

Plasma

^-Endorphin

concentrations

were

determined in duplicate using the unextracted radioimmunoassay technique
developed by Lim et al. (1982). The inter- and the intra-assay coefficients
of variation were 13.8% and 16.5% respectively. The sensitivity of the
assay ranged from 2 to 5 pg/ml. The antisera used in the assay was raised
in a rabbit and was the gift of Dr D. Shutt, NSW Dept Agriculture.
The antiserum was found to have the following cross-reactivities;
Peptide

Percentage Cross-reactivity
(%)

e-endorphin (1-39)

100

Humane-endorphin (1-31)

81

Porcine acetyl e-endorphin (1-31)

45

Porcine e-endorphin (1-31)

36

e-lipotropin (1-92)

35

Ovine e-endorphin (1-27)

30

Ovine ACTH (1-31)

2

Porcine ACTH (1-31)

0.2

flr-MSH

0.1

cr-endorphin

<0.01

y-endorphin

<0.01

e-MSH

<0.01

Leucine-enkephalin

<0.01

Methionine-enkephalin

<0.01

Ovine CRF

<0.01

ACTH (1-24) (synacthen)

<0.01
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Steroid Assays

3 .6 . Cortisol RIA

Plasma concentrations of Cortisol were determined in duplicate using the
modified technique of Foster and Dunn (1974). Sensitivity of the assay was
1 ng/ml and the inter and intra assay coefficients of variation were 5.5%
and 6.5% respectively.

Reagents

Buffer

3 .6 .1 . Buffer 3

This buffer was prepared by dissolving 2.48 g of H3BO and 2.0 g gelatin
(porcine skin, approx 300 bloom. Sigma Chemical Co, USA) to 1900 ml
distilled water. The solution was then heated to dissolve the gelatin and
then following this 1 g of NaN3added. The pH of the solution was adjusted
to 7.6 with 4M NaOH and the final volume was then made to 2000 ml.
3 .6 .2 . Dextran Coated Charcoal

The dextran coated charcoal was prepared by dissolving 6.25 g of Norit A
charcoal and 625 mg Dextran T70 (Amrad Pharmacia, Melbourne, Aust.) in
250 ml of distilled water. This solution was stored at 4°C and was freshly
prepared every three weeks.

3 .6 .3 . Primary Antibody

The cortisol antibody used in this assay was raised in rabbits at the
CSIRO,

Division of Animal

Production,

Prospect,

NSW.

A

primary

immunisation of 1 mg Hydrocortisone 3-(o-Carboxymethyl)0xime:BSA
(Sigma Chemical Co.), was dissolved in 1 ml sterile saline and emulsified
with 1 ml of Freund's Complete Adjuvant. New Zealand White rabbits were
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given a 1 ml intra-muscular injection into each hind leg. Six weeks later the
same rabbits were given a booster injection consisting of 1 mg of the
cortisol antigen dissolved in 1 ml sterile saline and this was injected into the
ear vein. One week post-boost the rabbits were bled as described in section
3.1.2. and the serum processed accordingly and stored frozen at -2 0 °C .
The primary antibody used for assays described in this thesis was Tig Pen'
and this was sampled on the 12/10/92.

The antiserum was found to have the following cross-reactivities;
Steroid

Percentage Cross-reactivity
(%)

Cortisol reference standard

100

Hydrocortisone

100

Cortisone
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Corticosterone

3

Deoxycorticosterone

0.3

Hydroxyprogesterone

0.3

Progesterone

<0.1

Androstenedione

<0.1

Estrone

<0.1

3 .6 .4 . Cortisol Standard

A

stock

standard

solution

was

prepared

by dissolving

12.8

g

Hydrocortisone 3-(o-Carboxymethyl)Oxime:BSA (Sigma Chemical Co.) in
100 ml AR Ethanol (Ajax Chemicals, Sydney) to give a concentration of
128//g/ml. The stock standard solution was kept at 4°C until required.
When needed, 50//I of the stock standard was made up in 10ml of Buffer 3
to give a concentration of 640 ng/ml. The assay standards were prepared
by serially diluting the 640 ng/ml standard down to a concentration of 0.31
ng/ml.
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3.6.5. Assay Procedure
All assays were carried out in 12mmx75mm 'Borex' glass tubes (Crown
Scientific, NSW, Australia). The samples and the internal standards were
assayed in duplicate and the standards for the standard curve were assayed
in triplicate.

On day one, 20//I of sample was diluted with 680//I of Buffer 3. The
standard curve was prepared by adding 20//I of the cortisol standard with
20//I of the hormone stripped plasma and 660//I of Buffer 3. The samples
and the standards were then heat extracted by placing them in a 60 °C
water bath for 60 min at which time they were removed and stored at 4°C
for 24h. On day two the cortisol antisera was diluted with Buffer 3 to give
an initial dilution of 1:25,000. A volume of 100//I was added to the assay
tubes which were then vortexed. The cortisol tracer (Amersham Pty Ltd.
Aust.) was diluted with Buffer 3 to give a concentration of 6,000 CPM in
100//I. A 100//I tracer was added to all the tubes before being vortexed.
The tubes were then incubated at room temperature for 60 min. A 100//I of
the dextran coated charcoal was added to each tube before vortexing
again. The tubes were then incubated at 4°C for 15 min before they were
centrifuged at 1,500 g for 45 min. The supernatant was removed and the
pellet counted on a gamma counter and a specific RiaCalc programme was
used to determine the cortisol concentrations.

To determine the inter- and intra-assay variation, internal standards of a
known cortisol concentration (low, medium and high) were repeatedly
spaced throughout each assay.

3.7. Catecholamine Assay

Plasma catecholamine samples were absorbed onto alumina using the
extraction procedure of Henry et a/. (1975) and then quantified by HPLC
with electrochemical detection (ECD). These analysis were kindly carried
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out by Nerille Willis, of the Dept of Renal Medicine, Royal Prince Henry
Hospital, Sydney, NSW.
3.7.1. HPLC Conditions
The column used for the adrenaline and the noradrenaline analysis was a
Waters //Bondapak C18 3.9mm x 30 cm

stainless steel column (Cat No

27324) with a 10 ¡j particle size. An electro chemical detector was used
with a potential of + 0.6 - 0.75V oxidation. The full scale deflection was 1
nA, the pump flow rate was 1.0 ml/min and the injection volume used was
100//I.

3.7.2. Mobile Phase (isocratic Conditions)
The buffer used for the mobile phase was 0.15M P04 and contained in 1
litre of distilled water 20.7 g NaH2P042H20, 500 mg EDTA, and 50 mi of
MeOH.

The sensitivity of the assay was 0.1 nm/Litre and the inter-assay and
intra-assay coefficients of variation were: noradrenaline 7.5% and 8.2%,
adrenaline 7.6% and 7.5%.
Metabolite Assays
3.8. Plasma Free Fatty Acid Analysis

Plasma FFA's were measured by enzymic analysis using a kit supplied by
Boehringer Mannheim Ltd (Germany). The assay is based on the action of
acetyl-CoA synthetase in the presence of coenzyme A and adenosine-5'triphosphate. The analysis uses the modified method of Dunshea et al.
(1989) in which reagents were further diluted with 0.1M P04 at pH 7.8 to
increase the number of samples assayed per kit. The inter- and intra-assay
coefficients of variation were 10.6% and 8.1% respectively.
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3 .9 . Plasma Glucose Analysis

For the samples assayed in chapter 4 the plasma glucose levels were
determined by the glucose oxidase method of Huggett and Nixon (1957).
Reagents

3 .9 .1 . 0.5M Phosphate Buffer

This buffer was prepared by dissolving 78 g of NaH2P042H20 in 1 litre of
distilled water. The pH

of the buffer was adjusted to 7.0 using 10 N

NaOH.

3 .9 .2 . Colour Reagent

The colour reagent was prepared by dissolving 12.5 mg of type 2 glucose
oxidase (from Aspergillus niger, Sigma Chemical Co.), 0.7 mg of peroxidase
type 2 (from horseradish, Sigma Chemical Co.) and 100 mg of 2,2'-Azinobis(3-ethylbenzthiazoline-6-sulfonic acid) (Sigma Chemical Co.) in 100 ml of
0.5M P04.

3 .9 .3 . Glucose Standard

A stock glucose standard solution of 1 mg / 100//I was prepared by
dissolving 1 g of D-( + )-Glucose (Sigma Chemical Co.) in 100 ml of a
0.25% benzoic acid solution (Ajax Chemicals, Sydney Australia). From the
stock solution a range of standards, (10 mg to 300 mg), was made up in
0.25% benzoic acid.

3 .9 .4 . Assay Procedure

To a glass test tube, 100 p\ of sample or glucose standard was diluted
with

0.5 ml of a 6% perchloric acid solution and the contents then

vortexed. The solution was left to stand for 10 min before centrifuging for
20 min at 1,500 g. From these tubes 100 p\ of the supernatant was
removed and then diluted with 5 ml of the colour reagent before vortexing.
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The assay tubes were then incubated in a water bath at 37°C for 15 min
in the dark. Following the incubation the optical densities for the samples
and the standards were read at 436 nm using a Varian DMS 100
spectrophotometer.

For the samples assayed in chapters 5 and 6 the plasma glucose
concentrations were determined by the autoanalyser using the method of
Bergmeyer and Bernt (1963). The inter- and intra-assay coefficients of
variation were 1.0% and 1.1% respectively.

3.1 0 . Plasma Lactate Analysis

Plasma lactate was determined by autoanalyser using the method of Mann
and Shute (1970), the inter- and intra-assay coefficients of variation were
2.3% and 2.3% respectively.
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Chapter 4

Sympathetic Nervous
Exercise in the Ewe.

Activity

and

Glucocorticoid

Regulation

During

4 .1 . introduction

An animals physiological regulation of homeostasis when exposed to any
perceived stress is achieved by a series of complex endocrine interactions,
these include hormones from the adrenal glands (Harvey et al., 1984).
Physical exercise has been shown to stimulate both the sympathetic
nervous

system

(SNS)

(Christensen

and

Galbo,

1983)

and

the

hypothalamic-pituitary-adrenal axis (HPA) (Petrides et al.r 1994). Exerciseinduced activation of the SNS results in release of catecholamines,
principally adrenaline from the chromaffin cells of the adrenal medulla and
noradrenaline from the sympathetic nerve endings. Similarly, exerciseinduced activation of the HPA axis results in the release of glucocorticoids
from the adrenal cortex. Both catecholamines (Webber and Macdonald,
1993) and glucocorticoids (Odio and Brodish, 1988) promote lipolysis, with
the subsequent release of free fatty acids (FFA), and an increase in blood
glucose levels. These energy substrates are readily available to the working
muscle during exercise. Their effects are facilitated by the inhibition of the
secretion of insulin (Viru, 1985). Oxygen consumption (V02) also increases
during exercise and is associated with the high metabolic requirements
dictated by the enhanced demand for energy by the skeletal and heart
muscles (Blum and Eichinger, 1988). There is little published information as
to the contribution that both these "stress" axes play during exercise; not
only their involvement in the regulation of energy substrate availability and
release of other hormones but also their contribution to the cardiovascular
and respiratory response to stress.

Of all the changes during exercise, an increase in the sympathomedullary
61

activity becomes the most important autonomic neuroendocrine response
(Kjaer et aL, 1987). The increase in sympathetic tone influences many
physiological

processes

including

cardiovascular

adaptation,

thermoregulation, and water and electrolyte balance (Galbo 1981, 1983).
These physiological changes as well as changes in carbohydrate and lipid
metabolism are mediated by specific adrenergic receptors (Himms-Hagen,
1967). The use of a- and /?- adrenergic antagonists for in vivo studies has
been shown to facilitate the understanding the physiological processes that
are mediated by the catecholamines. In sheep, the /?-adrenergic antagonist,
propranolol HCI, and the a-adrenergic antagonist, phentolamine methanesulfonate, effectively block activation of these receptors during exercise
(Brockman and Halvorson, 1981).

4.2. Aims of the studies described in this chapter were;

1: To determine the cardiovascular, metabolic and endocrine changes in the
sheep during aerobic and anaerobic exercise.

2: To measure the physiological changes prior to, during and after exercise
in sheep that have been pre-treated with the adrenergic antagonists,
propranolol HCL or phentolamine methane-sulfonate .
The comparisons in these studies were between sheep given a control
immunisation or immunised against ACTH 1-24.
4.3. Materials and Methods

Animals

Six Border Leicester x Merino ewes were housed at the University of
Sydney farms Camden (latitude 34°S). Ewes were maintained at pasture
before being acclimatised to individual metabolic cages (Till and Downs,
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1967) and housed in a thermoneutral environment under a photoperiod
regime of 12 L : 12 D. All ewes had full access to water at all times and
were fed ad libitum a pelleted ration

consisting of 60% hammermilled

lucerne and 40% crushed oats. It was estimated that the diet supplied 10.4
MJ of metabolisable energy/Kg liveweight/day.

Three of the ewes were actively immunised against ACTH 1-24-ovalbumin
conjugate

(1mg)

in

Freund's

Complete Adjuvant

immunisation was given in mid December

(2ml).

A

primary

1993 and two

booster

immunisations prepared in incomplete adjuvant, were given at six weeks
and ten weeks after this primary vaccination. The three remaining ewes
acted as controls and were injected with the adjuvant alone.
Assimilation to Treadmill

All sheep were accustomed to walking on a motorised treadmill (Treadmill
Austredex, Emmans and Sons Pty. Ltd., Preston, Victoria, Aust.) prior to
the commencement of the experiment. Initial training was for a period of
less than 10 minutes at a speed of 1.5 km/h on a 0° incline. Once the
sheep were accustomed to these settings the exercise speed was increased
to 2.5 km/h and the time extended to 30 minutes. The speed was then
increased to 5 km/h for 30 minutes by the end of the training period. The
training was carried out in the presence of technical staff.

Surgical Procedures

Positioning o f Blood Flow Probe around the Pulmonary Artery.

Ewes were fasted for 24 hours and denied water for 12 hours prior to the
surgical procedure. To allow insertion of the endotracheal tube, the short
acting anaesthetic agent thiopentone sodium (Boehringer) was administered
intravenously at a rate of 15-20 mg/kg body weight. Ewes were then
induced with

2-4% Fluothane (ICI) in oxygen to maintain general
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anaesthesia. After anaesthetic induction, wool around the surgical area was
clipped, and the area was then washed, and sterilised with 70% ethanol
prior to the surgical incision. The thoracic surgical procedure was based on
the technique described by Sawyer and Stone (1966) and modified by Giles
and co-workers (1995). A 20 cm dorso-ventral incision was made on the
left side of each ewe beginning adjacent to the posterior edge of the
scapula and continuing into the pleural cavity via the third intercostal
space. Manual ventilation was used using a Autohand ventilator, set at 20
respirations per minute. The lung was displaced, then moved towards the
dorsal side of the pleural cavity to enable access to the pulmonary artery. A
5 cm incision was made through the pericardium in the direction of the
pulmonary artery, followed by both blunt and sharp dissection to separate
the connective tissue between the aorta and the pulmonary artery. A sterile
blood flow probe (16 mm diameter, S-series, Transonic Systems Inc,
Ithaca, USA) was secured around the pulmonary artery using the monitors
own reflector bracket. The probe was located so that the blood vessel was
positioned within the acoustic window of the probe (Gooden and Giles,
1991). The pericardium was sutured loosely over the probe body using
chromic gut suture and the probe lead excised near the ventral edge of the
incision to allow unrestricted movement of the lead during exercise. The
third and fourth ribs were tied together and the intercostal muscle layers
closed. Prior to the closing of the chest wall the lungs were inflated
manually to exclude excess air from the pleural cavity, the ventilator was
then discontinued to allow spontaneous respiration to re-commence.
Post-operative care consisted of daily intramuscular injections (4 ml) of an
antibiotic solution (Depomycin, Intervet, Australia) for 5 days following
surgery. Water and food were offered within 24 h after surgery and ewes
were carefully monitored until feed intake returned to pre-operative levels.
Gooden and Giles (1991) demonstrated that it took approximately 3 days
to allow for tissue build up around the probe and then this allows for the
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acoustic coupling between the pulmonary artery and the probe. For this
experiment the blood flow probes were assessed 10-12 days after surgery
thus ensuring adequate time for the acoustic coupling between the probe
and the pulmonary artery. Direct measurement of cardiac output was
achieved by connecting the blood flow probe to a bench top blood flow
meter

(Transonics T201,

Two-channel

ultrasonic

blood flow

meter,

Transonics Systems Inc., Ithaca, New York, USA). Data were recorded
either manually or automatically on a data logger (Tain Electronics,
Melbourne, Australia).

Fibre-Optic Catheter Placement in the Pulmonary Artery for Oxygen
Saturation Determination

Three days prior to the commencement of the experiment, the ewes were
prepared for surgery as described previously. A pre-calibrated Oximetrix
catheter (Oximetrix: Abbott Laboratories, North Chicago, USA, 2.5 mm
O.D.) was inserted into the pulmonary artery of each sheep via the jugular
vein, using a catheter inducer (8.5F with a 13 cm sheath, W.A. Cook,
Brisbane, Aust). The catheterisation procedure was carried out using the
Seldinger technique (Seldinger, 1953) which was modified by Giles and co
workers (1995). A latex balloon at the tip of each catheter was inflated to
allow easy movement of the catheter through the heart chambers. The
placement of the Oximetrix catheter within the pulmonary artery was
proximal to the blood flow probe and its correct position was determined by
the interference generated by the air filled balloon tip as it passed through
the acoustic window of the blood flow probe.

Carotid

Artery

Catheterisation

for

Arterial

Oxygen

Saturation

and

Haemoglobin Determinations

Catheterisation of the carotid artery using clear vinyl tubing (I.D. 1.0 mm,
O.D. 1.5 mm, Dural Plastics Ltd, Dural, NSW) was performed at the same
time as the catheterisation of the pulmonary artery. To expose the artery,
an incision was made parallel to the trachea at the level of the fifth
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vertebrae.

Jugular Vein Catheterisation

The jugular vein catheter (medical grade polythene tubing I.D. 1.0 mm,
O.D. 1.5 mm, Dural Plastics Ltd, Dural, NSW) was inserted into all animals
24 h prior to the commencement of the experiment. This was done using a
topical anaesthetic agent, Xylocaine 10% spray, (Astra Pharmaceuticals Pty
Ltd., Melbourne) and a sterile 14G catheter placement unit, (Jelco, Johnson
and Johnson Medical, Japan). Patency of the catheters were maintained by
flushing the catheters with heparinised saline (500 lU/ml of heparin).

Experimental Design

The exercise regime for this experiment was designed to subject the
sheep to low intensity exercise (2.5 km/h), the energy supply for which
should be met by aerobic metabolism, and to high intensity exercise (5
km/h), during which animals should be dependent on both aerobic and
anaerobic mechanisms to generate energy.
The exercise pattern is summarised in table 1.
Table 1

Rest

2.5 km/h

Rest

5 km/h

Rest

90 min

30 min

60 min

30 min

90 min

infusions

All infusions given to conscious ewes were administered intravenously via
the jugular catheter using a variable speed peristaltic pump (Gilson Medical
Electronics, Villiers le Bel, France) at an infusion rate of 0.5 ml/min.
Propranolol hydrochloride (Sigma Chemicals), was diluted in sterile saline
and infused for four hours at a concentration of 0.5 mg/kg/h (Bassett,
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1970). Phentolamine methane-sulfonate (Aldrich Chemical Co.) was diluted
in sterile saline and infused for four hours at a rate of 1.0 mg/kg/h (Bassett,
1970). Ewes were infused with saline for the first 30 min during the initial
rest period before drug treatment and again for 30 min at the end of the
final rest period. To recover from the exercise periods ewes were rested for
a period of 24 hours between treatments. One ewe from the non-immune
group and one from the ACTH-immune group were given the same
treatment for that day and this procedure was maintained throughout the
course of the experiment.

The pattern of treatments over the 11 days of the experiment is
summarised in table 2.
Day o f the experiment
ewe

1

1

S

a

p

2

S

a

p

2

3

4

5

6

3

a

p

S

4

a

p

S

7

8

9

11

10

5

p

S

a

6

p

S

a

Table 2.

Legend for the pattern of infusions given over the 11 days of the
experiment. S = saline,

a = phentolamine methane-sulfonate,

ft -

propranolol HCI

Blood Sampling

Venous blood samples (3 ml) were drawn from the jugular catheter using
a 2.5 ml syringe (Terumo Corporation Japan). After each sample, catheters
were flushed with heparinised saline (100 International lU/ml). Samples
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were taken at 30 min intervals during each rest period and at 5 min
intervals during both exercise periods. Blood samples were transferred into
plastic P4 tubes (John Morris Ltd, Sydney, NSW) containing kwickspin
separation granules (Kwickspin, Disposable Products Padstow, NSW). All
samples were kept on ice until centrifuged at 2000g for 15 min at 4°C.
Plasma samples were stored at -20°C until assayed.

Catecholamine Sample Collection

Venous blood samples for the determination of plasma adrenaline and
noradrenaline were collected in pre-cooled P4 plastic tubes containing 1mg
sodium metabisulphite per 10 ml blood. Samples were taken during each
rest period and immediately following the completion of each exercise
period. After collection, samples were immediately centrifuged and plasma
frozen at -70°C until assayed.

Respiratory and Circulatory Analysis

Measurement o f Whole Body Oxygen Consumption

Whole body oxygen consumption was determined

by the direct

measurement of cardiac output (L/min) and the difference in oxygen
content between arterial and mixed venous blood across the lungs (the Fick
technique). The Fick equation for the determination of oxygen consumption
used in this experiment is based on the application of the ultrasonic blood
flow and Oximetrix measurement techniques developed by Gooden and
Giles (1991).
The Fick equation is as follows:
Q02 = CO x (Sa02-Sv02) x Hb x 1.34 / 10
where Q 02 = oxygen consumption (ml/min)
CO = cardiac output (l/min)
Sa02= arterial oxygen saturation (%)
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Sv02 = mixed venous oxygen saturation (%)
Hb = blood haemoglobin content (g%)

Arterial Oxygen Saturation and Blood Haemoglobin Content

Both oxygen saturation and haemoglobin content was determined in blood
taken from the carotid artery. In the studies of Gooden and Giles (1991),
the saphenous artery was used. The carotid artery was selected for these
studies as the catheterisation and subsequent blood sampling would not
impede the ewe while exercising on the treadmill. Blood samples (1ml) were
withdrawn from the catheter using a 2.5ml syringe (Terumo Corporation,
Japan). Syringes were previously filled with heparinised saline (Fissons
Pharmaceuticals Vic; 100 lU/ml) and then evaporated to dryness prior to
sampling. Arterial blood samples were taken at the same time intervals as
for the other plasma samples for the determination of carotid oxygen
saturation and haemoglobin content and were placed manually in a
haemoximeter (Radiometer, Copenhagen, Denmark). The patency of the
catheters was maintained during the experiment by flushing catheters after
each sampling period with heparinised saline (100 lU/ml) and between
experiments, by filling the catheters with heparinised saline (1000 lU/ml).
Cardiac Output

Cardiac output in the sheep is measured as the volume of blood passing
through the pulmonary artery per unit of time (Gooden and Giles, 1991).
The measurement of blood flow by ultrasound is based on the time taken
for sound waves to pass through the pulmonary artery, by utilising the
ultrasonic,

transit-time

principle,

whereby

volume

independently of vessel size (Gooden and Giles,

flow

is

sensed

1991). Thus, the

determination of cardiac output in this experiment was measured by the
placement of a transit-time ultrasonic flow meter (Transonic System Inc.,
Ithaca, USA) around the pulmonary artery of each sheep. This transit time
ultrasonic blood flow method has been validated by Gooden and Giles
(1991) by comparing it to the dye-dilution technique using the jugular vein
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(Lush et ai., 1989) and to the stop watch/measuring cylinder technique
using the portal vein (Neutze et a!., 1989). In both comparisons, there was
no significant difference in blood flow between the techniques.

Mixed Venous Oxygen Saturation

Mixed venous blood oxygen content was determined using the Oximetrix
catheter containing a fibre optic bundle. This fibre optic bundle transmits a
light beam of three specific wave lengths to the tip of the catheter. The
level of the blood oxygen is determined by the amount of reflected light
transmitted back to a monitor (Oximetrix, Abbott Laboratories, North
Chicago, USA) from the red blood cells. The difference in light intensity
between the afferent and efferent fibre optic bundles is related to blood
colour and therefore to oxygen saturation. Before each experiment the
Oximetrix monitor was calibrated against a blood sample taken from the
pulmonary artery and measured manually on a haemoximeter (Radiometer,
Copenhagen).

Body Temperature

A thermocouple incorporated in the tip of the oximetrix catheter, situated
in the pulmonary artery, enabled the continuous measurement of deep body
temperature during the experimental procedure.

4 .4 . Statistical Analysis

All data are presented as the mean ± the standard error of the mean
(S.E.M.). The effects of exercise and infusion treatment and their
interaction were measured by repeated measures ANOVA test (CLR
ANOVA program; Clear Lake Research Inc., Houston TX, USA).
The differences in the mean catecholamine levels during exercise and
infusion were compared using an unpaired t-test (Steel and Torrie, 1980).
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4 .5 . Results

Plasma Cortisol Levels

The plasma cortisol levels are shown in figure 4.1. During the saline
infusion circulating cortisol levels in the non-immune group increased during
both exercise periods compared to the rest periods with a significant
increase (P< 0.05) in plasma cortisol occurring during the 5 km/h exercise
period {Fig 4.1a). There was no significant treatment effect with either of
the adrenergic antagonists. However, during the infusion with phentolamine
methane-sulfonate (Fig 1c) circulating cortisol levels in the non-immune
sheep were markedly higher during the 2.5 km/h exercise period and the
rest periods compared to either the saline or the propranolol HCI infusion.

There was no significant effect of exercise or infusion treatment on
plasma cortisol levels in the ACTH-immune group. Circulating plasma
cortisol levels in this group remained at or near basal levels for the duration
of the experiment regardless of treatment (Figs 4.1af 4.1b, 4.1c).

Plasma Noradrenaline Levels

The plasma noradrenaline levels are given in figure 4.2. During the saline
infusion

there

was

a significant

increase

(P<0.03)

in

circulating

noradrenaline levels in the non-immune group at the end of the first
exercise period (2.5 km/h) when compared to the initial rest period
(1.63±0.28 and 0 .95±0.15 mmol/L respectively). These levels remained
elevated into the following rest period and then increased during the second
exercise period (5km/h)

1.67 ±0.59 mmol/L to 4.46 ± 0.07 mmol/L

(P<0.02). Noradrenaline levels remained elevated during the following rest
period with the mean concentration being 5.83 ±2.67 mmol/L. A similar
plasma noradrenaline profile was observed in the ACTH-immune group
during saline infusion with increased circulating noradrenaline levels
occurring at both exercise periods, (2.5 km/h 2.26 ±0.66 mmol/L, 5 km/h
7.07 ± 0 .2 5 mmol/L) when compared with the levels attained in their
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preceding

rest periods

respectively;

(1.72±0.49

mmol/L and

1.73±0.3

mmol/L

Fig 4.2a). However, unlike in the non-immune group,

circulating noradrenaline levels returned to near basal levels during each of
the rest periods.

Pre-infusion of phentolamine methane-sulfonate before exercise to the
non-immune and the ACTH-immune groups resulted in a similar plasma
noradrenaline profile as with saline infusion (Fig 4.2b). The increase in
plasma noradrenaline concentrations for both groups during the 5 km/h
exercise period was greater than that seen during the saline infusion (Fig
4.2b). There was no significant difference of immunisation on the plasma
noradrenaline levels after phentolamine methane-sulfonate treatment.
The pre-infusion of propranolol HCI to both the ACTH-immune and the
non-immune groups resulted in an increase in plasma noradrenaline levels
during the exercise periods. The increase during the 5 km/h exercise regime
was

greater than during the saline infusion but was not significant (Fig

4.2c). There was no significant difference due to immunisation treatment.
However, the plasma noradrenaline levels during all the sampling periods
were elevated when compared to either the saline or the propranolol
treatment.

Plasma Adrenaline Levels

Plasma adrenaline levels are shown in figure 4.3. There was no significant
difference during the saline infusion in plasma adrenaline levels. For both
groups, the levels remained at or near basal levels until the 5km/h exercise
period when there was an increase, although this was not significant (Fig
4.3a). These increased levels remained into the following rest period.

The pre-treatment with either propranolol HCL (Fig 4.3b) or phentolamine
methane-sulfonate (Fig 4.3c) before exercise period gave a similar plasma
adrenaline profile as seen for the saline infusion. There was an increase in
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adrenaline levels during the 5 km/h exercise period for both treatment
groups given either pharmacological treatment when compared to the saline
treatment alone. There was no difference in plasma adrenaline levels
between the ACTH-immune and the non-immune groups with either of the
tw o antagonists during the study period.

Plasma Free Fatty Acid Levels

The plasma free fatty acid levels are given in figure 4.4. An immediate
increase in plasma FFA levels were observed in the non-immune group
during both exercise regimes (Fig 4.4a), although, this increase was not
significant until the ewes were exercised at the 5 km/h exercise (P< 0.01).
For the ACTH-immune group no increase in FFA levels occurred in response
to either of the exercise regimes. For these ewes the FFA levels remained
at or near basal levels for the duration of the experiment (Fig 4.4a).
Pre-treatment with phentolamine methane-sulfonate before exercise gave
rise to a gradual increase in the basal plasma FFA's levels in both groups
(Fig 4.4b). Exercise at 2.5 km/h resulted in a small but not significant
increase in circulating FFA's in both groups. When the intensity of the
exercise was increased to 5 km/h there was an immediate and significant
(P< 0.01) increase in FFA's in the non-immune group. Plasma FFA levels in
this group continued to increase throughout the exercise period and
declined after its cessation. In contrast, there was no increase in the
plasma FFA levels in the ACTH-immune group in response to the 5 km/h
exercise regime (Fig 4.4b) with levels remaining at the level seen during the
2.5 km/h exercise period.
The pre-treatment with propranolol HCI prevented the exercise induced
increase in plasma FFA levels in the non-immune group with FFA
concentrations remaining at or near basal values for the duration of the
experiment (Fig 4.4c). There was no significant difference between the
ACTH-immune

and

the

non-immune
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irrespective of the level of exercise (Fig 4.4c).

Plasma Lactate Levels

Plasma lactate levels (Fig 4.5) increased significantly (P<0.05 non
immune, P<0.01 ACTH-immune) in both groups during the 5 km/h exercise
period (Fig 4.5a). During this period circulating lactate levels increased in
both groups at the onset of the exercise and then continued to increase
throughout the exercise period. While there was no significant difference in
the lactate profile between the non-immune or the ACTH-immune groups
the concentrations in the ACTH-immune group tended to be higher (Fig
4.5a).

In contrast the pre-treatment with phentolamine methane-sulfonate before
the 2.5 km/h exercise period resulted in a small but insignificant increase in
plasma lactate levels in the non-immune ewes. No change in circulating
lactate levels for the ACTH-immune ewes in response to the 2.5 km/h
exercise (Fig 4.5b) was recorded. There were significant increases (P<
0.05 non-immune, P< 0.01 ACTH-immune) in plasma lactate levels in both
groups from the start of exercise at 5 km/h. The duration of this increase in
lactate levels tended to be longer in both groups when compared to
treatment with either saline or propranolol HCL. Plasma lactate was still
significantly elevated (P< 0.05) for at least 30 minutes after the exercise
ceased (Fig 4.5b), whereas during the propranolol and saline treatment
periods, the plasma levels tended to decrease more quickly.

The pre-treatment with propranolol HCI before and during the exercise
periods resulted in a similar plasma lactate profile to that following saline
infusion. Plasma

levels in both the ACTH-immune and the non-immune

groups increased in response to the 5 km/h exercise period (Fig 4.5c), but
there was no significant difference between groups, although again the
response in the ACTH-immune group to 5 km/h exercise tended to be
lower.
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Plasma Glucose Levels

Plasma glucose levels are given in figure 4.6. During the saline infusion
glucose levels in both groups did not increase until the 5 km/h exercise
period (Fig 4.6a). Plasma glucose levels for the ACTH-immune group were
significantly higher (P<0.05) during the 5 km/h exercise period when
compared to the levels in the non-immune group.

In the non-immune ewes the pre-treatment with phentolamine methanesulfonate before exercise resulted in a similar glucose profile to that seen
during saline infusion, there being no increase in plasma glucose levels until
the 5 km/h exercise period (Fig 4.6b). However, in the ACTH-immune group
plasma glucose levels tended to decline from the start of the phentolamine
infusion, resulting in a significant decrease in glucose levels (P<0.01)
during the 2.5 km/h exercise period. During the 5 km/h exercise period
there was a significant (P<0.05) increase in plasma glucose levels in the
ACTH-immune group. Although glucose levels increased in the non-immune
group in response to the exercise the increase was not significant.
For both groups, plasma glucose levels increased during the 2.5 km/h and
then significantly increased (P<0.05) during the 5 km/h exercise regime
when pre-treated with propranolol HCI (Fig 4.6c), however, there was no
significant difference between the groups.

Plasma Insulin Levels

The plasma insulin levels are shown in figure 4.6. No significant changes
in circulating insulin levels were observed in either the non-immune or the
ACTH-immune groups, although insulin levels

tended to increase in

response to the intensity of exercise during the study (Fig 4.6a) in both the
ACTH-immune and the non-immune groups.
Phentolamine methane-sulfonate treatment caused an increase in plasma
insulin levels before the 2.5 km/h exercise period (Fig 4.6b). Insulin levels
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for both groups increased further in response to exercise with the largest
increase occurring during the 5 km/h. However, the increase in insulin
levels for both groups at both exercise regimes was not significant. No
significant differences between either group were observed.

Propranolol HCI treatment prior to exercise decreased plasma insulin levels
in both the ACTH-immune and the non-immune groups (Fig 4.6c). For both
groups insulin levels decreased from the start of the infusion with a
significant decrease (P<0.05) occurring in the non-immune group during
the 5 km/h exercise period. Although the insulin levels declined in the
ACTH-immune group during the 5 km/h exercise, the decrease was found
to be insignificant.

Arterial Haemoglobin (Hb) Concentrations

Arterial Hb concentrations are shown in figure 4.7. Exercise at 2.5 km/h
and at 5 km/h induced an increase in arterial Hb concentrations in both
groups (Fig 4.7a) with no significant difference between groups, although
there was a tendency for ACTH-immune ewes to have lower Hb
concentrations.

Neither antagonist had any significant effect on arterial Hb concentrations
(Fig 4.7b, Fig 4.7c). During both the propranolol and phentolamine
treatments the Hb concentrations in the ACTH-immune ewes were
consistently

lower

than

the

non-immune

ewes.

Treatment

with

phentolamine tended to suppress these levels in both groups over the entire
study, although a similar effect was not apparent in response to the saline
and propranolol infusion.

Body Temperature

Body temperature in both groups tended to rise from the onset of the
saline infusion and then increase during both exercise regimes (Fig 4.8a).
There was a significant increase (P<0.01) for the ACTH-immune group
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during the 5 km/h exercise. However, even though body temperature
increased in the ACTH-immune ewes in response to the exercise the
increase was not significantly different when compared to the rest periods.
A similar pattern of body temperature to that seen during the saline infusion
was observed after treatment with both antagonists. The ACTH-immune
group had a consistently lower body temperature when compared to the
non-immune group throughout the study.

Blood Flow Levels (Cardiac Output)

Blood flow levels are given in figure 4.9. Blood flow increased significantly
(P<0.05) in both groups during the 2.5 km/h and 5 km/h exercise periods
(Fig 4.9a) but no significant difference between the treatments was
observed.

Cardiac output in both groups tended to increase from the onset of the
phentolamine infusion. There was a further increase during the 2.5 km/h
exercise period and then significantly increased (P<0.05) during the 5 km/h
exercise period (Fig 4.9b). Phentolamine treatment tended to increase
cardiac output when compared to the saline and the propranolol treatments,
but again there was no significant difference between the ACTH-immune
and the non-immune groups throughout the experimental period.
The infusion of propranolol HCI tended to decrease cardiac output over
the

experimental

period

when

compared

to

both

the

saline

and

phentolamine treatments. There was no significant difference between
either the ACTH-immune and the non-immune groups. During the 2.5 km/h
exercise period cardiac output increased and significantly increased
(P<0.05) during the 5 km/h exercise period (Fig 4.9c).

Oxygen Consumption

Oxygen consumption levels are shown in figure 4.10. Exercise caused a
77

(a) saline Infusion

(c) propranolol Infusion

(b) phentolamine Infusion

Blood Flow
L/min

B lo o d F lo w
L /m ln

12

5km/h

Blood Flow
L/min

n
0

Infusion tim e (m inutes)

3 0 60

90 1 2 0 1 5 0 1 8 0 2 1 0 2 4 0 2 7 0 3 0 0 3 3 0

Infusion tim e (m inutes)

0

r
30

1
60

1

1 1 1

■] ■

1

1

1

1

1 1 1

ACTH-immune

□

Non-immune

1 1 1

90 1 2 0 1 5 0 1 8 0 2 1 0 2 4 0 2 7 0 3 0 0 3 3 0

Infusion tim e (piinutes)

Figure 4.9 Changes in cardiac output levels in response to exercise at 2.5 km/h and 5.0 km/h
■

■

(b) phentolamine Infusion

(a) saline infusion
0 2 m ls/m in

i -p | i | i |
0

30 60

■ ....

'1 1 I 1 I

' I 1I ' I 1I

90 1 20 1 5 0 1B02 1 0 2 4 0 2 7 0 300 3 3 0

..

--............... ■

Infusion tim e (m inutes)

(c) propranolol infusion
0 2 m ls/m in

0 2 m ls/m in

T T I111I1I1I11111111
0

30

60 9 0 1 2 0 1 5 0 1 8 0 2 1 0 2 4 0 2 7 0 3 0 0 3 3 0

■— .........

0

30 60

90 1 2 0 1 5 0 1 8 0 2 1 0 2 4 0 2 7 0 3 0 0 330

... .... . ■

Infusion tim e (m inutes)

Infusion tim e (minutes),

Figure 4.10 Changes in oxygen consumption levels in response to exercise at 2.5 km/h and 5.0 km/h
ACTH-immune

□

Non-immune

significant increase (P<0.01) in 0 2 consumption in both the ACTH-immune
and the non-immune ewes (Fig 4.10a). The 0 2 consumption profile over the
experimental period was similar for both groups, however, the ACTHimmune group tended to consume less oxygen at both exercise periods.

Phentolamine or

propranolol treatments

resulted

in a similar 0 2

consumption in both groups as seen during the saline treatment with
significant (P<0.01) increases in 0 2 consumption during both exercise
periods. Oxygen consumption in the ACTH-immune group was reduced
when compared to the non-immune group during the 2.5 km/h and the 5
km/h exercise period (Fig 4.10b). On the other hand treatment with
propranolol resulted in a significant (P<0.05) reduction in 0 2 consumption
at both exercise periods in the ACTH-immune group compared to the non
immune group (Fig 4.10c).

S a02 and S v02 Saturation Difference

The difference between arterial 0 2saturation and the venous 0 2 saturation
are shown in figure 4.11. Oxygen saturation in the arterial blood of all
animals

remained at or near 100% throughout the experimental period

regardless of treatment. Therefore the difference in oxygen saturation was
principally derived from the 0 2 saturation of the venous return.

The A-V 0 2 saturation difference increased in the ACTH-immune ewes and
significantly increased (P<0.05) in the non-immune during both exercise
periods (Fig 4.11a). There was no significant difference in this parameter
between the two exercise periods; however, the oxygen saturation for the
ACTH-immune group tended to be lower for both exercise periods when
compared to the non-immune group.
The A-V 0 2 saturation difference profile during both of the antagonist
treatments were similar to that seen during the saline treatment with an
increase in this parameter during both exercise periods (Fig 4.11b, Fig
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4.11c). Treatment with phentolamine resulted in an insignificant increase
for both groups at both exercise periods, whereas

treatment with

propranolol tended to increase the difference in the A-V 0 2 saturation
profile during exercise resulting in a significant increase (P<0.05) in the
non-immune ewes when compared to either the saline and phentolamine
treatments (Fig 4.11c). The A-V 0 2 saturation difference in the ACTHimmune group tended to be lower compared to the non-immune group
throughout the experimental period.

5.6. Discussion
Adrenaline and Noradrenaline

In man, the plasma concentrations of both adrenaline and noradrenaline
have been shown to increase in response to exercise and the amount of
catecholamines released are a function of both the intensity and the
duration of the exercise (Christensen and Galbo, 1983). Chin and Evonuk
(1971) reported a significant increase in noradrenaline concentrations in
exhaustively exercised rats compared to those which were moderately
exercised. A similar observation was reported for calves by Blum and
Eichinger (1988): in this study of ewes, catecholamine levels increased in
proportion to the intensity of exercise, with no

increase in either

adrenaline and noradrenaline in ewes exercised on a treadmill at 2.5 km/h
but a significant increase in both when they were exercised at 5 km/h.
Interestingly, the increases in adrenaline and noradrenaline levels during
exercise were enhanced during the infusion of the adrenergic antagonist
phentolamine methane-sulfonate. In a recent experiment of Benthem et al.
(1995), the pre-treatment of rats with phentolamine before exercise
induced

both adrenaline and noradrenaline release. The increase in

catecholamine levels in response to the infusion of phentolamine may be
due to a lower level of feedback to the central nervous system, with the
result of an enhancement of neural excitation in the absence of negative
feedback. This teleological hypothesis is in agreement with the arguments
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put forward by Benthem et a/. (1995) when explaining their results on the
sympathetic

response

in

rats

following

treatment

with

adrenergic

antagonists. They suggested that such a response was due to an alteration
in the negative feedback control mechanism following the antagonism of
adrenergic receptors within the sympathetic nerve endings. In the rat there
are both a2- and /?2-adrenergic receptors in the pre-synaptic membranes of
the sympathetic nerve endings (Scheurink et aL, 1989a). Benthem et al.
(1995) suggested that a masking of the or2-adrenergic receptors within the
synaptic membranes would lead to an elimination of the inhibitory role of
this

receptor type on catecholamine secretion thus leading to the

exaggerated catecholamine release. A similar mechanism may be operating
in ewes following administration of phentolamine.

Cortisol

Circulating cortisol levels increased during exercise with the greatest
increase

occurring

during

the

5

km/h

exercise

period.

As

with

catecholamines, this rise in cortisol secretion during exercise has been
shown to be proportional to the intensity of the exercise, a response similar
to that reported in sheep by Apple et al. (1994). These workers determined
that in sheep, activation of the hypothalamic-pituitary-adrenal axis occurs
when the exercise intensity provokes a greater than 70% V 0 2 max.
Treatment with either a- or ^-adrenergic antagonists did not significantly
alter the cortisol profile or the circulating levels of cortisol in

the non

immune group during the present study.
In the ACTH-immune group, circulating cortisol levels were unaffected by
exercise

or by treatment with

the adrenergic antagonists.

Cortisol

concentrations remained at or near basal levels for the duration of the study
period. This lack of adrenal responsiveness to exercise clearly demonstrates
the efficacy of ACTH 1-24 immunisation in suppressing stress-induced
cortisol secretion.
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The physiological significance of the rise in cortisol secretion during
exercise is still to be determined. Glucocorticoids are thought to play a
minor role during exercise with the effects of these hormones generally
taking hours to be manifested. There is some evidence to show that the
glucocorticoids may increase intrahepatic gluconeogenesis, although this is
only seen during prolonged exercise periods rather than in response to brief
periods of intensive exercise (Wasserman, 1995). It is known that the
glucocorticoids act permissively to mediate the actions of glucagon and
adrenaline and this is done by influencing gluconeogenic enzymes in the
liver. There is recent evidence to suggest that the glucocorticoids may be
acting directly to influence adrenergic sensitivity at the level of the
adrenergic receptor. A recent study using human lymphocytes (Allolio et
a!., 1994) demonstrated a direct influence of the glucocorticoids on the

regulation of the /?2-adrenergic receptor status. This group reported a
correlation between glucocorticoid concentration, the density of the binding
sites and altered c-AMP levels. A reduced glucocorticoid concentration
decreases the binding site density of the /?2-adrenergic receptor and
reduces intra-cellular c-AMP levels in response to agonist activation. Thus,
it appears that glucocorticoids may influence energy substrate metabolism
during intense exercise indirectly by modulation of the /?-adrenergic
receptor. This may be especially pertinent to FFA metabolism, quantitatively
the most important fuel used for energy generation during exercise (Harman
1991).

Free Fatty Acids

In the present study, FFA levels in the non-immune ewes increased during
exercise, presumably in response to the elevated catecholamine levels. The
exercise-induced release of adrenaline and noradrenaline has a direct
influence on lipid metabolism and results in increased peripheral glycerol
and FFA levels, (man Christensen and Galbo, 1983; sheep Bird et a!.,
1981). Interestingly, there was no increase in FFA levels in the ACTHimmune ewes during either of the exercise regimes. A similar result was
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obtained during a-adrenergic blockade.

The failure of FFA levels to increase during exercise in the ACTH-immune
ewes may reflect an association between glucocorticoid concentration and
the ^-adrenergic receptor status. The low levels of FFA's seen during
exercise in the ACTH-immune ewes may be a result of a decrease in /?adrenergic receptor concentration, resulting from the suppression of
glucocorticoids

by

the

immunisation

regime.

The

requirement

for

glucocorticoid interaction in the regulation of lipid metabolism during
exercise is made even more prominent when the catecholamine levels are
considered. There was no significant difference in the catecholamine levels
between the ACTH-immune and the non-immune groups during the study
period regardless of treatment. This result indicates that the catecholamines
per se are unable to initiate FFA release during exercise without the
secretion of the glucocorticoids.

The a-adrenergic antagonist, phentolamine, induced an abnormal elevation
in insulin secretion, especially during the 5km/h exercise period; however,
this treatment did not appear to affect lipolytic activity. This is of interest
because insulin is highly antilipolytic, especially in the ruminant (Vernon,
1980; West and Passey, 1967). A similar result to the current study was
reported by Benthem et al. (1995) in exercising rats during a-adrenergic
blockade with phentolamine. These workers suggested that the effects of
elevated insulin levels may have been negated by the increase in plasma
noradrenaline and adrenaline levels which occurred during exercise and
following a-adrenergic blockade. This hypothesis could explain the results
from

the

present study in which there was a 7-fold

increase in

noradrenaline levels and a 6-fold increase in adrenaline levels which was
measured in response to the 5 km/h exercise period.

Insulin

Insulin levels for both the ACTH-immune and the non-immune ewes
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treated with saline were mostly unaffected during the study up until the
end of the 5 km/h exercise period, when levels increased sharply,
particularly in the ACTH-immune group. Presumably the insulin levels
increased at this time in response to the elevation in glucose levels which
rose at the onset of the exercise. Insulin levels remained unchanged during
the 5 km/h exercise period even though plasma glucose levels had
increased. This finding is in agreement with other studies for the sheep
(Brockman, 1979) and for studies done in other species including man
(Galbo, 1981) cattle (Blum and Eichinger, 1988) and rats (Benthem et a!.,
1995). These authors reported that plasma insulin concentrations declined
during exercise. The apparent disassociation between circulating insulin and
glucose levels may be a consequence of the elevated catecholamine levels
observed during the more intensive exercise period.

Both adrenaline and noradrenaline inhibit insulin secretion in humans and
in cattle through their interaction with the a-adrenergic receptor sites on the
pancreatic fi-ce\\s (Smith and Porte, 1976; Blum and Eichinger, 1988). The
present experiment indicates clearly that for the sheep, inhibition of insulin
release is mediated via the a-adrenergic receptors on the pancreatic islet
cells. Insulin release is enhanced when the a-adrenergic receptors are
blocked and conversely is suppressed when the /^-adrenergic receptors are
blocked. These effects were only apparent when animals were exercised
intensively, which also corresponded to the higher circulating levels of the
catecholamines. The possible involvement of the /^-adrenergic receptor in
the regulation of insulin secretion during exercise is also highlighted by this
study in that both stimulatory (/?-adrenergic) and inhibitory (a-adrenergic)
receptors are activated on the pancreatic /?-cells during intensive exercise. It
is likely therefore, that the ratio of stimulatory to inhibitory adrenergic input
which is altered by the intensity of the exercise, presumably via the
circulating catecholamine concentrations, is the ultimate determinant of the
nature of the catecholaminergic response in the pancreas.
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Glucose

Plasma glucose levels increased in both the ACTH-immune and the non
immune ewes only during the more intense exercise (5 km/h) period. This
result is in keeping with other studies for the sheep (Brockman 1979,
Pethick et aL, 1991, Apple et al., 1994) and similar results have also been
reported in man (Wasserman, 1995). Wasserman (1995) suggested that
during moderate exercise an increase in glucose production matches the
rate of glucose utilisation in muscle and as a result only small deviations in
blood glucose levels are detected. In contrast, during the high intensity
exercise, the glucoregulatory response resembles a stress condition
resulting in overt glucose production which exceeds the increase in glucose
utilisation as the glucoregulatory system strives to maintain the supply of
energy substrate for the CNS. Therefore, during high intensity exercise
blood glucose levels rise. These considerations may account for the
observations seen in the current experiment where both adrenaline and
noradrenaline levels, known for their primary role as stimulators of
glycogenolysis (Christensen and Galbo, 1983) increased only in response to
the intense exercise. Similar reports for rats (Scheurink et al., 1989a) and
calves (Blum and Eichinger, 1988) showed that a rise in blood glucose was
matched by increases in catecholamine concentrations. A similar close
relationship between glucose mobilisation and catecholamine status has
been found in man subjected to intensive exercise (Marliss et a!., 1992).

In the current study, ^-blockade with propranolol enhanced the plasma
glucose response during both exercise periods in both the ACTH-immune
and the non-immune ewes. This increase in plasma glucose may be the
result of an altered hepatic or-adrenergic receptor activity which may have
been sensitised in response to the /?-blockade. Consistent with the present
finding is that glucose production, when measured as the glucose
appearance rate, is also mediated by the hepatic a-adrenergic receptors, in
man (Sigal et al., 1994) and rat (Morgan et a!., 1984). In addition to the
proposed

glucoregulatory effects of the catecholamines,
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propranolol

induced up-regulation of the a-receptor which resulted in an inhibition in
insulin secretion may also have contributed to the increase in plasma
glucose levels.

The o-adrenergic antagonist phentolamine, failed to prevent the rise in
plasma glucose observed during the 5 km/h exercise period, although
glucose levels did decline during the 2.5 km/h exercise regime. This decline
may have been the result of a number of altered physiological mechanisms
which are mediated via the cr-adrenergic receptor. Most important among
these is the inhibition of liver glycogenolysis and enhanced plasma insulin
levels. The increase in plasma glucose levels during the 5 km/h exercise
period is of interest as it demonstrates either ineffective adrenergic
blockade with phentolamine or an increase in the efficacy of some
hormones involved in glucose mobilisation especially the catecholamines.
This is an important consideration as both

responses to adrenaline and

noradrenaline increased dramatically during the a-adrenergic blockade. The
largest increase was in plasma noradrenaline levels, suggesting that the
increase in plasma glucose may be a consequence of an elevation in
noradrenaline levels.

Lactate

Circulating lactate levels in both the ACTH-immune and the non-immune
ewes increased only during the 5 km/h exercise period, indicating that both
groups had surpassed the anaerobic threshold (Pethick et a!., 1991) during
this time. The fact that lactate levels did not increase during the 2.5 km/h
exercise is in agreement with other studies for the sheep (Pethick et af.,
1991; Harman, 1991). Pethick and co-workers (1991) suggested that the
circulating lactate levels are dependent on the intensity of the exercise and
they reported that lactate levels increase dramatically at exercise intensities
which require anaerobic metabolism. Although there was no observed
increase in peripheral lactate levels during exercise at 2.5 km/h, this does
not exclude the possibility of increased lactate turnover during this exercise
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period. Studies in man (Stanley et a!., 1988) and in the dog (Issekutz,
1984) have shown increased lactate turnover during submaximal exercise
without a concomitant increase in plasma lactate levels.

The increased circulating lactate levels observed during the 5 km/h
exercise period may be a consequence of the increased adrenaline and
noradrenaline levels. The association between exercise intensity, lactate
production and catecholamine levels in the sheep has been suggested by
Apple et at. (1994). Support for this hypothesis come from studies
conducted in man, where there is a direct linear relationship between the
catecholamine concentration and lactate production during exercise of
increasing intensity (Mazzeo and Marshall, 1989). It would appear that the
catecholamine

effects

are

not the

only

means

by

which

muscle

glycogenolysis and the associated increase in circulating lactate levels are
affected. Studies in the rat, (Richter et al., 1982) and the dog (Issekutz,
1984) have shown that muscle glycogenolysis is under the dual control of
both adrenaline and intracellular Ca2+ levels acting on the /?2-adrenergic
receptor to stimulate the generation of cAMP. Muscle contractions elevate
intracellular Ca2+ levels and this in turn stimulates muscle glycogenolysis
early in exercise, whereas adrenaline causes a sustained increase in muscle
glycogenolysis (Richter et a!.f 1982, Issekutz, 1984).
In the current experiment, ^-adrenergic blockade with propranolol failed to
inhibit the rise in circulating lactate levels during the 5 km/h exercise
period. This failure was unexpected as ^-adrenergic blockade has previously
been

shown

to

inhibit

the

exercise

induced

increase

in

muscle

glycogenolysis in dogs (Issekutz, 1984) and cattle (Blum and Fluckinger,
1988). In addition, Bassett (1970) demonstrated, using propranolol HCI in
the

sheep

an

effective

^-adrenergic

receptor

blockade

of

muscle

glycogenolysis by preventing the adrenaline-induced increase in lactic acid.
It is difficult to give a reason for this failure of plasma lactate to rise in the
sheep.

However,

it may be associated with the increased muscle
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contractions induced during the 5 km/h exercise period. A recent study
using human lymphocytes has shown that dynamic exercise induces the
translocation of ^-adrenergic receptors from intracellular sites to the cell
surface (Fujii et a!., 1993). These workers also demonstrated that the
increase in the rate of translocational activity of the ^-adrenergic receptor
was proportional to the exercise intensity. The concentration of propranolol
HCI level used may not have been sufficient to have blocked all the
receptors during the intense exercise period. The possible failure on the
antagonist to completely block /^-adrenergic receptor activity may be related
to

an increase in cell surface /^-adrenergic receptor status similar to that

reported by Fujii et a/. (1993). The exercise induced increase in /?-adrenergic
receptor status may also account for the graded physiological response
observed during the two exercise regimes.

The concentration of propranolol used in the current study was effective
in preventing the rise in FFA's at both exercise regimes. This may reflect
the specificity for the increase in translocational activity of the /^-adrenergic
receptor in that its regulation may be confined to the working tissue, in this
case the exercising muscle. This suggestion is supported by Bassett's
(1970) study in which he demonstrated effective blockade of /?-adrenergic
induced muscle glycogenolysis using propranolol HCI in the resting sheep.
The elevated lactate levels observed during blockade of the ^-adrenergic
receptors seen in the present study may be a direct consequence of an
increase in muscle contractions. This may be an explanation for the
difference observed in Bassett's study where sheep were infused with
exogenous catecholamines but not subjected to exercise. As a result
neither the activation in intracellular muscle Ca2+ levels nor an activation of
the increased number of ^-adrenergic receptors would have occurred.
The increased lactate levels at these two exercise regimes demonstrates
the efficacy of the ^-adrenergic receptor in mediating adrenergic activation
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of muscle glycogenolysis. It would appear that the phentolamine enhanced
catecholamine levels may have contributed to the increased plasma lactate
levels. The plasma lactate levels were still significantly elevated by the end
of the experiment, 90 minutes after the completion of the exercise. This
may simply reflect a slower return to basal levels owing to the higher
lactate concentration attained during the 5 km/h exercise period (a 30%
increase in concentration compared to the saline treatment). However, the
dramatically increased insulin levels, resulting from the a-adrenergic
blockade, may have also contributed to this high lactate level post exercise.
In man, insulin has been shown to have a direct inhibitory effect on
gluconeogenesis firstly by decreasing the flow of gluconeogenic substrates
from the peripheral tissues and secondly by directly inhibiting their
conversion into glucose within the liver (Liljenquist et a/., 1979). For the
sheep, insulin has also been shown to inhibit gluconeogenesis by reducing
the net hepatic uptake of gluconeogenic substrates (Brockman and
Laarveld, 1986). Interestingly, the uptake of lactate has been shown to be
more sensitive to insulin effects than the other gluconeogenic substrates
(Brockman and Laarveld, 1986) and so a reduction in hepatic uptake of
lactate in response to insulin may occur before reduced uptake of the other
gluconeogenic substrates.

Haemoglobin

Arterial haemoglobin (Hb) levels increased in response to both exercise
regimes. This increase is most likely due to the release of blood from the
splanchnic bed and in particular from the spleen. The elevated Hb levels
observed in this study may be related to the exercise induced increase in
catecholamine levels. Studies in man have shown the spleen is innervated
by a dense sympathetic adrenergic network which, when activated, results
in the expulsion of blood (Donald, 1983). In addition, neural activation of
the spleen during exercise results in an increased discharge of erythrocytes
into the circulation

with an accompanying

increase in haematocrit

(Detweiler, 1984). The increased release of erythrocytes, especially during
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exercise increases the supply of oxygen to the tissues. The ability to
increase Hb levels and therefore oxygen carrying capacity is an important
mechanism which enables ruminants to increase oxygen transport to the
exercising muscle (Kuhlmann et a/., 1985).

During the 2.5 km/h exercise, Hb levels initially increased and then
declined throughout the remainder of the exercise period. When the
intensity of the exercise was increased to 5 km/h, Hb levels were
maintained at an elevated level for the duration of the exercise. The
maintenance of elevated Hb levels throughout the 5 km/h exercise period
probably reflects an oxygen debt that the animal develops during this more
intensive exercise and which the animal attempts to overcome by
maximising blood haemoglobin levels. These elevated Hb levels during
anaerobic exercise have also been reported in other studies for sheep
(Apple et a!., 1994) and calves (Kuhlmann et a!., 1985).
One of the most interesting results which arose from this study was the
observed difference in Hb levels between the ACTH-immune and the non
immune ewes. Haemoglobin levels for the ACTH-immune group tended to
be lower throughout the experimental period regardless of the treatment. It
appears from the results of this study that manipulation of the HPA axis by
the immunisation of ACTH 1-24 may result in an alteration of the Hb
content

and

possibly

the

oxygen

carrying

capacity

within

sheep

erythrocytes The reason for this reduction in Hb levels in the ACTH-immune
group remains to be elucidated.

Oxygen Consumption

In the current experiment, oxygen consumption (V02 ) increased in
response to both exercise regimes, the greater increase being observed
during the 5 km/h exercise period. This finding is in accordance with other
studies which have shown a similar relationship between exercise intensity
and V 0 2 for the sheep, (Mundie et a/., 1991; Apple et a
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1994) calves

(Kuhlmann et al., 1985) and in man (Epstein etaL, 1965). This relationship
was

further

expanded

by

Pollock

(1973),

who

showed

that

V02

represented the total muscular effort expended and that it was influenced
by both the intensity and the duration of the exercise. A number of
physiological factors are involved in the alteration of V 0 2 in response to
exercise, with changes in cardiovascular control, including cardiac output
and differences in arterial and venous 0 2 saturation being the most
prominent. In addition, the availability and type of energy substrate oxidised
(glucose, FFA's) is also important to V 0 2 during exercise (Benthem et at.,
1995).

An intriguing result from the present study was the observation from the
ACTH-immune ewes consumed less oxygen during both exercise regimes
compared to the non-immune ewes. This reduced V 0 2 in the ACTH-immune
group was consistent throughout the exercise periods regardless of the pre
treatment.

The

finding

that

ACTH

immunisation

reduced

the

02

consumption in exercising ewes was first reported by Shahneh et al.,
(1994).

Shahneh

and

co-workers

(1994)

also

found

that

cortisol

replacement of ACTH-immune ewes did not alter the reduced V 0 2 in
response to aerobic and anaerobic exercise. It thus appears that factors
other than reduced cortisol levels may be responsible for the reduction in 0 2
consumption observed in the ACTH-immune ewes.

Cardiac Output

Cardiac output increased in response to both exercise regimes with the
greater response occurring during the more intense exercise period. Skinner
and McLellan (1980) have reported that in man there is a linear relationship
between heart rate and exercise intensity. A similar relationship has been
reported for sheep when exercised on a treadmill (Apple et a!., 1994;
Newman et a!., 1986).

The increase in cardiac output during exercise, especially during the more
90

intense exercise, is the result of the requirement for the increased oxygen
demand imposed by the working muscles of the sheep. In man, the normal
pacemaker of the heart is under the opposing influences of the sympathetic
and parasympathetic nervous systems. The effects of ^-adrenergic receptor
blockade decreased cardiac output both during exercise and during the rest
periods. This finding was also observed in man by Epstein and co-workers
(1965) who demonstrated that treatment with propranolol reduced cardiac
output at rest. In contrast, a-adrenergic receptor blockade tended to
increase cardiac output during exercise and the rest periods. The fact that
both propranolol and phentolamine influenced cardiac output during the rest
periods indicates that sympathetic regulation of the heart is also important
in maintaining cardiac output during the resting state.

During exercise it seems that sympathetic stimulation does not appear to
be the only regulatory mechanism by which cardiac output is modulated.
Although /^-adrenergic blockade with propranolol reduced cardiac output
during rest periods, the same antagonist was unable to prevent the
substantial increase in cardiac output observed during exercise. This finding
is in agreement with studies conducted in man that show an increased
cardiac output in response to exercise in the presence of /?- receptor
blockade with propranolol (Epstein et a/., 1965). Therefore, in sheep as in
man, the contribution of the sympathetic nervous system to the stimulation
of cardiac output during exercise appears to be relatively small and so
control may be modulated by other mechanisms.

Arteriovenous Oxygen Difference

During exercise, the arteriovenous oxygen difference of the mixed venous
blood (AVD) increased during the two exercise periods. In man, this
difference is mainly due to the escalation in the oxygen extraction ratio
from the blood (Brundin, 1978). The increase in the AVD in the present
study appears to be associated with the level of cardiac output. During /?receptor blockade, the decline in cardiac output was compensated for by
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the increase in the AVD, indicating that there was an increase in the
oxygen extraction. Conversely, when cardiac output increased during areceptor blockade the decrease in the AVD was not as great, indicating a
reduced requirement for oxygen uptake from the blood. Thus, the animal is
highly sensitive to its oxygen requirements and is able to acutely regulate
oxygen extraction to meet this need.

Interestingly, the AVD in the ACTH-immune ewes was not as great as in
the non-immune ewes, indicating a reduced 0 2 extraction from the mixed
venous blood. This finding also reflects and confirms that the ACTHimmune ewes' have a reduced 0 2 requirement for the same work load. As
yet, it is difficult to determine why active immunisation against ACTH 1-24
should have such a marked effect on oxygen consumption during exercise.
Thus, the need for further investigation into this area is evident.

Body Temperature

Body temperature, as measured in the pulmonary artery increased in
response to both exercise regimes; the more intense exercise give rise to
the greater increase in this parameter. The measurement of body
temperature using the mixed venous blood has been shown to represent
the true body temperature as it more accurately reflects the balance
between the production and the elimination of heat (Brundin, 1975). Nelson
(1969) demonstrated in man that the increase in body temperature during
dynamic exercise was the result of increased muscular activity. In addition,
the rise in temperature during exercise has been shown to be directly
related to the amount of energy released and is inversely related to the
magnitude of the perfusion of blood to the skin as increased skin blood
perfusion can increase the heat loss (Johnson et at., 1974). This finding
appears to be analogous to the current experiment, as the increase in body
temperature mirrored the V 0 2, and therefore energy expenditure.
Adrenergic receptor blockade with either propranolol or phentolamine
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increased the arterial body temperature during both exercise regimes. This
was expected as adrenergic blockade has previously been shown to
interfere with the thermoregulatory response to short term exercise in man
(Brundin, 1978). This interference by the adrenergic blockade may be due
to the suppression of skin blood perfusion by 0- blockade (Johnsonef a/.,
1974) and the known effects of a- blockade on the dilation of the blood
vessels (Van Zwieten, 1988).

4 .7 . Conclusions.

This experiment clearly demonstrates that dynamic exercise in the ewe is
an

effective

means

of

activating

the

two

"stress

axes",

the

sympathomedullary axis and the hypothalamic pituitary adrenal axis. As
with humans, the degree to which these axes are stimulated is proportional
to the intensity of the exercise, and as such, influences the degree of the
physiological response. Exercise induced an increase in plasma FFA's,
plasma glucose and plasma lactate, while insulin secretion remained at or
near basal levels. The increase in plasma FFA's during surgery is mediated
by the ^-adrenergic receptor, and plasma glucose levels by the a-adrenergic
receptor. The inhibition of insulin secretion from the pancreatic /?-cells is
mediated by both a- and /?-adrenergic receptors. The a- receptor inhibits
insulin secretion and the 0- receptor stimulates insulin secretion.
The cardiovascular response was also altered in response to exercise;
increased cardiac output, and oxygen extraction from the blood, increased
oxygen consumption and an increase in the haemoglobin levels were all
demonstrated. The adrenergic involvement of the above responses was not
conclusive with little or no change during receptor blockade. Although, as
expected cardiac output declined during treatment with the 0- blocker
propranolol and increased when treated with the a- blocker phentolamine.
The ACTH-immune ewes consumed less 0 2 than the non-immune ewes
during exercise. The greatest demand for 0 2 was during the more intensive
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exercise, at 5 km/h. The ACTH-immune ewes requirement for less 0 2 was
also reflected in this groups reduced 0 2 extraction from the venous return
during exercise when compared to the non-immune ewes.

The stimulation of the sympathomedullary stress axis and the subsequent
release of the catecholamines was found to be the most important of the
two stress axes in mediating the physiological responses seen during
dynamic exercise. However, the HPA axis also plays a significant role
during dynamic exercise, especially in its ability to influence energy
substrate mobilisation and in particular the release of FFA's into the
peripheral circulation.

94

Chapter 5

Metabolic and Blood Pressure Changes Associated with the
Endogenous Release of Noradrenaline Induced by Tyramine Hydrochloride
Infusion

5.1. Introduction

Stimulation of the sympathetic nervous system results in the rapid release
of the catecholamines, (dopamine, adrenaline and noradrenaline) from the
adrenal chromaffin cells and sympathetic nerve terminals into the peripheral
circulation

(Harvey

et

a!.,

1984).

This

increase

in

circulating

catecholamines, principally adrenaline and noradrenaline has been shown to
have wide ranging effects on intermediary metabolism and results in the
rapid mobilisation of energy substrates from the storage tissues of the body
(Webber and Macdonald, 1993). Catecholaminergic effects on metabolism
can be by direct stimulation of the adrenergic receptors in metabolically
active tissues, and by indirect interactions with other endocrine regulators
(Webber and Macdonald, 1993).
Previous studies in many species have demonstrated both metabolic and
haemodynamic

changes

following

the

infusion

or

injection

of

catecholamines (for review see Himms-Hagen, 1967). These changes are
mediated by stimulation of specific adrenergic receptors that influence
blood

pressure

and

metabolic

processes

carbohydrate metabolism (Himms-Hagen,

which

include

lipid

and

1967). Increases in plasma

glucose, lactic acid and free fatty acids have been reported after infusions
of adrenaline and noradrenaline into sheep (Bassett, 1970; Halmagyi et al.f
1967). Increases in systemic arterial pressure and cardiac output following
adrenaline infusion have also been reported for the sheep (Halmagyi et a!.,
1967).
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The investigation of the physiological effects of any hormone when
administered exogenously to animals is inevitably compromised by the
failure of the mode of administration to mimic endogenous secretory
pattern of the hormone. Thus it is not surprising that studies involving
catecholamine infusions suffer from the same compromise (Webber and
Macdonald,
administration

1993).
is

This

especially

problem

of

exogenous

apparent

when

defining

catecholamine
the

metabolic

consequences of noradrenaline release. Noradrenaline primarily functions as
the major neurotransmitter within the sympathetic nervous system and thus
it's physiological effects are directed at a local tissue level. Therefore, the
administration of exogenous noradrenaline does not reflect the typical
endogenous sympathetic response (Himms-Hagen, 1967).
The administration of tyramine HCI results in the displacement of
noradrenaline from it's storage vesicles and displaces noradrenaline into the
cytosol (Poch and Kopin, 1966) and in turn, can stimulate the noradrenergic
receptors (Usdin and Snyder, 1973). Haemodynamic changes in the sheep
have been demonstrated after the infusion or injection of tyramine HCI
resulting in increased blood pressure (Lumbers et a/., 1980; Walker and
Schuijers, 1989). As well, alteration of the secretion rates of both insulin
and glucagon from the rat pancreas have been demonstrated after the
administration of tyramine HCI (Hirose et aL, 1994).
The use of a- and /?- adrenergic antagonists has been shown to facilitate
the understanding of the metabolic responses mediated by the activation of
the sympathetic nervous system. In the sheep, the a-adrenergic antagonist
propranolol HCI and the ^-adrenergic antagonist phentolamine methanesulfonate have been used in to determine the metabolic responses after
infusion with catecholamines (Bassett, 1970).

In the present study, we have investigated the physiological effects of
catecholamines by altering the pattern of endogenous secretion using the
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sympathomimetic amine tyramine hydrochloride. This method of initiating
catecholamine release more closely mimics the stress induced cascade of
events that result in catecholamine secretion.
5.2. Aims

1: To determine the blood pressure, metabolic and endocrine changes in the
sheep during infusion with tyramine HCI.

2: To determine the blood pressure, metabolic and endocrine status when
sheep are pre-treated alone or in combination with the adrenergic
antagonists, propranolol HCI and phentolamine methane-sulfonate prior to
tyramine HCI infusion.

5.3. Materials and Methods

Animals

Eight mature Border Leister x Merino ewes with a mean body weight of
67.9 ± 1.2 kg were housed at the CSIRO Division of Animal Production
Prospect N.S.W. (latitude 34°S). Ewes were acclimated to single pens and
handled frequently for a period of three months to accustom them to the
experimental procedure. Subsequently, the ewes were transferred to
individual metabolic cages (Till and Downes, 1963) and housed in a
thermoneutral environment under continuous light. Ewes had access to
water at all times and were fed a pelleted ration (800 gms) consisting of
60% hammermilled lucerne and 40% crushed oats. It was estimated that
the metabolisable energy the ewes were receiving was 10.4 MJ/Kg. All
ewes were fed 2 hours after the final infusion.
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Surgical Procedures

Saphenous /Femoral Artery Cannulation for Blood Pressure Determination

Ewes were fasted for 24 hours and denied water for 12 hours prior to the
surgical procedure. To allow insertion of the endotracheal tube, the short
acting

anaesthetic

agent

Thiopentone

sodium

(Boehringer)

was

administered intravenously at a rate of 15-20 mg/kg body weight. Ewes
were then induced with 2-4% Fluothane (ICI) in oxygen to maintain general
anaesthesia.
Sterile catheters, medical grade single lumen polyethylene tubing (1.0mm
i.d., 1.5mm o.d, Dural Plastics, N.S.W.) were introduced approximately
100mm into the femoral artery via the saphenous artery. Catheters were
filled with heparinised saline (Fissons Pharmaceuticals Vic; 250 lU/ml.)
containing Terramycin (Pfizer N.S.W.) at 200 mgs / ml. saline (Baxter
Healthcare N.S.W.).
All ewes were given an intramuscular injection (4ml) of an antibiotic
solution (Depomycin, Intervet, Australia) for 5 days following surgery.

Jugular Vein Catheterisation

A cannulae (medical grade polyethylene tubing i.d. 1.0 mm o.d. 1.5mm)
was inserted into both jugular veins using a local topical anaesthetic
(Xylocaine 10% spray, Astra Pharmaceuticals Pty Ltd., Melbourne). The
cannulae were inserted through a sterile 14G catheter placement unit,
(Jelco, Johnson and Johnson Medical, Japan) 100mm into each vein. Daily
the contents of the cannulae were withdrawn and then flushed with sterile
saline to maintain patency, and then refilled with fresh heparinised saline
(500 lU/ml of heparin).

Measurement o f Arterial Blood Pressure

To measure arterial blood pressure the established femoral artery cannulae
was connected to a disposable strain gauge pressure transducer (Viggo98

Spectramed Aust.). The blood pressure transducer was placed at the level
of the sheep's heart and connected to a recorder (Neo Trace). Calibration of
the physiological recorder and transducer was carried out using a mercury
manometer. The graded changes in Hg pressure were transposed onto
thermal chart paper (Graphtec Corp. Japan Chart No PZ468-2B).

5 .3 .1 . Experiment 1

All experimental procedures were carried out in accordance with the
requirements of the Ethics Committee, CSIRO Prospect.

Determination o f the Arterial Blood Pressure Response to Tyramine Doses

The first need was to determine what tyramine dose would be effective in
raising the arterial blood pressure by not more than 50% above resting
levels.
Concentrations of 0.1, 0.5, and 1.0 mg Tyramine HCI (Sigma Chemicals)
Kg body weight were diluted in 10 mis sterile saline (Baxter Healthcare
N.S.W.) and infused into 2 ewes via a jugular cannulae using a peristaltic
pump at a rate of 0.22 mis / min.

5.3 .2 . Experiment 2

Noradrenergic Regulation o f Metabolism and Blood Pressure Procedure

Six ewes were divided randomly into two groups of 3. Identical
procedures were carried out on both groups with a time interval of 2 weeks
between each group. The saphenous artery was catheterised 7 days prior
and jugular catheters were inserted 2 days prior to the commencement of
the treatments. Two ewes from the first treatment group were selected for
the experiment based on the patency of the saphenous arterial catheter.
The remaining ewe was used as
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a reserve and was not used for the experiment.
Infusions

All infusions into conscious ewes were given intravenously via one of the
jugular cannulae. Tyramine hydrochloride (Sigma Chemicals) was diluted in
10 mis of sterile saline and infused for 45 min at a concentration of 0.5
mg/kg/45 min. Propranolol HCI (sigma Chemicals) a non selective /?adrenergic receptor antagonist was diluted in 20 mis sterile

saline and

infused for 60 min. at a dose rate of 0.5 mg/kg/60 min (Bassett 1970).
Phentolamine methane-sulfonate, (Aldrich Chemical Co.) a non selective aadrenergic receptor antagonist was diluted in 20 mis sterile saline and
infused for 60 min. at a dose rate of 1.0 mg/kg/60 min (Bassett 1970).
During and after treatment periods ewes were infused with sterile saline.
The treatments were administered in the following order:
Day 1: Tyramine HCI.
Day 3: Propranolol HCI followed by Tyramine HCI.
Day 5: Phentolamine methane-sulfonate followed by Tyramine HCI.
Day 7: A combination of Propranolol HCI + Phentolamine methanesulfonate followed by Tyramine HCI.

The above experimental procedure was repeated on the second group of
ewes 14 days later.

Blood Sampling

Venous blood samples were withdrawn from the second jugular cannulae
using a 5ml syringe (Terumo Corporation Japan) after each sample
catheters were

flushed with heparinised saline (100 International lU/ml).

Samples were taken at 15 min intervals for 30 min prior to the
commencement of all infusions and again at 20 min intervals for 12 hours
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post infusion treatment. During infusion of the tyramine HCI, blood samples
were taken at 5 min intervals for 60 min. During infusion of the antagonists
blood samples were taken at 10 min. intervals for 60 min.

Blood samples were transferred into plastic P4 tubes (John Morris Ltd,
Sydney, NSW), containing glass separation granules (Kwickspin Disposable
Products Padstow) to facilitate plasma separation after centrifugation. All
samples were kept on ice prior to centrifugation at 2000g for 15 min at
4°C (Beckman GPR, USA). Plasma samples were stored at -20°C. until
assayed.

Catecholamine Sample Collection

Blood samples for adrenaline and noradrenaline analysis were collected
into sterile 5ml blood collection tubes containing EGTA and reduced
glutathione

(Amersham U.K.). A sample was taken 25 min before

commencement of all infusions, and again at 15 min and 6 hours after the
end of the tyramine infusion. During the tyramine infusion samples were
taken at 20 and 40 min after the infusion began. During the infusion of the
antagonists a sample was taken at 30 min after the start of the infusion.
After collection, the samples were immediately centrifuged and the plasma
collected and stored at -70°C.

5.4. Statistical Analysis

All data are presented as the mean ± S.E. of the mean. Baselines and
post treatment measurements were analysed via ANOVA. For all data
except noradrenaline repeated measures ANOVAs with Greenhouse and
Geisser (1959) adjustment were carried out on pre-tyramine infusion data
or during and/or post tyramine infusion. In addition, numbers of cortisol
peaks

and

related

statistics

were estimated

by Littlejohn's

(1989)

modification to Diggle and Zeger's (1989) model for time series with
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pulses.
5.5. Results
Experiment 1

The pre infusion (resting level), blood pressure was 79.3 ± 2.3 mm Hg.

Changes in Arterial Blood Pressure to 3 concentrations o f tyramine HCI

tyramine HCI

0.1 mg/Kg

0.5 mg/Kg

1.0 mg/Kg

B.P.

x 79 mm Hg

x 145 mm Hg

> 150 mm Hg

From the above table a dose rate of 0.5 mg / kg was chosen for the
tyramine HCI infusions in experiment 2.

5 .5 .1 . Experiment 2

Plasma Noradrenaline Levels

By 20 min after the start of the tyramine HCI infusion there was a small
but insignificant increase in peripheral noradrenaline levels in 3 of the 4
ewes (fig 5.1a) 2.59 ± 0.36 nmol/L compared to the pre-infusion level of
1.48 ± 0.67 nmol/L. Circulating noradrenaline levels in all 4 ewes were
elevated although not significantly 40 min after the commencement of the
infusion ( 2.23 ± 0.91 nmol/L) and noradrenaline levels remained unaltered
6 hours post infusion (2.13 + 0.88 nmol/L).
There was no change in plasma noradrenaline concentrations during the
infusion of propranolol HCI in any of the 4 ewes (1.84 ± 1.43 nmol/L)
compared to the pre-infusion concentration of 1.71 ± 1.33 nmol/L (Fig
5.1b). However, circulating noradrenaline levels increased to 3.20 ± 1.53
nmol/L after 20 min infusion with tyramine HCI. Noradrenaline levels then
declined to 1.70 ± 0.72 nmol/L at 6 hours post tyramine infusion.
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Figure 5.1 changes in circulating noradrenaline levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion

Legend
phent=phentolamine methane-sulfonate, prop=propranolol HCI, T20 &
T40=tyramine HCL 20 min. & tyramine HCI 40 min.
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Figure 5.2 changes in circulating adrenaline levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion

Legend
phent=phentolamine methane-sulfonate, prop=propranolol HCI, T20 &
T40=tyramine HCL 20 min. & tyramine HCI 40 min.

There was no significant change in plasma noradrenaline levels during the
infusion of phentolamine (Fig 5.1c) (2.83 ± 1.37 nmol/L) when compared
to the pre-infusion concentration (1.96 ± 1.11 nmol/L). Noradrenaline
levels increased significantly by 20 min after the start of the tyramine HCI
infusion (6.73 ± 1.53 nmol/L, P<.05). Levels fell to 3.76 ± nmol/L by 6
hours post tyramine infusion, although, this concentration was still elevated
compared to the pre- infusion sample.

There was a significant rise (Pc.05) in plasma noradrenaline levels during
the infusion of both antagonists when compared to the pre-infusion (3.79
± 1.45 nmol/L and 1.34 ± 0.81 nmol/L respectively) (Fig 5.1 d). Plasma
noradrenaline levels remained elevated during the subsequent tyramine HCI
infusion and then declined to basal levels (1.42 ± 0.60 nmol/L) by 6 hours
post-tyramine HCI infusion.

Plasma Adrenaline Levels

The plasma adrenaline levels are shown in figure 5.2. There was no
observed change in circulating adrenaline levels for any of the treatments.
Concentrations were either low (tyramine HCI infusion alone Fig 5.2a and
propranolol HCI infusion Fig 5.2b). or undetectable (phentolamine infusion
fig 5.2c and the combined antagonist infusion Fig 5.2d).

Plasma Free Fatty Acid Levels

The plasma free fatty acid levels are given in figure 5.3. Free fatty acids
rose following the tyramine HCI infusion when compared to the pre-infusion
level (Fig 5.3a). This increase in plasma FFA's occurred 35 min after the
start of the infusion. The mean FFA concentrations decreased 20 min after
the cessation of the infusion to 0.36 ± .06 /ymol/L, which was similar to
the pre-treatment level.
Infusion of propranolol HCI before tyramine HCI prevented the rise in FFA
seen after tyramine infusion alone in 3 of the 4 ewes (Fig 5.3b). The other
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Figure 5.3 changes in plasma free fatty acid levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion

animal had significantly higher basal FFA levels and this higher level
persisted throughout the experimental period, but the maximum levels
occurred during the tyramine infusion. Levels of FFA's began to increase in
the ewes at the end of the tyramine infusion (0.92 ± 0.30 //mol/L) when
compared to a pre infusion levels (0.57 ± .09 //mol/L).

Infusion with phentolamine before tyramine failed to prevent the rise in
FFA levels following tyramine infusion alone (Fig 5.3c). Phentolamine
infusion alone had no effect on FFA concentrations. Plasma FFA levels
increased from the onset of the tyramine infusion reaching a maximum
concentration of 1.54 ± 0.41 //mol/L after 40 min. Levels then declined to
a mean level of 0.57 ± 0 .1 4 //mol/L 80 min post tyramine infusion.

There was no increase in circulating FFA concentrations during tyramine
infusion

in

ewes

previously

infused

with

both

propranolol

and

phentolamine. The combined infusion of the antagonists resulted in FFA
levels which were higher than for the infusion of tyramine HCI (0.82 ±0.24
//mol/L and 0.58 ± 0 .1 6 //mol/L respectively) but this was not significant.

Plasma Glucose and Plasma Insulin Levels

Circulating glucose and insulin levels for the treatments are shown in
figure 5.4.
Both circulating glucose and insulin levels increased in response to the
tyramine infusion (Fig 5.4a). Whereas the glucose levels increased gradually
by 60 min at the end of the infusion, insulin levels showed a bi-phasic
response, with an initial peak 20 min after the commencement of infusion
followed by a higher peak 5 min after the cessation of the infusion. Both
parameters decreased near to basal levels by 100 min after the cessation of
the infusion.
Infusion of propranolol HCI before tyramine failed to prevent the increase
in plasma glucose seen with the tyramine infusion alone (Fig 5.4b).
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F igure 5.4 changes in plasma glucose and circulating insulin levels in
response to:
(a) : tyramine HOL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion

However, the pre-treatment with this antagonist resulted in lower insulin
levels for the first 35 min of the tyramine infusion. Propranolol infusion
alone had no effect on plasma glucose concentrations. The maximum
glucose concentration of 85.2 ± 7.0 mg% occurred 40 min after the start
of tyramine infusion while insulin levels began to increase 35 min after,
increasing by 2 fold during the last 10 min of the infusion. Insulin levels
continued to be high for the remainder of the study.

Infusion of phentolamine before tyramine prevented the rise in plasma
glucose seen following tyramine infusion alone (Fig 5.4c). There was a
small decrease in glucose levels during the infusion of tyramine HCI alone.
In contrast, phentolamine infusion alone induced a significant increase
(P<0.05) in plasma insulin levels which persisted for the first 15 min of the
infusion and thereafter fell to basal levels by the end of the study. Glucose
levels rose significantly (P<0.05) following the end of tyramine HCI
infusion (49.23±1.82 mg% compared to the pre infusion concentration of
4 6 .1 3 ±0 .9 9 mg%). Phentolamine infusion alone had no effect on glucose
levels.

The combined infusion of propranolol + phentolamine before tyramine HCI
prevented the rise in glucose concentrations seen following tyramine alone
(Fig

5.4d). Similarly the combined antagonist infusion prevented any

increase in insulin levels with the insulin concentrations remaining at pre
infusion levels throughout the study.

Plasma Cortisol Levels

Plasma cortisol levels are shown in figure 5.5. Plasma cortisol levels were
not affected during the tyramine infusion (Fig 5.5a). However, 15 min after
the cessation of the infusion levels increased to reach a peak of 3 2 .4 ± 10.9
ng/ml although, this increase was not significantly different from the pre
infusion levels.
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(a)
cortisol ng/ml

Time (minutes)

(b)

Time (minutes)

Figure 5.5changes in circulating cortisol levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion

The pattern of plasma cortisol during the propranolol and the tyramine
infusion was similar to that for the infusion of tyramine alone (Fig 5.5b).
The mean levels in the propranolol treated group were higher than the
tyramine treated group. These higher cortisol levels were attributed to ewe
1309 which had higher cortisol levels for the duration of the study period.
Propranolol per se had little effect on cortisol levels although the
subsequent infusion of tyramine resulted in a 2 fold increase within 40 min
of the commencement of the infusion.

Blood Pressure Levels

The blood pressure levels are shown in figure 5.6. Blood pressure (Fig
5.6a) was elevated during the tyramine HCL infusion when compared to the
pre-infusion level (157.9±7.8 mmHg, 94.7±3.3 mmHg respectively).
Blood pressure levels fell immediately following the end of the tyramine
infusion.

Infusion of propranolol HCI before tyramine prevented the tyramine
induced increase in blood pressure (Fig 6b). There was no response in
blood pressure to the propranolol infusion and blood pressure levels
remained constant throughout the experimental period.

Infusion of phentolamine before tyramine prevented the tyramine induced
increase

in blood pressure (Fig 6c). Blood pressure levels remained

constant throughout the experimental period.
Infusion of propranolol + phentolamine before tyramine prevented the
tyramine induced rise in blood pressure (Fig 6d). Blood pressure levels
remained constant throughout the experimental period.
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Figure 5.6 changes in arterial blood pressure levels in response to:
(a) : tyramine HCL infusion
(b) : propranolol HCI followed by tyramine HCI infusion
(c) : phentolamine methane-sulfonate followed by tyramine HCI infusion
(d) : propranolol + phentolamine followed by tyramine HCI infusion

5.6. Discussion

Plasma Noradrenaline

Intravenous infusions of tyramine HCL resulted in an increase in
circulating noradrenaline levels regardless of prior treatment with either an
a- or /?-adrenergic antagonist. The finding that tyramine HCL infusion

increases circulating noradrenaline levels is consistent with previous
infusion studies in foetal sheep (Walker and Schuijers, 1989), and man
(Scriven et aL, 1983), however, adrenergic antagonists were not used in
either of these studies.

The increase in peripheral noradrenaline levels following tyramine infusions
were variable with the greatest increase in concentration after pre
treatment with phentolamine methane-sulfonate before tyramine HCL The
two adrenergic antagonists, propranolol HCI and phentolamine methanesulfonate when infused alone had no effect on the release of plasma
noradrenaline. When both antagonists were infused together plasma
noradrenaline levels increased. This increase in noradrenaline levels could
be as a result of noradrenaline released during synaptic transmission which
is unable to bind to either the a-adrenergic or ^-adrenergic receptors
because of the action of the antagonists. A result of this could be an
increase in plasma noradrenaline levels due to a

"spill over" into the

peripheral circulation from the sympathetic nerve endings. This response
may be magnified by the loss of negative feedback to the central nervous
system, resulting in further neural excitation. This may be the case
following the adrenergic blockade by the combined antagonists.

Plasma Adrenaline Levels

The infusion of tyramine HCL or tyramine infusion following the infusion
of propranolol or phentolamine alone or in combination had no effect on
plasma adrenaline levels. This is in agreement with Walker and Schuijers
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(1989) who showed that tyramine HCI failed to significantly change either
plasma adrenaline or dopamine concentrations when infused into foetal
sheep. The increase in

plasma noradrenaline levels is consistent with

tyramine HCI being a specific competitive inhibitor for noradrenaline uptake
(Burgen and Iverson, 1965).

Plasma Free Fatty Acids

Tyramine HCL infusion caused a dramatic increase in plasma FFA levels.
This increase occurred during the period of the tyramine HCI infusion and
the levels decreased within 5 min following the end of the infusion. This
increase in FFA levels was associated with the increase in endogenous
noradrenaline. The increase in noradrenaline levels may stimulate FFA
release because exogenous noradrenaline given to sheep (Bassett, 1970)
and cattle (Blum et al., 1982) stimulate FFA release. The involvement of
noradrenaline in FFA release is supported by the modulatory influences of
the application of both a- and /?- adrenergic receptor antagonists.
Pre-treatment with the non selective ^-antagonist propranolol HCI
prevented the tyramine induced rise in FFA, whereas pre-treatment with the
non selective or-antagonist, phentolamine had no effect on the FFA release
induced by tyramine. These results agree with studies in adipocytes which
possess

both

stimulatory ^-adrenergic

receptors

and

inhibitory

a2-

adrenergic receptors (Vernon, 1980). The anti-lipolytic effect of propranolol
HCI in preventing the tyramine induced rise in FFA release is in agreement
with infusion studies that have used propranolol HCI to prevent the
adrenaline induced rise in FFA's in the sheep (Bassett, 1970) and in steers
(Blum et al., 1982). Of interest from Bassett's study was the finding that
pre-treatment with either phentolamine or phenoxybenzamine (a non
selective cr-adrenergic antagonist) also prevented the adrenaline induced
release of FFA. This result is in contrast to our own and is difficult to
explain as both the concentration of the antagonist and the method of
infusion were the same for both studies. However, the results reported here
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are in agreement with studies in other species, where treatment with
phentolamine had no effect on the adrenaline induced release in FFA levels
in steers (Blum et at., 1982; Frohli and Blum 1988) and in rabbits
(Knudtzon, 1984).

The influence of the combined antagonists in preventing lipolysis is most
likely due to the effects of the propranolol HCI with its ability to
competitively inhibit the noradrenergic inputs via the /^-adrenergic receptors.
Plasma Glucose and Plasma Insulin

Tyramine HCI infusion increased plasma glucose and levels remained
elevated throughout the infusion period. The increased plasma glucose
could be as a result of the effect of noradrenaline whose levels increased
during the tyramine infusion. Noradrenaline is known to stimulate peripheral
glucose levels by increasing glycogenolysis and gluconeogenesis (HimmsHagen, 1967). Glucose levels are influenced by activation of the /?adrenergic receptors and more specifically, the /?2-receptor in response to
increased circulating levels of adrenaline and noradrenaline (McDowell and
Annison, 1991). The idea that the increased noradrenaline levels resulting
from the tyramine infusion give rise to the increase in plasma glucose is in
contrast to the study of Bassett (1970), who showed that in sheep,
infusion of noradrenaline had little effect on circulating glucose levels. This
difference is in the two studies may be due to the problems associated with
exogenous

infusion

of catecholamines,

especially with

infusion. In Bassett's study (1970) the amount of

noradrenaline

noradrenaline infused

may not have been sufficient with noradrenaline being broken down before
it reached the adrenergic receptors but, more likely, the peripheral infusion
used in his study was not appropriate, as it fails to mimic the normal
manner of endogenous noradrenaline release.

Tyramine HCI infusion and the associated release of noradrenaline had no
direct influence on circulating insulin levels. The observed lag between
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changes in glucose status and insulin levels suggest that changes in insulin
status are due to a response in glucose levels rather than a direct
catecholaminergic effect on the pancreas. Insulin levels increased during
the infusion periods and this increase appeared to be correlated with the
rise in plasma glucose levels and not associated with the increased
noradrenaline levels because plasma insulin concentrations fell only when
plasma glucose levels fell. The pattern of insulin secretion was surprising
as it had been expected that the insulin levels would be suppressed due to
an increase in noradrenaline levels. This is a result that is contrary to other
published studies in sheep (Bassett, 1970) and cattle (Frohli and Blum
1988) where the intravenous infusion of noradrenaline and adrenaline were
found to attenuate the insulin response to an increase in glucose and
FFA's. Of relevance to the present study, is the recent observation of
Hirose et at. (1994) who showed that the rate of insulin secretion from the
isolated rat pancreas decreases when incubated with tyramine HCI.

The results of the present study are further complicated by the
observations following treatment with the /^-adrenergic receptor antagonist
propranolol HCI before the infusion of tyramine HCI. Pre-treatment with
propranolol inhibited insulin secretion during both the infusion of propranolol
HCI and tyramine HCI regardless of the increase in glucose levels in
response to the tyramine HCI infusion. Inhibition of insulin secretion

has

been shown to be mediated by a2-adrenergic receptors of the /?- pancreatic
cell (Clutter et a!., 1980) and enhanced via the /?2-adrenergic receptors
(Remie et a!., 1989). Therefore, the specific blockade of the pancreatic /?adrenergic receptors, thus leaving the a-adrenergic receptor population
intact and available for noradrenergic binding would then result in the
suppression of insulin release and a concomitant increase in plasma glucose
levels. The question that this study has not been able to answer entirely is
whether the decrease in plasma insulin and the simultaneous increase in
plasma glucose seen during the tyramine infusion the result of a-adrenergic
receptor stimulation due to the associated noradrenaline release or as a
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result of the propranolol HCI infusion itself? However, it does appear from
the data that tyramine per se increases insulin release and that propranolol
HCI per se decreases insulin release.

Pre-treatment with phentolamine stimulated insulin release before the
tyramine HCI was infused resulting in an uncoupling of the close
association between insulin and glucose levels seen in previous studies.
This regime was presumably due to the blockade of the suppressive
influence of a2 adrenergic mechanisms on insulin release which in turn
suppressed glucose levels by increasing uptake into peripheral tissues.
These results are important as they demonstrate that metabolic processes
can be altered by the use of adrenergic antagonists and that care should be
taken in determining the metabolic action of catecholamines especially
when agonists and antagonists are infused simultaneously. It also highlights
the metabolic role the catecholamines play in the tonic regulation of plasma
insulin.

When both or-and ^-adrenergic receptors are blocked, there are no
stimulatory or inhibitory effects on either plasma insulin or plasma glucose
production. This combined antagonist infusion negates any physiological
response to tyramine infusion and plasma levels of both insulin and glucose
remain at basal levels throughout the infusion period. However, should any
specific demand on glucose supply be imposed such as for example a
stressor such as exercise it is unlikely that the animal undergoing such
pharmacological blockade would survive.

Plasma Cortisol

Circulating cortisol levels were measured in this study to determine
whether tyramine HCI could induce an increase in the secretion of this
glucocorticoid and if so whether this rise would correlate with the metabolic
changes observed during the tyramine HCI infusion.
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During the period of tyramine HCI infusion there were no significant
changes in circulating cortisol levels. Therefore, the metabolic changes
mediated by the tyramine HCI infusion are not associated with increased
cortisol levels but are more likely a direct response to the increased
noradrenaline levels rather than a change in glucocorticoid status.

Following termination of the tyramine HCI infusion, cortisol levels
increased and reached a peak by 45 min. This peak may coincide with an
endogenous circadian rhythm because the timing of the peak level for the
tyramine infused treatment was similar to that of the propranolol HCI
infused treatment, occurring at 1100 hrs and 1115 hrs respectively. The
circadian rhythm for cortisol secretion is entrained to the prevailing
photoperiod (Fischman et aL, 1988), with peak levels corresponding to the
period of darkness. Photic information received by the eye modulates a
circadian pattern of release of melatonin, which is translated into a neural
signal in the hypothalamus. This release pattern of melatonin has been
demonstrated to mediate the circadian rhythm for other endocrine profiles
including those of the pituitary-adrenal axis, in sheep (Jones, 1990) and
deer (Newman et aL, 1991). In the present study, peak cortisol levels from
both infusion treatments occurred in the mid morning. This finding is in
agreement with studies in deer (Newman et aL, 1991) and in the sheep
(Fulkerson and Tang, 1979). These groups showed a bi-phasic cortisol
rhythm in the fallow buck and in the Merino ewe with peak cortisol
concentrations occurring during the hours of darkness and mid morning. Of
interest in the present study was that the increase in cortisol levels
occurred even though the ewes were subject to a constant light
photoperiod regime (24L:0D). Therefore, factors other than entrainment to
the prevailing photoperiod may also modulate these endocrine rhythms.

Blood Pressure

Changes in arterial blood pressure were used as a reference to monitor the
physiological action of the tyramine HCI infusion and that blocking the
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adrenergic receptors was also effective. This physiological parameter
proved a very sensitive measure of adrenergic bioactivity, irrespective of
whether it is a stimulation or a blockade of adrenergic receptors.

Tyramine HCI infusion resulted in an increase in arterial blood pressure
from the onset of the infusion, a response that persisted for the duration of
the

infusion period. These findings are in agreement with other studies

using tyramine HCI infusion and injection in foetal sheep, (Walker and
Schuijers, 1989) and new born lambs, (Lumbers et a/., 1980) in which
increases in blood pressure were recorded. The Infusion of tyramine HCI
has also been shown to elevate systolic blood pressure in humans, (Scriven
et aL, 1983). In the present study the increase in arterial blood pressure

was associated with the increase in plasma noradrenaline levels induced
during the tyramine HCI infusion, which most likely caused systemic
vasoconstriction. In agreement with this finding is the study by Hjemdahl et
a!., (1983) who showed that the intravenous infusion of noradrenaline also

elevated both systolic and diastolic blood pressure in man.

Pre-treatment with either propranolol HCI or phentolamine methanesulfonate significantly reduced the tyramine HCI induced response. Again,
this result is in agreement with those observed in sheep by Wood et aL
(1979) and Halmagyi et aL (1967) who have shown that the prior infusion
of either propranolol HCI or the infusion of the non selective a-adrenergic
antagonist phenoxybenzamine inhibited the catecholamine induced rise in
blood pressure. This result

demonstrates that there are both a- and /?-

adrenergic receptors within the systemic circulation that are involved
equally in the modulation of blood pressure responses.
5.7. Conclusions
This experiment has demonstrated that by the intravenous infusion of
tyramine HCI modulation of both metabolic and haemodynamic parameters
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can

be achieved.

noradrenaline,

the

In view of the
changes

known

in metabolic

physiological

and

actions

haemodynamic

of

status

observed in response to the tyramine infusion in the present study are most
likely the result of the endogenous release of noradrenaline. This finding is
further substantiated from the results that demonstrated that neither
adrenaline or cortisol, both potent mobilisers of energy substrates, were
released during tyramine HCI infusion. In addition, the metabolic and
haemodynamic changes observed in this study were mediated by the
adrenergic

antagonists,

propranolol

HCI and

phentolamine

methane-

sufonate. These agents bind to the catecholamine receptor thus preventing
their activation by the catecholamines.

The endogenous noradrenaline released in this experiment stimulated the
release of free fatty acids, and glucose as well as blood pressure levels.
The release of FFA's were attenuated after /7-receptor blockade confirming
that in the ewe the ^-adrenergic receptor function is responsible for the
liberation of FFA after stimulation by noradrenaline. The haemodynamic
effects (increased blood pressure) were also substantially blocked by the
prior infusion of either a- or ^-adrenergic antagonists and completely
blocked by the combination of both agents.
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Chapter 6

Effects of Anaesthetic Stress and Surgical Stress on Selected Metabolic and
Hormonal Parameters in ACTH Immune Ewes

6.1. Introduction

Surgery under general anaesthesia elicits an acute stress response which
activates

both

the

sympathetic

hypothalamic-pituitary-adrenal

nervous

axis,

system,

(HPA).

(SNS),

Cortisol,

and

the

the

major

glucocorticoid in the sheep, is released from the adrenal cortex in response
to adrenocorticotropin (ACTH). It has been demonstrated in man (Ichikawa
et aL, 1971) and more recently in the sheep (Jones, 1990) that both ACTH

and cortisol levels increase in response to surgical stress. Cortisol is a
potent mobiliser of energy substrates, chiefly glucose and free fatty acids
and plasma levels of these substrates rise during surgery. Fraioli et a!.
(1980) established that acute stressors which stimulate ACTH release also
elevate plasma concentrations of /?-endorphin. This increase in ^-endorphin
has been suggested by Grossman (1988) to decrease responsivity of the
"stress hormone' axes, including the SNS and the HPA axis.
Changes in other circulating hormone levels have also been reported
during surgical stress. These include increases in prolactin and growth
hormone (Hagen et aL, 1980), increases in thyroxine and a decrease in
triiodothyronine (Brandt et aL, 1976). These changes may be mediated
directly through afferent neurogenic stimuli from the traumatised tissue, via
the sympathetic nervous system, or indirectly through the influence of
cortisol.
Little is known of the above endocrine responses to anaesthesia alone or
with

surgery in the ewe, or about the factors which may influence this
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stress response to these procedures.
6.2. Aim

This experiment seeks to determine firstly what effects anaesthesia alone
has on the sheep stress response, and secondly what roles the HPA axis
may play during surgical stress in relation to the regulation of endocrine and
metabolic status in the ewe.

6.3. Materials and Methods

Animals

Six Border Leicester-Merino ewes were housed at the University Sydney
farms Camden (latitude 34°S). Ewes were maintained at pasture before
being acclimated to metabolic cages in a thermoneutral environment under
a photoperiod regime of 12 L: 12 D. Ewes had free access to water and
were fed a pelleted ration of 60% hammermilled lucerne and 40%
hammermilled oats at 95% ad libitum.

Three ewes were actively immunised against ACTH 1-24-ovalbumin
conjugate (0.5 mg) in Freunds Complete adjuvant (2ml). A primary injection
was given in mid December 1993 and subsequently booster immunisations
made up in incomplete Freunds adjuvant were given at six weeks and ten
weeks after the primary injection. Another three ewes were injected with
adjuvant alone at each of these times.
All six ewes underwent major surgery (catheterisation of the carotid
artery). Eighteen days later the three ewes which were not immunised
against ACTH 1-24 underwent general anaesthesia without the invasive
surgery.
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Surgical Procedures

Jugular Vein Catheterisation

A catheter, made from medical grade polythene tubing i.d. 1.0 mm o.d.
1.5 mm (Dural Plastics Ltd, Dural, NSW) was placed into a jugular vein.
Catheterisation was performed 24 hr prior to the major surgery using a
topical anaesthetic agent (Xylocaine; 10% spray; Astra Pharmaceuticals Pty
Ltd., Melbourne). Catheters were inserted through a sterile 14G catheter
placement unit, (Jelco, Johnson and Johnson Medical, Japan) and patency
was maintained by filling the catheters with heparinised saline (500 lU/ml
of heparin).

Catheterisation o f the Carotid A rtery

Ewes were fasted for 24 hr and denied water for 12 hr prior to surgery.
General anaesthesia was induced with intravenous (iv) thiopentone sodium
(Boehringer) at a dose rate of 15-20 mg/kg body weight. Following
orotracheal intubation, anaesthesia was maintained with 2-4% Fluothane
(halothane BP) in oxygen. The oxygen delivery rate was 6-10 mls/min and
the fluothane rate was regulated according to the reflex responses of the
individual sheep. The anaesthetic gases were delivered using a Flurotec 3
vaporiser, and the ewes were maintained at stage 3 (depression of
respiratory, circulatory, protective reflexes and muscle tone) and plane 2
(defined as the point where eyeballs remain eccentrically fixed) of
anaesthesia (Hall and Clarke, 1983). This level of anaesthesia was
maintained throughout the surgical period which commenced approximately
20 min after the induction of anaesthesia. Sheep were held in the dorsal
position throughout surgery upon completion of the surgery, administration
of the

anaesthetic ceased. Duration of the anaesthesia was between 40

and 50 min after which the ewes were placed in the ventral recumbency
position until they regained consciousness. The ewes were then left
undisturbed in a recovery pen until the completion of the experiment.
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To determine the endocrine response to anaesthesia alone, the above
protocol was repeated 18 days later on the non-immune sheep without
invasive surgery.

Blood Sampling

Venous blood samples (3 ml) were taken from the indwelling catheters
using a 5 ml syringe (Terumo Corporation Japan) and after each sample the
catheters were flushed with heparinised saline (100 lU/ml). Samples were
taken at 15-min intervals for one hour prior to surgery then every 5 min
during the surgery, and then every 15 min for one hour after surgery.

Blood samples were transferred to plastic P4 tubes (John Morris Ltd,
Sydney, NSW), containing Kwick Spin separation granules (Disposable
Products

Padstow,

NSW). All samples were kept on ice prior to

centrifugation. Plasma was harvested and stored at -2 0 ° C until assayed.

Catecholamine Samples

Venous blood samples were collected for determination of plasma
adrenaline and noradrenaline and placed in pre-cooled P4 plastic tubes
containing 1mg sodium metabisulphite per 10mls blood. Samples were
taken 15 min before the onset of inhalation anaesthesia,

just after

inhalation anaesthesia but before surgical incision, at the completion of the
surgical procedure and coinciding with the time when the anaesthesia
mixture was discontinued, and at 60 min after completion of the surgery.
Samples were immediately centrifuged and frozen at -7 0 ° C until assayed.
6.4 . Statistical Analysis

All data are presented as the mean ± S.E. of the mean. The effects of
time and anaesthesia or anaesthesia plus surgery on all ewes and their
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interaction were measured by a repeated measures ANOVA test (CLR
ANOVA program; Clear Lake Research Inc., Houston TX, USA).
The differences in the mean catecholamine levels for baseline, anaesthesia
and recovery periods were compared by using an unpaired t-test (Steel and
Torrie, 1980).

6.5. Results

Plasma Noradrenaline Levels

Plasma noradrenaline levels are shown in figure 6.1. There were large
differences in plasma noradrenaline levels between each animals within
treatment

groups.

There

was

no

significant

difference

in

plasma

noradrenaline levels in the non-immune groups (anaesthesia only and
surgery + anaesthesia) in response to either anaesthesia or surgery.
However,

plasma levels of noradrenaline in the

non-immune ewes

(anaesthesia only and surgery + anaesthesia) tended to increase when
anaesthesia

was

discontinued.

There

was

little

change

in

plasma

noradrenaline levels in the ACTH-immune group in response to surgery,
although noradrenaline concentrations tended to decline when anaesthesia
was discontinued. Peripheral noradrenaline levels in the samples taken
before and after surgery from the ACTH-immune group were significantly
greater (P<0.05 ) than those of the non-immune group.

Plasma Adrenaline Levels

Plasma adrenaline levels are given in figure 6.2. Circulating adrenaline
levels were also variable between each animal and for each treatment
group. There was no significant difference in peripheral adrenaline levels in
the non-immune group during surgery, however, plasma adrenaline levels
tended to decrease in response to the anaesthetic induction then rise when
anaesthesia was discontinued. Circulating adrenaline levels in the ACTHimmune group were unaffected by either anaesthesia or surgery with levels
remaining at or near pre-surgery concentrations.
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Plasma Cortisol Levels

Circulating cortisol levels are shown in figure 6.3. Anaesthesia stress
followed by surgical stress resulted in a highly significant (P<0.01)
increase in circulating cortisol levels in the non-immune group. Plasma
cortisol levels increased in response to anaesthetic induction with a mean
pre-induction concentration of 15.3 ± 3.4 ng/ml rising to 48.8 ± 10.2
ng/ml at anaesthetic induction. Cortisol levels continued to increase
throughout

the

surgical

procedure,

a

maximum

plasma

cortisol

concentration of 168.3 ±53.0 ng/ml occurring 15 min after the completion
of surgery. Plasma cortisol levels continued to remain elevated throughout
the recovery period.

In the ACTH-immune group, there was no increase in circulating cortisol
levels in response to either anaesthetic induction or surgery, hormone levels
remaining at or near basal levels throughout the period of surgery.
However, at the completion of surgery and anaesthetic withdrawal cortisol
levels increased to a maximum concentration of 49.0 ± 11.0 ng/ml. This
result being recorded 45 min after the completion of surgery.

In the non-immune anaesthesia only group, there was a significant
increase (P<0.01) in circulating cortisol concentrations in response to
anaesthetic induction. Plasma cortisol levels remained elevated throughout
the period of anaesthetic treatment with elevated cortisol levels persisting
into the recovery period. However, the relative increase in circulating
cortisol levels were not as great as those observed in the non-immune
surgically treated group.

Plasma Growth Hormone Levels

Plasma growth hormone (GH) levels are shown in figure 6.4. Anaesthetic
induction resulted in a significant increase (P<0.05) in circulating GH levels
in both non-immune and ACTH-immune surgical treated groups. This
increase was further enhanced in both groups from the onset of surgery.
120

cortisol
ng/ml

Fig 6.3

Changes in circulating
cortisol levels in
response to anaesthesia
and surgery.

220 ~

recovery

I'

200 “
-

180 “
-

160 ~
140 “

♦

Non-immune surgically treated

120 -

O Non-immune anaesthesia only
■

ACTH-immune surgically treated

incision
-

100 80 -

“
60 40 20 -k
0 —
0

20

40

60

80

100 120 140 160

Time (minutes)
GH ng/ml

Fig 6.4

Changes in circulating
GH levels in response to
anaesthesia and surgery

♦

N o n -im m u n e s u rg ic a lly tre a te d

O

N o n -im m u n e a n a e s th e s ia o n ly

■

A C T H -im m u n e s u rg ic a lly tre a te d

0

20

40

60

80

100 120 140 160

Time (minutes)

Plasma GH levels in these groups followed an episodic release pattern
which was maintained throughout the period of surgery. The GH release
pattern and circulating levels were similar for both groups, peaks in GH
concentrations occurring at 20 min intervals. Plasma GH levels declined
when surgery and anaesthesia were discontinued, GH concentrations
returning to basal levels during the recovery period.

There was a marked difference, although this was not significant, in both
the release pattern and circulating levels of GH in the non-immune
anaesthesia only group compared to the non-immune and ACTH-immune
surgically treated groups. In the non-immune anaesthesia only group there
was an increase in GH levels after anaesthetic induction. However, unlike
the tw o surgical operated groups there was no episodic release pattern in
plasma GH concentrations with levels gradually increasing over time
reaching a maximum of 14.9 ± 2.9 ng/ml

25 min after the onset of

anaesthetic induction.

Plasma Glucose Levels

Plasma glucose levels are given in figure 6.5. For the non-immune
surgically treated group plasma glucose levels tended to increase from the
time of the surgical incision with a maximum concentration of 4.3 ± 0 . 6
mmol/L being recorded 20 min from the start of surgery (Fig 6.5a). This
contrasts with the mean pre-induction level of 3.4±0.1 mmol/L. Plasma
glucose concentrations declined in all three ewes after 20 min of surgery
and continued to decline during the recovery period (Fig 6.5a).
In the ACTH-immune surgically treated ewes there was no increase in
plasma glucose (Fig 6.5b) following the surgical procedure.

For the non-immune ewes given anaesthesia only the plasma glucose
concentrations remained at or near basal levels (Fig 6.5c). One ewe showed
a slight increase during anaesthesia.
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Pasma Insulin Levels

Plasma insulin levels are shown in figure 6.5. All three ewes which were
non-immune but surgically treated had increased plasma insulin levels in
response to induction of anaesthesia (Fig 6.5a). During the surgical
procedure plasma insulin levels varied markedly. This variability continued
for 20 min post incision after which time insulin concentrations declined
and then stabilised remaining at or near basal levels for the remainder of the
study.

In the ACTH-immune surgically treated ewes there was an increase in
plasma insulin levels (Fig 6.5b) following induction of anaesthesia. Similarly
to the non-immune surgically treated ewes, insulin levels varied markedly
during the surgical procedure. However, unlike in the non-immune group
this variability continued throughout the period of surgery.
When the non-immune ewes were anaesthetised only, a significant
increase (P<0.01) in plasma insulin levels from the pre-induction levels
occurred (Fig 6.5c).

This increase continued for 20 min after which the

levels declined and remained at or near basal levels for the remainder of the
study.

Plasma Free Fatty Acid Levels

Plasma free fatty acid (FFA) levels are displayed in figure 6.6. There was a
significant decline (P<0.01) in plasma FFA levels in all three treatment
groups following either surgical incision or induction of anaesthesia alone.
In the non-immune surgically treated ewes plasma FFA levels tended to
increase around 25 min after the surgical incision was made. In the ACTHimmune and the non-immune anaesthesia only groups FFA levels did not
increase until

the recovery period. The FFA profile for the non-immune

anaesthesia only group was similar to that of the ACTH-immune surgically
treated group throughout the experimental period.
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Plasma ¡3-endorphin Levels

The plasma /?-endorphin levels are given in figure 6.7. For the non-immune
sheep anaesthesia alone and surgery + anaesthesia resulted in a significant
rise in plasma ^-endorphin levels (Fig 6.7a)

(P<0.01) in response to

induction with anaesthesia. Maximum levels occurred either 20 minutes
(anaesthesia only) or 25 minutes (surgical treated) after the onset of
anaesthesia and then declined to near pre-anaesthetic induction levels by
the end of the recovery period. Plasma ^-endorphin levels for the
experimental period in the non-immune groups were similar with the
surgical procedure having no significant effect on circulating /7-endorphin
levels.

For 2 of the 3 ACTH-immune surgically treated ewes, the plasma /7endorphin levels were similar to the non-immune groups, although the rise
in circulating /7-endorphin levels for these two ewes occurred 5 minutes
after the surgical incision. The plasma /?-endorphin levels for the remaining
ewe were significantly elevated (P<0.01) from the onset of the study when
compared to the two other ACTH-immune ewes and its /?-endorphin levels
remained elevated throughout the treatment period.

6.6. Discussion

Cortisol

The most striking result from this experiment was the demonstration that
the circulating cortisol concentrations in the ewes immunised against ACTH
1-24 remained at or near basal levels during the period of surgery. Of
interest was the finding that cortisol levels in the ACTH-immune group
increased significantly during the recovery period. This increase in cortisol
levels may reflect the decrease in the ratio of circulating ACTH antibodies
to plasma

ACTH concentration following its increased release from the

pituitary.
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In contrast, cortisol levels in the non-immune group increased in response
to both anaesthesia and surgery with a greater increase in plasma cortisol
levels elicited by the surgical procedure. An increase in cortisol levels
during surgery has been reported by other investigators and has been
shown to occur in a number of different species, including man (Fellander
et a!., 1994; Bickel et a\., 1991; Clarke et a!., 1970) the sheep (Jones,

1990; Shutt et a!., 1987) and the horse (Robertson et al., 1990). The
magnitude and the duration of the cortisol response in man is correlated
with the intensity of the surgical procedure. Intra-abdominal surgery gives a
greater response in cortisol release compared to body surface surgery. Little
or no effect on cortisol secretion is observed during anaesthesia without
surgery (Clarke et aL, 1970). A similar effect has been demonstrated in the
horse. Taylor (1985) reported a 10 fold increase in cortisol concentrations
in pony mares during abdominal surgery, whereas Robertson and co
workers (1990) reported a 1.6 fold increase in plasma cortisol levels
following arthroscopic surgery with no significant changes in cortisol
concentrations during body surface surgery (Robertson, 1987). In the ewe
an increase in cortisol secretion was reported by Jones (1990) during and
following

ovarian auto transplant surgery. However, unlike the present

study or those reported for man, plasma cortisol was released in an
episodic pattern during surgery and did not increase over time. This
difference in the release pattern between the present study and that of
Jones (1990) may reflect the association between cortisol and the degree
of surgical trauma as ovarian transplant surgery involves simultaneous
surgical procedures of the abdomen and neck (Goding et a!., 1967).
In the present study, anaesthesia alone induced a rise in plasma cortisol
levels in the non-immune group. This result is in keeping with that of Taylor
(1985) who reported an increase in plasma cortisol for Welsh ponies during
halothane anaesthesia. Contrary to these findings is that of Clarke and co
workers (1970) who found little to no change in the human following
induction of anaesthesia. This difference may reflect differences in the
124

methods of plasma cortisol analysis. Clarke eta !., (1970) measured plasma
cortisol fluorimetrically while we measured cortisol using radioimmunoassay
techniques. These assays differ greatly in their sensitivity to plasma
cortisol. The values reported by Clarke et al. (1970) appear to exceed the
sensitivity of the assay. Different anaesthetic agents have been shown to
alter the rate of cortisol released into the circulation, ether and halothane
being the most potent (Oyama, 1983). Gaseous anaesthetic agents such as
halothane when introduced into the upper respiratory tract have to be
transported to the brain before they produce a loss of consciousness (Hall
and Clarke, 1984). These anaesthetic agents exert their effects on synaptic
transmission by selectively targeting synaptic ion channels on receptors
within the central nervous system (Franks and Lieb, 1994). It was
postulated by these researchers that some anaesthetic agents may act by
potentiating

inhibitory

synaptic

receptors

while

inhibiting

excitatory

receptors (Franks and Lieb, 1994). An anaesthetic induced alteration in
cortisol secretion may be a result of the stimulation of CRH secretion via
halothane acting at the level of the hypothalamus.

Noradrenaline and Adrenaline

Plasma noradrenaline levels in the ACTH-immune and both the non
immune groups change very little in response to either anaesthesia or
anaesthesia and surgery. Circulating noradrenaline levels in the non-immune
group appeared to increase when the anaesthesia was discontinued
although this increase was not significant. This finding was not expected as
studies in man have shown an increase in plasma noradrenaline levels
during surgery (Tonnesen et a!., 1984: Halter and Pflug, 1980, Halter et a!.,
1977). It has been demonstrated that anaesthetic agents themselves can
alter the catecholamine response to surgery (man Bickel et a!., 1991; rat
Roizen et al., 1974). Bickel and co-workers (1991) reported a significant
difference between the effects of the inhalation anaesthetic agents
enflurane

and

neurolept when

administered to

patients

undergoing

cholecystectomy. Patients given enflurane had lower catecholamine levels
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during and after the surgical procedure compared to patients maintained
under

neurolept

anaesthesia.

Also,

catecholamine

levels

remained

unchanged during surgery and recovery in the patients who were induced
and maintained with enflurane anaesthesia. Halothane the anaesthetic
agent used in the present study when administered to rats decreased
peripheral catecholamine concentrations (Roizen et aL, 1974). Roizen and
co-workers found a significant decrease in total catecholamine levels when
halothane was used at 1 % and the levels were depressed further when the
halothane concentration was increased to 1.5%. In the human halothane
will not depress catecholamine levels (Tonnesen et a/., 1984: Halter and
Pflug, 1980, Halter et aL, 1977). All ewes in the present study were
induced and maintained with halothane within a range of
(dependent on the

anaesthetic state of the

ewe).

1%-5%

The fact that

catecholamine levels in the ewe did not increase during surgery could be a
function of not just the anaesthetic agent but possibly a combination of the
anaesthetic agent and its physiological influence in this species.

For the ACTH-immune ewes the plasma noradrenaline levels were
significantly elevated before surgery and during the recovery period when
compared to the non-immune ewes. This finding was not related to any
change in metabolic parameters such as free fatty acid levels, which have
previously been shown to be sensitive to sympathetic nervous activity
(Newman unpublished observations). Increased activity of the sympathetic
nervous system in the ACTH-immune group is difficult to explain but may
be a response to the handling procedures.
The pattern of plasma adrenaline levels for the non-immune ewes during
anaesthesia alone or anaesthesia and surgery is similar to what has been
reported for man during both anaesthesia and surgery (Halter and Pflug,
1980, Halter et a!., 1977 and Bickel et aL, 1991). Interestingly, as in man,
plasma adrenaline levels declined in response to the anaesthetic induction.
This decline may not be a result of the halothane itself, but may be an
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attribute intrinsic to all anaesthetic agents, as other agents such as
enflurane and neurolept also depress plasma adrenaline levels (Bickel et a!.,
1991). The decrease in plasma adrenaline levels during anaesthetic
induction in man is not associated with a decline in plasma noradrenaline
levels. Halter and co-workers (1977) have suggested that this specific
adrenomedullary

suppression

observed

during

anaesthesia

may

be

representative of distinct sympathetic nervous system pathways to the
adrenal gland and to the peripheral neurones. This hypothesis may also be
be true for the sheep. In the present study there was only a small increase
in peripheral adrenaline levels when anaesthesia was discontinued. This is
in contrast to studies in man, where Halter and co-workers reported a 4.3
fold increase in plasma adrenaline levels at the end of surgery.
Glucose

The early study of Clarke (1970) demonstrated an association between
the rise in blood glucose levels and the trauma of surgery. This rise was
shown to be proportional to the stress of the surgical procedure and its
duration. Subsequent studies by Madsen et a!., (1976) confirmed this
finding in patients undergoing major surgery (hysterectomy) compared to
minor surgery (tympanoplasty). Madsen et at., (1976) reported parallel rises
in cAMP, blood glucose and plasma cortisol concentrations. The release of
these three parameters were all shown to be related to the degree of
surgical trauma. In the present study, blood glucose levels in the non
immune group increased during surgery, while there was no significant
increase in response to anaesthesia without surgery. Anaesthetic agents
will modulate blood glucose levels (Clarke, 1970). Of relevance to the
present study is the finding that in man halothane does not give rise to a
significant increase in blood glucose levels in the absence of surgery
(Hunter, 1959).

A number of investigators have alluded to the role of increased cortisol
levels during surgery contributing to an increase in blood glucose levels,
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(Clarke eta !., 1970, Lacoumenta et al., 1987). Lacoumenta and co-workers
(1987) demonstrated the plausibility of this by infusing hydrocortisone into
patients upon the completion of their surgery. Hydrocortisone resulted in a
significant increase in blood glucose levels without altering plasma GH,
ACTH, or insulin levels. Our finding that blood glucose levels did not
increase during surgery in the ACTH-immune group in which plasma cortisol
was ablated implies that the relationship between plasma cortisol and blood
glucose levels exists in the sheep.

It is of interest to speculate as to how increased cortisol levels during
surgery

affect

glucose

levels.

Ingle

(1952)

postulated

that

the

glucocorticoids play a "permissive' role in the modulation of metabolic
processes and act to influence the actions of both glucagon and adrenaline.
These hormones use cAMP as their intracellular second messenger
(Sutherland et a/., 1968). As mentioned previously Madsen et al. (1976)
demonstrated in man the elevation of plasma cortisol, blood glucose and
cAMP levels during surgery . These observations led Madsen et al. (1976)
to

suggest that the catabolic hormones such as glucagon or the

catecholamines may account for the liberation of glucose into the peripheral
circulation. Plasma glucagon was not measured in this study, therefore, it's
role in the mobilisation of energy reserves and increased plasma glucose
during surgery is unable to be assessed. Studies in man suggest that
glucagon is not a likely mediator of the immediate hyperglycaemic effect
seen during surgery (Giddings et a!., 1976). Giddings and co-workers
(1976) reported increased levels of plasma glucagon, but this increase only
occurred post-operatively and did not coincide with the rise in plasma
glucose levels which had occurred during surgery. It is more likely that the
increased levels of catecholamines and plasma cortisol observed in man
during surgery are responsible for the associated increase in blood glucose
levels. This association is unlikely to produce an explanation for the
increased levels of blood glucose seen in the ewe because catecholamine
levels were not significantly elevated in the current study. In the ewe, it
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would appear that some other catabolic agent is responsible for the
hyperglycaemic effect seen during surgery.
Insulin

The finding that peripheral insulin levels increase in response to the
anaesthetic induction is of interest. Increased circulating insulin levels
occurred regardless of the treatment with the ACTH-immune group
responding similarly to the non-immune group. The increase in peripheral
insulin levels following anaesthetic induction has not previously been
reported in either man or the sheep. Robertson and co-workers (1990)
found increased plasma insulin levels in the horse approximately 10 minutes
after anaesthetic induction with halothane. In their study, the delay in
insulin response to the anaesthetic induction may be attributed to the
timing of the blood sampling regime as it was 10 minutes after anaesthetic
induction that the first blood samples were taken. In contrast to the
ruminant, studies in man have shown either a decline (Halter and Pflug,
1980) or no change in plasma insulin levels (Clarke et al., 1970) at the time
of anaesthetic induction. Therefore, it appears from our study and that of
Robertson et al. (1990) that anaesthetic induction using the anaesthetic
agent, halothane, initiates insulin release in the ruminant.
The alteration in synaptic transmission within the central nervous system
in response to anaesthesia (Franks and Lieb, 1994) may influence insulin
release from the /?-cells of the islets of Langerhans. Both parasympathetic
fibres from the vagus nerve and sympathetic fibres from the splanchnic
nerve innervate the pancreas (Berthoud et aL, 1991) providing central
neural input for the control of hormonal synthesis (Strubbe and Steffens,
1993). The release of insulin into the peripheral circulation during the
induction of anaesthesia could be the result of a central neural input in
response to a perceived glucose depravation in the central nervous system
following halothane anaesthesia.
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In the ewe, insulin secretion during surgery appears to be influenced by
the surgical procedure itself, as plasma insulin levels in the non-immune
surgically treated group remained elevated but variable for a further 25
minutes after anaesthetic induction. Contrasted to this was the sustained
variability

in insulin secretion observed in the ACTH-immune group

throughout the surgical procedure and the recovery period. Insulin levels in
man have been reported to either decline or to remain constant during the
surgical procedure (Traynor and Hall, 1881; Giddings et a!., 1976). Further
studies also in man have demonstrated lower insulin levels in patients
during surgery who received the /?-adrenergic antagonist propranolol HCI
(Cooper et a!., 1980). It would appear then that this decline in insulin
secretion in man is mediated by altered adrenergic activity and most likely
via the o-adrenergic receptor (Allison, 1971). Porte and Robertson (1973)
have shown that activation of the or2-adrenergic receptor inhibits insulin
secretion independently of blood glucose concentrations and that /?2adrenergic receptor activation stimulates insulin release.
In the current experiment, the decline in plasma insulin observed in the
non-immune group mid-way through the surgery is difficult to explain, as
catecholamine levels were not significantly elevated, although this may be
the result of direct innervation via a2-adrenergic receptors on the pancreatic
¡3 cells. It does appear, however, that the decline in insulin secretion may be

associated with the elevation in cortisol levels in response to the surgery as
plasma insulin levels did not fall in the ACTH-immune group. Although
glucocorticoids generally induce peripheral tissue insulin resistance, thereby
stimulating plasma insulin levels it is possible that this role is reversed
during

anaesthesia.

Thus glucocorticoids

in this

condition

may

be

suppressing insulin action by regulating circulating levels rather than by
altering insulin receptor effects on glucose transport mechanisms in target
tissues. This is consistent with the hypothesis of Munk and co-workers
(1984) who have suggested that the function of the glucocorticoids is to
prevent insulin-induced hypoglycaemia. Mediation of insulin action by the
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glucocorticoids

has also

been demonstrated

by studies

in the

rat

(Barseghian and Levine, 1980). These workers showed that corticosterone
given at physiological doses strongly inhibited both glucose and arginine
induced insulin release and that corticosterone had direct effects on the
pancreatic islet cells. Further, lymphocyte studies conducted in the mouse
have demonstrated that adrenaline decreased glucose uptake but only in
the presence of cortisol (Boyett and Hofert, 1972). Therefore, it would
appear from the present experiment, the decline in circulating insulin levels
during surgery in the non-immune group may have been mediated either by
the increased levels of plasma cortisol acting synergistically with the
catecholamines (specifically adrenaline) or by the direct action of cortisol
alone.

Free Fatty Acids

Circulating FFA levels decreased in all three treatment groups after the
induction of anaesthesia and this decline occurred after the anaestheticinduced increase in peripheral insulin concentrations. The decline in free
fatty acids could be a consequence of the elevation in insulin levels
because insulin is the principal antilipolytic hormone in ruminants (Vernon,
1980). This has been demonstrated graphically by studies in which the
administration of insulin caused a rapid reduction (within 5 min) of
circulating FFA's and glycerol concentrations (West and Passey, 1967).
Similar results have been achieved in the horse by Robertson et al. (1990).
This group also showed a decrease in plasma free fatty acid levels and a
corresponding increase in peripheral insulin concentrations in response to
surgery. In contrast, to the effects in ruminants, studies in man have
demonstrated that lipolysis occurs during both surgery and the induction of
anaesthesia (Felländer et al., 1994; Clarke et al., 1970). Interestingly, there
was no increase in plasma insulin levels during either study.
In the human, insulin and the catecholamines are the dominant hormones
in the acute regulation of lipid mobilisation (Arner, 1988). Both adrenaline
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and noradrenaline are potent lipolytic agents in the sheep (Bassett, 1970).
The decrease in plasma free fatty acid levels described in the present study
may be interpreted in two different ways. Firstly, it is possible that
anaesthesia and surgery induce a marked and acute increase in FFA uptake
as a source of energy substrate which cannot be compensated for by
lipolytic mechanisms. Presumably this is due to the suppression of
adrenomedullary and sympathetic neural activity by the anaesthesia of
central

mechanisms.

Thereafter,

glucoregulatory

mechanisms

are

responsible for supplying the appropriate energy requirements. This is
evident from the shift in plasma levels of insulin and cortisol, with cortisol
being

generally recognised as the regulator of longer term energy

requirements as the animal adapts to the stressor (Munk et al., 1984).
Alternatively, it is possible that the FFA's are unimportant substrates for
the acute energy needs of the animal during anaesthesia and surgery.
Therefore, the depletion of circulating levels is simply the result of normal
peripheral tissue utilisation in response to the stress, which is not replaced
by lipolytic mechanisms. Thus in this situation glucose becomes the major
energy yielding substrate and as such, the associated increase in insulin
levels suppressed any lipolytic response. Evidence for this is provided by
the finding that when circulating insulin levels declined in the non-immune
surgically treated ewes mid way through surgery, there was also a
corresponding increase in plasma FFA concentrations. The finding that FFA
levels were not suppressed in the non-immune surgically treated group to
the same degree as and in the ACTH-immune group again implicates
cortisol indirectly as a possible lipolytic regulator during surgery in the ewe.
The increase in plasma FFA concentrations in the non-immune surgically
treated group appears to be a result of the combination of both lipolysis as
well as reduced insulin levels. However, insulin is not the sole regulator of
this response since in the anaesthesia only group insulin levels declined
without a corresponding increase in plasma FFA levels.
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Growth Hormone

Circulating growth hormone (GH) levels in humans increase in response to
surgery (Lacoumenta etaL, 1987; Hagen et a!., 1980; Noel et aL, 1972;
Ichikawa et a/., 1971). Plasma GH levels increase after the surgical incision
and a peak concentration occurring some 30 to 60 minutes later
(Lacoumenta et a/., 1987; Hagen et aL, 1980). In contrast, the GH
response to surgery in the present study was

different, not only in the

timing of both the onset and the peak in maximal concentration but also in
the pattern of release. In the non-immune surgically treated group GH
increased after anaesthetic induction but before skin incision and then
reached a maximum concentration 5 minutes after the incision. This
difference in the timing of the release in response to surgery to that
reported in man may simply be a consequence of the experimental design.
The frequency of blood sample collection during surgery in man, for the
previously mentioned studies, varied between 15 minutes (Ichikawa et aL,
1971) to an hour (Lacoumenta et aL, 1987; Hagen et aL, 1980) in
comparison to the present study where blood samples were taken at 5
minute intervals. The sampling regime may also have contributed to the
different release patterns for GH during surgery for those studies reported
for man and that for the ewe given here. Growth hormone was released in
a pulsatile fashion during surgery in the current experiment whereas in the
human studies blood levels were elevated consistently.
There was no difference between the non-immune and the ACTH-immune
surgically treated groups in either the timing of the GH release in response
to surgery or the pattern of release. An interesting observation was that
there was an apparent synchronisation of plasma GH release in relation to
both groups in response to surgery. This synchronisation is most likely due
to the surgical trauma evoking a response via the lateral spino thalamic
tract of the spinal chord, the S1, S2 singulate gyrus areas of the brain
cortex.

Neuroendocrine mechanisms regulating GH release from the

pituitary are provided from a number of sources in the CNS to the arcuate
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nucleus and the paraventricular nuclei to control the synthesis and release
of somatostatin and GH releasing hormone respectively. This results in the
modulation of a synchronous release pattern (Tindal et a!., 1982). The
failure to demonstrate any difference in the timing of the GH stimulation
between the non-immune and the ACTH-immune groups demonstrates that
the stress-induced increase in cortisol levels did not influence GH secretion,
although basal levels may have facilitated this response. This study also
shows that induction with halothane induces GH release in the ewe. It also
demonstrates that anaesthesia alone alters the timing of the peak in
secretion and the pattern of release.

It is difficult to interpret what physiological role GH may play in response
to surgical trauma in the ewe. Most studies dealing with GH and it's
involvement in the regulation of metabolism in ruminants have chiefly been
of a chronic rather than an acute nature. Growth hormone has been
demonstrated to induce insulin resistance, however, this requires several
days of hypersecretion for this to develop (Hart, 1983). Its role in the
stimulation of lipolysis is also well known but again this lipolytic action
requires at least 4 hours to become evident in sheep adipose tissue
(Duquette et a/., 1984). Interestingly, the administration of GH has been
shown to have acute insulin-like effects by significantly reducing blood
glucose levels in man (Frohman et at., 1967). Goodman (1968) has also
demonstrated increased glucose uptake and glucose oxidation in excised
adipose tissue after treatment with bovine GH. It has been suggested that
the acute effect of GH are to increase tissue permeability, thereby
increasing the rate of entry of glucose into the tissue (Merimee, 1979).
Recently, it was shown in the rat adipocyte that this insulin-like effect of
GH involves the stimulation of the Glutl and Glut4 glucose transporters by
their translocation to the plasma membrane (Tanner et a!., 1992). This
ability of GH to stimulate glucose uptake in cells may fulfil the unknown
acute role of GH in response to surgical trauma in the ewe. Further, Aoki
and co-workers (1974) have suggested that reparative tissue uses only
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glucose as a substrate. Therefore, during surgery, as tissue is traumatised,
the requirement for glucose by the cells may be enhanced, thus requiring
this insulin-like effect of GH to meet the increased glucose demand of the
traumatised cells.
Growth hormone may also be acting to stimulate local IGF-1 production to
increase glucose uptake into the traumatised cells (Jones and Clemmons,
1995). It has been shown that IGF-1 can also stimulate peripheral glucose
uptake without suppressing hepatic glucose production, in addition, IGF-1
has been demonstrated to have a positive effect on wound healing (Jones
and Clemmons, 1995).
/?-endorphin

Plasma /?-endorphin levels increased in both non-immune anaesthesia only
and

surgically treated groups in response to anaesthetic induction (Fig

6.7a). It appears from this study that this rise in circulating /7-endorphin
levels in the non-immune groups can be attributed to anaesthetic induction
and not to the surgical procedure, as there was no difference in either the
profile or the circulating levels of /7-endorphin between these two
treatments. Robertson and co-workers (1990) have reported elevated
plasma /?-endorphin levels during arthroscopic surgery in the horse with
maximum levels occurring 40 minutes after the onset of surgery. However,
of more interest to the present study was their observation that the rise in
plasma /7-endorphin levels began after the horses were sedated. An
increase in plasma /7-endorphin levels has been reported for sheep by Jones
(1990), however, unlike the present study and that of Robertson et a/.
(1990) there was no sequential rise in plasma /?-endorphin levels but an
immediate increase to maximum concentrations following the surgical
incision. This difference between the two studies is difficult to explain as
both the anaesthetic agent and the induction procedure were similar for the
tw o experiments.
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A similar pattern in plasma ^-endorphin levels was observed in two of the
three ACTH-immune ewes undergoing surgery, (ewes S12 and S15). The
third ewe (S14) had significantly elevated levels of /?-endorphins compared
to all other ewes regardless of treatment. This high level occurred from the
onset of the study. Neither anaesthesia or surgery had any effect on the
concentration of circulating ^-endorphins in this ewe with levels remaining
at or near the pre-anaesthetic induction level for the duration of the
experiment. This significantly higher level of plasma /?-endorphins for ewe
S14 was also associated with significantly lower cortisol levels compared
to the other ACTH-immune ewes. This higher level of ^-endorphin is
possibly caused by the immunological neutralisation of ACTH being more
effective

in this animal. Therefore,

little

negative feedback of the

glucocorticoids and ACTH on the expression of the precursor molecule, pro
opiomelanocortin was present resulting in hypersecretion of all the POMCderived peptides, including /7-endorphin.

The physiological role for the increased levels of plasma ^-endorphins
during anaesthesia and surgery is unclear, although its involvement in the
mediation of pain responses is worthy of consideration. In human patients
with intractable pain, endorphins acting via the opiate receptor act to
modulate this affliction Hosobuchi et at. (1977). However, we were not
able to determine the effect of pain on /7-endorphin release in the present
experiment, since the anaesthesia alone had a marked stimulatory effect on
circulating /?-endorphin levels. Certainly the surgery did not induce a further
incremental rise in circulating levels. Grossman (1988) has suggested that
the opioids may act to antagonise the stimulation of the HPA-axis by
counter-regulating excessive activity and the peripheral effects of CRH. This
suggestion, however, does not appear to be true for the sheep, because in
the current experiment cortisol levels increased significantly. Although,
suppression of the sympathomedullary system by the elevated /?-endorphin
levels cannot be discounted in the present work, as neither circulating
adrenaline nor noradrenaline levels increased during either anaesthesia or
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surgery. Of relevance to this study could be the finding that the acute
administration of opioids improves immune competence by increasing the
activity of NK (natural killer) lymphocytes (Morley et al., 1987). Tonneresen
and co-workers (1984) have shown an increase in NK cell activity during
abdominal surgery in both male and female patients. This rise in NK cell
activity occurred after pre-medication and continued during anaesthetic
induction and surgery, and thereafter, declining post-operatively. Although
plasma /?-endorphin levels were not measured in Tonneresen's experiment,
it would appear that the profile in NK cell activity observed in that report
resembles both the plasma /?-endorphin profile for the sheep in the current
experiment, and that for the horse as observed by Robertson et at. 1990.
However, further studies in the sheep would need to be undertaken to
determine if any association between NK cell activity and /?-endorphin levels
existed during anaesthesia and surgery.
6.7. Conclusions

This current experiment has delineated two distinct "stressors" that the
sheep experiences during surgery, those being anaesthetic stress and
surgical stress. As in man, anaesthetic stress exerts less influence on
endocrine function in the sheep than does the stress of surgical trauma.
This study has shown that in the sheep, the anaesthetic agent halothane
induced the release of the pituitary hormones ^-endorphin, GH and
presumably ACTH, because plasma cortisol levels also increased during
anaesthesia. More importantly, and unlike in man, anaesthetic induction
with halothane also modulates the release of insulin from the /?-cells of the
islets of Langerhans. This modified endocrine response to the anaesthetic
stress in turn alters the metabolic homeostasis of the sheep. A reduction in
circulating free fatty acid levels was demonstrated in the present study
indicating lipogenesis or preferential FFA oxidation. This may simply be due
to a rapid increase in the rate of utilisation of FFA's and a failure in the
lipolytic mechanism (i.e. no catecholamines) suggesting that glucose is the
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more important energy substrate during surgery.
The similarity in the endocrine and metabolic responses to both
anaesthetic induction and surgical trauma between man, a monogastric
animal, and the sheep, a ruminant animal, is of interest in itself. However,
one major difference between the two species does arise during surgery.
Unlike man, the sheep does not activate the release of catecholamines in
response to either anaesthetic stress or surgical stress and therefore relies
on the stimulation of the hypothalamic-pituitary-adrenal axis and the
subsequent release of the catabolic steroid cortisol to mobilise energy
substrates. This experiment demonstrates that in the sheep stimulation of
the hypothalamic-pituitary-adrenal axis and the resultant elevation in
cortisol levels during surgery acts to, suppress plasma insulin levels,
maintain plasma free fatty acid levels and to increase plasma glucose
concentrations. These metabolic and endocrine changes enable the ewe to
respond to stress, while the ewes immunised against ACTH 1-24 are not
capable of modulating these responses because of the failure to release
cortisol.
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Chapter 7

General Discussion

7.1 Synthesis

The results from the experiments described

in this thesis

have

demonstrated the physiological responses which occur when sheep are
exposed to an acute stress. Details are given of the changes which take
place

following

either

the

activation

and

integration

of

the

sympathomedullary axis and the HPA axis or following activation of only
one of these axes.
All three experiments show clearly that it is the very nature of the stressor
itself that dictates the way in which the two stress pathways respond. This
is certainly the case for the HPA axis. The independent responses of the
HPA axis to exercise or surgery as stressors is clearly demonstrated. These
two unrelated stressors elicited quite different responses from the HPA axis
and especially the expression of cortisol. Exercise resulted in a rapid
increase in peripheral cortisol levels, which was maintained for the duration
of the exercise and declined once the stressor had ceased. In contrast,
anaesthesia and surgery or anaesthesia alone produced both a greater and
more sustained increase in cortisol levels. In this experiment, cortisol
concentrations slowly increased in response to the stressor and remained
elevated after the stress was removed. These results suggest that there
could be a difference in the way in which individual stressors are received
and processed by the central nervous system. It appears from the nature of
the cortisol release that anaesthesia and surgery produces a more
pronounced release of CRF and AVP into the hypophysial-portal circulation
than does exercise. As exercise produces a rapid increase and decrease in
cortisol levels it is possible that one or more peripheral humoral factors are
augmenting CRF and AVP to stimulate ACTH release from the pituitary.
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One such peripheral humoral agent is adrenaline, and it should certainly be
considered in light of the fact that it is secreted from the adrenal medulla
during exercise. In addition, adrenaline has also been reported to act on
anterior pituitary a- and ^-adrenergic receptors to stimulate the release of
ACTH (Giguere et al., 1981). The results from this thesis also indicate that
of the two catecholamines studied, adrenaline (but not noradrenaline) may
function as a peripheral humoral agent. Support for this comes from the
results in chapter 5 which demonstrated that cortisol levels are not
influenced by tyramine HCI stimulated noradrenaline release.
The interrelationship between the two stress pathways which was first
proposed by Long (1952) and then by Axelrod and Reisine (1984) was also
demonstrated during exercise in chapter 4. It appears from these data that
the HPA-axis may be influenced by catecholaminergic input, specifically the
tonic regulation of cortisol. The cortisol basal level increased in response to
or-adrenergic

receptor

blockade

with

phentolamine

and

conversely

decreased slightly during ^-adrenergic receptor blockade with propranolol
HCI. Support for possible catecholaminergic regulation of cortisol secretion
comes from studies which have identified adrenergic receptors within
bovine adrenocortical cells (Kawamura et a!., 1984) as well as within the
rat anterior pituitary (Giguere et a!., 1981). It is possible therefore that
adrenergic receptors may also be present in the ovine pituitary and adrenal
cortex. Evidence of this interrelationship between the two stress axes may
be manifested when one axis is prevented from functioning as it was during
surgery in chapter 6
The major objective of this thesis was to determine the physiological role
of the sympathomedullary and the HPA axis in response to acute stress.
The fact that the type of stressor appears to affect the nature of the stress
response has made the task difficult. Consequently it is only possible to
comment on the effects of the two stressors studied, exercise and surgery.
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Exercise as a stressor, (chapter 4) produced the "classical" stress
response in which both the sympathomedullary and HPA axes are
stimulated.

From the

results,

I postulated

that

activation

of

the

sympathomedullary axis is the primary stress pathway which is initiated in
the sheep as a consequence of exercise. The catecholamines, released
during activation of this axis and stimulation of their associated receptors,
provides a potent combination which alters the physiological state of the
animal and prepares it for either "fight or flight". The stimulation of both
adrenaline and noradrenaline during exercise induced the rapid mobilisation
of FFA's, glucose and lactate from their storage sites while inhibiting insulin
release.
The capacity of the catecholamines and their ability to mediate metabolic
and haemodynamic changes in response to stress was more closely defined
in chapter 5 when only the sympathetic nervous system (SNS) was
stimulated without the confounding effects of either adrenaline and or
cortisol.

The

results

from

this

experiment

demonstrate

that

the

noradrenaline released in response to activation of this nervous system
facilitates plasma FFA release and stimulates blood glucose levels. More
importantly, this experiment also demonstrated that in the sheep the
inhibition of insulin secretion from the pancreatic /?-cells is not attributed to
noradrenaline released from the SNS, but instead presumably to circulating
adrenaline levels.
The role of the HPA axis during exercise and in particular that of cortisol
appears to be a secondary response which has a major affect on energy
substrate metabolism, in particular the lipolytic mechanism. One of the
interesting findings revealed from this experiment was the result that low
cortisol levels appear to constrain the animals lipolytic mechanisms
resulting in a reduced rate of lipolysis. A working hypothesis is that plasma
levels of cortisol regulate the lipolytic mechanism by influencing the status
of the /7-adrenergic receptor. Support for this comes from studies which
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have shown that the glucocorticoids can increase the number of /?adrenergic receptors in rat adipose tissue (Giudicelli et a/., 1989).
The influence that cortisol levels may have on lipolysis was also observed
during the infusion experiment in chapter 5. In this experiment it was found
that the treatment with propranolol HCI before tyramine failed to prevent
the tyramine-induced rise in plasma FFA levels in one of the four treated
ewes. This occurred even though all the ewes were given the same massspecific dose of propranolol HCI. The plasma FFA levels for this ewe were
significantly higher from the onset of the study when compared to the other
three ewes and as were her cortisol levels.

The similarity of the metabolic responses between species especially
between man, a monogastric animal, and sheep, a ruminant animal, were
clearly shown during exercise. Not only were the metabolic responses
similar but the adrenergic receptor type which the physiological response is
mediated was, on the whole, the same across a large range of species
including man. This consistency of this stress response between species
demonstrates the intimacy of the "evolutionary blueprint" of both stress
axes and their subsequent effects on physiological responses.
Surgical stress (chapter 6) demonstrates the synergistic nature of the two
stress pathways. One of the major findings from this work is that when the
sympathomedullary pathway is denied, as it is during surgery, the HPA axis
can facilitate catecholamine-like effects in which the metabolic status of the
sheep is altered to accommodate for the stressor. The increased cortisol
levels had profound effects on the mobilisation of FFA's and the elevation
in

blood

glucose

levels.

More

importantly,

this

experiment

also

demonstrated for the first time in the sheep, that cortisol per se can acutely
modulate insulin secretion. The key feature of this experiment however,
demonstrates again the interrelationship between the two stress axes by
the animals ability to switch from one pathway to another when one is
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denied. Thus, the capacity of the animal's homeostatic mechanism to
maintain internal order is maintained.

A problem which could be perceived from the studies described in this
thesis is the low number of animals which were used in all three
experiments. The low number of animals used for these experiments was
both a function of cost and logistics. However, even though there is a
biological variability, inherent in the use of small animal numbers, the
results have produced clearly defined trends. These defined trends would
surely result in statistically significant outcomes if a greater sample size
were used.

Future Research and Possible industry Application

The finding that low cortisol levels impinge on the animals lipolytic
mechanism and that this effect may be the result of an altered /?-adrenergic
receptor status needs to be clarified. It is possible that cortisol not only
influences lipolysis but may alter other physiological responses that are also
mediated by this receptor. The results from this thesis also suggest that
low cortisol levels may modulate glycogenolysis in the non-exercising
muscle. It could be that physiological levels of cortisol are required to
maintain "normal" ^-adrenergic receptor function and that by lowering
cortisol levels the affinity of the /?-adrenergic receptor to agonist coupling is
impaired. It is conceivable that cortisol levels may have a direct influence
on the status of all /?-adrenergic receptor sub-types. If this is so, then the
manipulation of the cortisol levels may influence the physiological response
of the stress axes. This could be especially pertinent to the animal meat
production industries where problems such as dark cutting meat and
ecchymosis (blood splash) are a result of acute stress and as a result have
a deleterious effect on meat quality.
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